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Ontogeny of t i s s u e s p e c i f i c p r o t e i n markers p r o v i d e s 
use fu l expe r imen ta l model fo r i n v e s t i g a t i n g r e g u l a t i o n of 
gene exp re s s ion d u r i n g d i f f e r e n t i a t i o n . Alpha f e t o p r o t e i n 
and albumin a r e impor tan t s p e c i f i c d i f f e r e n t i a t i o n markers 
and they bea r a r ec ipQfca l r e l a t i o n s h i p du r ing ontogeny. 
The fo l lowing l i n e s summarize t h e r e s u l t s ob ta ined 
r e g a r d i n g ontogeny of APP and albumin i n d i f f e r e n t t i s s u e s 
of r a t a s we l l a s developmental p r o f i l e of APP i n human 
b r a i n . 
AN IMPROVED PROCEDURE FOR ISOLATION OF AFP 
A d i r e c t n e g a t i v e immunoabso l o t i o n procedure was 
developed t o i s o l a t e homogeneous p r e p a r a t i o n of r a t and 
human AFP from amnio t i c f l u i d . I t r e q u i r e s no more t h a n 
two s t e p s : (a ) removal of a d u l t serum p r o t e i n s p r e s e n t i n 
amnio t i c f l u i d by a d i r e c t n e g a t i v e immunoabsorption 
( immunoprec ip i t a t ion ) with r a b b i t a n t i - n o r m a l a d u l t r a t 
or human serum IgG, and (b) removal of excess of immuno-
g l o b u l i n s u s i n g DEAE-cellulose chromatography. P u r i f i e d 
ikPP was c h a r a c t e r i z e d by double immunodiffusion, Immuno-
e l e c t r o p h o r e s i s , c rossed immunoe lec t rophores i s , PAGE, 
SDS-PAGrE, Con-A a f f i n i t y chromatography, and e s t r a d i o l 
b i n d i n g . Rat AFP has Ka = 1.4 x 10® M""-^  fo r e s t r a d i o l - 1 7 p 
wi th one b ind ing s i t e for e s t r a d i o l per mole of AFP. 
I s o l a t i o n of homogeneous AFP by a d i r e c t n e g a t i v e 
immunoabsorption i s a s i g n i f i c a n t improvement over t h e time 
consuming, m u l t i s t e p p rocedures r e p o r t e d f o r AFP. In 
d 
a d d i t i o n , t h e p r e s e n t p rocedu re d id not r e q u i r e s p e c i f i c 
an t i se rum a g a i n s t AFP and employed ve ry g e n t l e i s o l a t i n g 
c o n d i t i o n s . The p rocedure y i e l d e d 87/° recovery of AFP. 
ONTOGENY XiUD DISTRIBUTION OF / J P IN FETQ-NEONATAL TISFUES 
OF RiiT AND HUMAN FETAL BRAIN 
Most of t he f e t o - n e o n a t a l t i s s u e s , excep t thymus, 
sp leen and pance^as , of r a t were found to c o n t a i n e l e v a t e d 
l e v e l s of AFP, H i ^ l e v e l s of AFP observed d u r i n g f e t a l 
l i f e i n v a r i o u s t i s s u e s r e g i s t e r e d a d e c l i n e wi th 
development . Ontogeny of AFP i n t h e s e t i s s u e s was 
d i f f e r e n t from t h a t observed i n serum. AFP d i s a p p e a r s 
a f t e r 7 d of p o s t n a t a l l i f e (p) i n b r a i n and a d r e n a l s ; 
14 P i n l u n g , h e a r t , s tomach, i n t e s t i n a l and k idneyj 21 P 
i n l i v e r and s k i n . De te rmina t ion of heme c o n c e n t r a t i o n i n 
t h e s e t i s s u e e x t r a c t r e v e a l e d t h a t con tamina t ion of AFP 
from f e t a l blood could no t account fo r more than 5-10;^- of 
t h e observed l e v e l s of AFP i n v a r i o u s f e t o - n e o n a t a l 
t i s s u e s of r a t , 
AFp p r e s e n t in v a r i o u s f e t o - n e o n a t a l t i s s u e s of r a t 
was immunological ly i d e n t i c a l t o serum AFP. AFP from 
serum, b r a i n , sk in and k idney a l s o d i s p l a y e d a s i m i l a r 
e l e c t r o p h o r o t i c m o b i l i t y on lO/o PAGE and lEP. E s t r a d i o l 
b i n d i n g as say of AFp i n b r a i n and sk in gave an a s s o c i a t i o n 
c o n s t a n t , Ka = 1.3 x 10 M and 1.0 x 10 M . However, 
b r a i n and s k i n c y t o s o l s from newborn r a t were found t o 
di f fe r in the r e l a t i v e amounts of Con A-non r eac t ive AFP 
var ian t and contained 375^  and 425^  of t h i s va r i an t 
r e s p e c t i v e l y . In view of these observations i t appears 
t h a t AFP in various fe to-neona ta l t i s s u e s of r a t does not 
e n t i r e l y represent f e t a l blood contamination and probably 
a r i s e s as a r e s u l t of i t s independent synthesis in each 
t i s s u e . 
Studies on the d i s t r i b u t i o n of AFP in fe to-neonatal 
r a t brain have revealed t h a t i t i s d i s t r i b u t e d uniformally 
throughout the b ra in . Ontogeny of AFP in ol factory region, 
cerebrurm, cerebellum and r e s t port ions of the r a t brain 
was s imi lar to t ha t in whole brain and i t disappeared in 
these d i s c r e t e regions a f t e r 7 d of pos tna ta l development. 
Presence of AFP was also demonstrated in human f e t a l 
b r a i n . I t was immunologically and e l ec t rophore t i ca l l y 
i d e n t i c a l t o human f e t a l serum AFP. Developmental p ro f i l e 
of AFP in human brain was d i s t i n c t from tha t observed in 
serum compartment. I t r e g i s t e r e d a peak l e v e l in brain a t 
20th week and declined rap id ly to low l eve l s a f t e r 24th week 
of ges t a t ion . I t was absent (as measured by rocket assay) 
in the human f e t a l bra in of subsequent ages . Unlike rodent 
AFP and l i k e human AFP, i t did not i n t e r a c t with 
e s t r a d i o l . Brain AFP does not a r i s e from f e t a l blood 
contamination since the blood contamination could account 
for t r a c e s of the AFP present in b r a i n . Fur ther ontogeny 
or AFP in brain i s d i s t i n c t from tha t obseipved i n serum. 
DEVELOPMENTAL CH/iNGBS IN /iPP /JJD ALBUMIN GONTMT IN 
SERUM OF R/iT 
D e v e l o p m e n t a l p r o f i l e o f serum AFP e x h i b i t e d a n 
i n v e r s e r e l a t i o n s h i p w i t h a g e d u r i n g p o s t n a t a l l i f e of r a t 
Serum AFP l e v e l d e c l i n e d a f t e r b i r t h t o 2 . 4 ^ o f t h e l e v e l 
o b s e r v e d i n newborn r a t , a t 2 1 s t day of p o s t n a t a l l i f e , 
AFP cou ld n o t be d e t e c t e d i n s e r a of 28 d o l d r a t s by t h e 
p r e s e n t p r o c e d u r e . In c o n t r a s t serum a l b u m i n e l i c i t e d an 
i n c r e a s e by J?/" d u r i n g t h e same p e r i o d . The a l b u m i n l e v e l 
r o s e i n serum c o n t i n u o u s l y t o a d u l t v a l u e of 3 7 , 5 mg ml 
i n 9 weeks o l d r a t , 
SYNTHESIS AND SEnPETION OF AFP MT) ALBUMIN BY ISOLATED 
HEPATOCYTES IN CULTURE: CORBELATION OF SERUM AFP MD 
ALBUMIN PROFILES l ^ H THE LIVER CONTENT AND THEIR RiiTE 
OF SYNTHESIS IN THE HEPATOCYTES DURING DEVELOPMENT 
AFP and a l b u m i n a r e s y n t h e s i z e d i n t h e h e p a t o c y t e 
and s e c r e t e d i n t o t h e s e r u m . Serum l e v e l of t h e s e p r o t e i n s 
u n d e r g o e s s t r i k i n g change d u r i n g f e t o n e o n a t a l d e v e l o p m e n t . 
H e p a t o c y t e s p r e p a r e d from r a t l i v e r a t v a r i o u s s t a g e s 
of deve lopmen t ( 1 8 , 20 E and 1 , 7 , 1 4 , 2 1 , 2 8 , 35 P and 
a d u l t ) by c o l l e a g e n a s e d i g e s t i o n p r o c e d u r e were m a i n t a i n e d 
i n s h o r t t e r m ( 2 4 h r s ) c u l t u r e . R a t e of s y n t h e s i s and 
s e c r e t i o n of AFP aad a l b u m i n were d e t e r m i n e d by f o l l o w i n g 
t h e i n c o r p o r a t i o n of [ C ] - l e u o i n e i n t o i m m u n o p r e c i p i t a b l o 
AFP and a l b u m i n by t h e h e p a t o c y t e s c u l t u r e d i n l e u c i n e - f r e e 
medium, H e p a t o c y t e s from newborn r a t s y n t h e s i z e d AFP a t a 
J 
very high r a t e accounting for ahout 85'/° of the t o t a l 
prote in synthesis while albumin synthesis was only 9^, 
Rate of APP synthesis and secre t ion declined with the 
maturation of the hepatocytes , Hepatocytes from 21 d old 
r a t demonstrated only jfo of the r a t e observed in f e t a l 
hepatocyte from 18 E r a t . No synthesis of APP could be 
demonstrated in the hepatocytes prepared from 4 week old 
r a t s . Serum APP l eve l and i t s content in l i v e r a lso 
reduced t o 1,3/0 and 4^ respec t ive ly in 3 week old r a t when 
compared to the values observed in 18 E f e t a l r a t s . I t 
appears t h a t age r e l a t ed change in serum APP leve l and i t s 
content in l i v e r i s governed by the r a t e of APP synthesis 
and secre t ion by the developing hepatocytes . 
Maturation of the hepatocyte was accompanied by a 
marked increase in the r a t e of albumin syn thes i s , secre t ion 
and i t s i n t r a c e l l u l a r conten t . Ratios of the r a t e s of 
albumin t o AFP synthesis in the hepatocytes from 18 B fe tus 
and 1, 7, 14, 21, 28 d old neonatal r a t s were 0.05, 0,10, 
0 .28, 3.5 and 48 r e spec t i ve ly . I t would thus appear t h a t 
an increase in serum albumin l eve l and i t s i n t r ahepa t i c 
content i s due to a propor t ionate increase in the r a t e of 
albumin synthesis and sec re t ion in the developing r a t 
l i v e r . 
I t may be concluded t h a t d i f f e r en t i a t i on and maturation 
of the hepatocyte i s accompanied by a sequent ia l i n a c t i v a t i o n 
of APP and ac t iva t ion of albumin gQXiQ expression. 
o 
DEMQMSTR/.TION OF AFP MP ALBUMIN F1YNTHE3IS IS DEVELOPING 
RAT BRAIN MD SKIN; CORRELATION OF TTFiHUE CONTENT OF AFP 
MT> ALBUMIN WITH THEIR R/.TE OF SYNTHESIS 
D i s s o c i a t e d mammalian b r a i n c e l l s and sk in e x p l a n t s 
i n primary c u l t u r e s o f f e r s a u s e f u l system t o i n v e s t i g a t e 
t h e b iochemical e v e n t s accompanying d i f f e r e n t i s m and growth 
of t h e s e t i s s u e s . D i s s o c i a t e d b ra in c e l l s and sk in exp lan t 
c u l t u r e s from newborn r a t were used t o answer the fo l lowing 
q u e s t i o n s : I s e s t r a d i o l b i n d i n g p r o t e i n i n deve lop ing r a t 
b r a i n and sk in AFP ? I f s o , where does t h i s p r o t e i n 
o r i g i n a t e from ? 
Our o b s e r v a t i o n s , d e r i v e d from f C*]-leucine 
i n c o r p o r a t i o n i n t o immunoprec ip i tab le AFP and albumin by 
d i s s o c i a t e d b r a i n c e l l s and sk in exp lan t ma in ta ined i n sho r t 
term c u l t u r e s , have p rov ided evidence fo r the ^ n t h e s i s of 
AFP and albumin i n b r a i n and sk in of newborn r a t , 
r l 4 -, 
Cycloheximide inhibited the linear incorporation of [ Cj-
leucine into immunoprecipitable AFP and albumin as a 
function of time by these cultures. It strongly suggests 
that [ C]-labelled ilFP and albumin observed in brain colls 
and skin lysates (synthesis) coid in medium (secretion) are 
constantly synthesized and secreted by these cultures. In 
addition, the intracellular content of both AFP and albumin 
in brain cells did not change significantly during the vrholo 
culture period. Moreover, those cells elicited a linear 
accumulation (secretion) of the quantitable amounts of 
AFP and albumin into the medium. Total amounts of AFP and 
albumin secreted by brain cells were far in excess of their 
intracellular content at the initiation of the cultures. In 
view of these observations it was concluded that developing 
brain and skin represent an independent pool of APP and 
albumin. 
AFP and albumin secreted by newborn rat brain cells 
and skin explants cultures was immunologically, electro-
phoretically and with regards to molecular weights and 
estradiol binding properties similar to serum AFP and 
albumin. It may be concluded that genes for /iFP and albumin 
in developing brain and for AFP in skin are also oxproosed 
these tissues. 
Rates of sjmthesis of AFP and albumin during feto~ 
neonatal development of rat brain showed a continuous 
decline and their synthesis seems to bo turned off after 7 d 
of postnatal life. High levels of these protein in fetal 
brain were due to their high rates of ^nthosis. Age 
related decrease in brain AFP and albumin reflected a 
proportionate decrease in the rates at which they are 
synthesized in this tissue. 
Rate of ^nthesis of AFP in skin also decreased with 
increasing a.ge cuid its synthesis is turned off after 14 d of 
postnatal life. A decrease in the skin AFP level can be 
accounted for by corresponding decline in the rate of its 
9 
HORMONAL CONTROL OF AF^ /xND ALBUMIN SYJ^TKESIS PT NEWBORN 
RAT IJYW, PRAH^ m^ g|CiN 
Effect of various hormones on the rate of AFP and 
albumin synthesis in the hepatocytes, brain cells and skin 
explant from newborn rats, was studied to gain some insight 
into ontogeny related regulation of synthesis of these 
proteins in rat tissues, 
Dexamethasone was the most effective in inhibiting the 
rate of iiFP synthesis and secretion in vitro cultures of 
hepatocytes (-45f°)» brain cells (-40%) and skin explant 
(-25/0* It also caused an accelerated decrease in serum AFP 
level in vivo in newborn rats. dbcAMP also decreased the 
rate of synthesis and secretion of AFP in brain cells (~15^ )» 
hepatocytes (-7/0 and skin explants (-4^). It also 
suppressed the serum AFP level in vivo in newborn rats 
supporting its in vitro effect. 
Insulin exhibited a dual effect on the rate of AFP 
synthesis in various tissues. It increased AFP synthesis in 
hepatocytes (+21'^ ) and demonstrated an opposite effect in 
brain cell (-155^ °) and skin explant (-4/0). However, it did 
not affect serum AFP levels of newborn rats in. vivo. 
Neither did estradiol significantly affect the rate of 
AFP synthesis in various tissues in vitro nor did it change 
serum AFP level in vivo. The effects of dexamethasone, 
dbcAMP, insulin and estradiol on the rate of albumin 
JLO 
synthesis in vitro or its level in vivo wore not significant. 
It appears that effects of those hormones are specific for 
APP synthesis. 
It appears that expression of APP gene is a function 
of undifferentiated or less differentiated stem cells or 
embryonal cells. Different embryonal cell types with diverse 
ontogenic history do indeed synthesize AFT although the 
extent of synthesis is different. Thus expression of i\PP 
and albumin genes during development offer a usefUl model 
for investigating molecular mechanism underlying tissue 
differentiation. 
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Cell differentiation during development is an 
expression of orderly and sequential gene regulation. 
Accumulation or loss of gene products, e.g. structuiral 
and functional proteins, prepares the tissue for the next 
stage of development resulting in well observed functional 
differentiation. Sometimes re-expression of certain fetal 
antigens during oncogenesis has proved invaluable in 
diagnosis of malignancy. Alpha-fetoprotein (AFP) is an 
important serum glycoprotein of this category. It is 
synthesized by the cells derived from endoderm - like yolk 
sac and liver, early in fetal development. AFP and albumin 
are good differentiation markers. They bear a reciprocal 
relationship during ontogeny. Probably this reason has 
prompted some investigators interested in its function to 
call it as 'fetal albumin'. 
Ontogeny of AFP and albumin were investigated in 
different ti ssues of rat and human brain and the following 
leads were obtained. 
1. A simple method based upon immunoabsorption of 
proteins other than AFP from amniotic fluid followed by 
DEAE-cellulose chromatography was developed for the isolat-
ion of rat and human alpha fetoprotein. This procedure 
gives high yield of AF? (87/0 and may also find applications 
11. 
in the isolation of other phase specific antigens like 
carcino-embryonic antigen and uteroglobin, 
2. Distinct ontogeny of APP in human fetal brain, and 
feto-neonatal rat brain suggests that these tissues may form 
independent pools of AFP probably contributed by its in 
situ synthesis, 
3, Cells and tissue explants from developing rat brain 
and skin have been found to synthesize and secrete estroph-
ilic AFP in culture. AFP secreted by these tissues is 
immunologically, electrophoretically and -with regards to 
molecular weight and estradiol binding similar to serum AFP. 
Brain cells from developing rat also synthesise albumin, 
4, Age related decline in brain and skin AFP levels 
reflects a proportionate decrease in the rate of synthesis of 
the protein. Synthesis of AFP is turned off after 7,14 and 
21 d of postnatal life in brain, skin and liver of rat. 
5. Dexamethasone and dboAMP are negative regulators of 
AFP synthesis in different tissues with differing sensitivity. 
From the foregoing it appears that expression of AFP 
and albumin genes is a useful tool for understanding tissue 
differentiation. Although final proof is still awaited, it 
appears that undifferentiated cells do express AFP gene. It 
would be of interest to quantitate mRNA.^p levels in different 
tissues during development. Further, demonstration of factors 
that control the switch off of AFP gene during development and 
switch on during hepatic injury or carcinogenesis may provide 
some clue to mechanism of tissue differentiation as well as 
malignancy. 
i i i , 
ABBREVIATIONS & SYMBOLS 
A 
Ab 
AGTH 
AF 
BSA 
cDNA 
Con A 
CP 
cpm 
CM 
CMS 
dbciiHP 
DEiiE-
dpia 
3 • - D ; I B 
DEI^  
B 
\ 
\ 
EDTA 
FE 
ES 
HAPP 
HEPES 
A d u l t 
A n t i b o d y 
A d r e n o c o r t i c o t r o p h i c hormone 
A l p h a - f e t o p r o t e i n 
A m n i o t i c f l u i d 
B o v i n e scrum a l b u m i n 
Complementary DNA 
C o n c a n a v a l i n A 
C e l l p r o t e i n 
C o u n t s pe r m i n u t e 
C o n c e n t r a t e d c u l t u r e medium ( b r a i n ) 
C o n c e n t r a t e d c u l t u r e medium ( s k i n ) 
N , 0 , d i b u t y r y l c y c l i c 3 ' , 5 ' - m o n o p h o s p h a t e 
D i e t h y l a o i n o e t h y l 
D i s i n t e g r a t i o n p e r m i n u t e 
3 • - m e t h y l - d i a m i n o a z o b e n z e n e 
Di e t h y l n i t r o s a m i n e 
Day of embryon ic o r f e t a l l i f e 
E s t r o n e 
E s t r a d i o l 1 7 - f 
E t h y l e n e d i a m i n e t o t r a a c e t i c a c i d 
F e t a l e x t r a c t 
F e t a l serum 
Human AFP 
N - 2 - h y d r o x y e t h y l - p i p e r a z i n o - N • - 2 - e t h a n e s u l p h o n i c 
a c i d 
I V . 
HSXi. Hunan serum a l b u n i n 
IgG Immunoglobulin G 
lEP Immunoelec t rophores is 
LGA Jjena c u l i n a r i s a g g l u t i n i n 
mRNA_^ p^ Messenger UNA fo r AFP 
mRNA Tu . Messenger RNA f o r albumin 
albumin ° 
NRS Normal r a t serum 
NHS Normal human serum 
P Day of p o s t n a t a l l i f e 
PAGE Polyacry lamide ge l e l e c t r o p h o r e s i s 
PBS Phosphate bu f fe red s a l i n e 
PHC Primary h e p a t o c e l l u l a r cancer 
PPO 2 ,5 -d ipheny l oxazole 
POPOP 1 , 4 - b i s - ( 5 - p h e n y l o x a z o l y l ) b e n z e n e 
PRS Pregnant r a t serum 
RCA Ric inus compiuni^ a g g l u t i n i n 
RER Rough endoplasmic r e t i c u l u m 
RNA Ribonuc le ic a c i d 
RSA Rat serum albumin 
SDS Sodium dodecyl s u l p h a t e 
SER Smooth endoplasmic r e t i c u l u m 
TGA T r i c h l o r o a c e t i c acid 
TP T o t a l p r o t e i n s 
T r i s (Hydroxyme thy l ) -a ra inon e thane 
I N T R O D U C T I O N 
Fetus specific serum protein was first discovered by 
Pederson (1944) in fetal calf serum and by Borgstrafid 
and Czar (1956) in human fetal serum. The protein migrated 
between albumin and a-globulin on paper electrophoresis and 
was called alpha-fetoprotein (AFp), Similar fetal proteins 
have since been demonstrated in all mammals studied so far 
(Gitlin and Boesman, 1967; Gitlin, 1975). However, the 
findings of Abelev et al (1963) brought AFP into lime 
light by demonstrating the presence of fetus specific 
alpha-globulin in the serum of adult mice with chemically 
induced primary and transplantable hepatocellular cancer. 
Shortly afterwards Tatarinov (1964) demonstrated the 
presence of AFp in the serum of human with primary hepato-
cellular cancer (PHC). This heralded exciting prospects 
for AFP as an immunochemical marker which could be used 
both in clinical diagnosis of this tumor and in epidemiolo-
gical surveys. Naturally this has determined the main 
direction of subsequent studies. However, relatively 
little is known about the dynamics of the protein during 
the course of the disease, and even less about the reason 
for the resumption of its synthesis by the tumor, and 
finally its physiological role in the normal and abnormal 
conditions. 
c 
Serum albumin i s the most abundant and the most studied 
of the p ro te ins in c i r c u l a t i o n . One of the f i r s t p ro te in 
to be recognized, i t s name der ives from the ear ly name for 
p r o t e i n s , albumen, derived from l a t i n word albus-white in 
the case of white of an egg. The bas ic p roper t i e s of 
albumin were recognized as ear ly as 1837 by Ancel l , who 
noted tha t albumin was needed for t r anspor t funct ions , fo r 
maintaining the f lu id i ty of the vascular system and for the 
prevention of oedema. Serum albumin i s a highly f l e x i b l e , 
s ingle polypeptide chain of about 65OOO molecular w e i ^ t 
containing 583 amino a c i d s . Albumin molecule i s grouped 
i n to a s e r i e s of nine dilsulphide-bonded loops a s soc i a t i ng 
in to three small domains which may be spec i f i c in l igand 
binding (Pe te r s , 1977; Brown, 1977; Zahringer et a l , 1977). 
Albumin i s charac ter ize by i t s extreme s o l u b i l i t y in 
water , negative charge of 10 a t pH 7.4 , and lack of a 
caxbohydrate moiety. Albumin (human and bovine) appears 
t o be the longest peptide chain Trdiose complete amino acid 
sequence has been determined (Brown, 1977). Known functions 
a t t r i b u t e d to albumin include the binding and t ranspor t of 
long chain f a t t y acids and an ions ; the binding and 
de tox i f i ca t ion of unconjugated b i l i r u b i n , the t ranspor t of 
metal ions , amino ac id s , me tabo l i t e s , enzymes, drugs, 
hormones, a depot for a constant supply of amino a c i d s , and 
maintenance of co l lo ida l osmotic pressure (Mullar and 
Wollert , 1979; Lehane et a l , 1978; P e t e r s , 1977). 
ONTOGENY ANp SITE OF SYNTHESIS OF AFP AND ALBUMIN 
The primary sites of AFP synthesis in the developing 
embryo are the yolk sac and liver (Mackiewicz and 
Breborowicz, 1980; Breborowicz and Nishi, 1979; Gitlin, 
1975; Gitlin et al, 1972). Small amount of AFP synthesis 
has also been demonstrated in the placenta, kidney 
gastro-intestinal tract (Mackiewicz and Breborowicz, 1980; 
Ruoslahti and Seppala, 1979; Gitlin, 1975) and immature 
rat uterus (Smalley and Sarcione, 1978), There is no 
evidence for the synthesis of AFP by other fetal tissues 
(Gitlin, 1975). In humans, AFP is first synthesized by the 
yolk sac and liver and then predominantly by the liver as 
yolk sac becomes involuted during the first week of 
2nd trimester. 
Feto-neonatal estradiol binding protein has been 
demonstrated to be AFP (Attardi and Ruoslahti, 1976; 
Plapinger et al, 1975)• Estradiol binding protein have 
also been found in immature rat skin cytosol but the 
identity of AFP has not been reported (Eppenburger and 
Hsia, 1972). The origin of E binding protein in brain and 
skin is yet to be clarified. 
The same pattern of AFP synthesis has been observed 
in other species with some variation. In the mouse, rat, 
chicken (Gitlin and Gitlin, 1975; Sell and Skelly, 1976) 
and in rabbit (Branch and Wild, 1972) synthesis by the 
i^ 
yolk sac continues after birth. In chicken , AFP 
synthesis takes place almost exclusively in the yolk sac 
and only small amounts are produced by liver (Gitlin, 
1975; Gitlin et al, 1973). All mammalian species so far 
studied, including subhuman primates, carnivores, rodents, 
lagamorphs, ruminants, edentates, and marsupials 
synthesize one or more homologoues of AFp during develop-
ment (Gitlin, 1975). Thus, an AFS homology may exist as 
far back in evolution as 400 million years. 
Albumin is produced in the liver, and no other site 
for its production has been demonstrated (Peters, 1977j 
Rothschild et al, 1977). Albumin may comprise 50/o of tho 
total protein synthesis in adult liver and about 14 g of 
albumin is synthesized daily by the human liver (Peters, 
1977). Synthesis of both AFP and albumin in the human 
embryo can be detected as early as 29 days after 
conception (Rothschild et al, 1977; Gitlin et al, 1972) 
when liver is little more than a diverticulum of hepatic 
buds and ducts, and there is only slight, if any, evidence 
of lobe formation. During subsequent development, the 
synthesis of other plasma proteins becomes apparent. Thus, 
early morphologic differentiation of the liver is 
accompanied by the development of hepatic plasma protein 
synthesis. 
The actual site of AFP (Bolanger et al, 1979a; 
Kuhlman, 1979; Gitlin, 1975) and albumin (Belanger et al. 
1979a; Peters, 1977) synthesis is the hepatocytes; 
kupffer cells, bile duct epithelium and hepatic haematopo-
ietic tissues or other cells which make upto 40/^  of the 
liver cell population, are not involved. Monolayer fetal 
hepatocytes cultures are AFP and albumin producers 
(Brazier et al, 1977; Tsukada and Hirai, 1975; Sell and 
Skelly, 1975; Leffert and Sell, 1974). 
Albumin and AFF have been demonstrated to be 
synthesized in the same hepatocyte and that hepatocyte can 
also differentiate into either AFP or albumin producing 
ones (G-uillouzo et al, 1978; Nayak and Mittal, 1977). 
During early embryonic life the serum concentration of AFP 
and albumin shows a reciprocal relationship. AFP is the 
major serum protein early in fetal development, whereas in 
the adult albumin is the major serum protein, and AFP is 
barely detectable (Abelev, 1971). Upto SOfo of the 
hepatocytes in fetal liver have been found to synthesize 
AFP (Abelev, 1979). During postnatal development, the 
number of albumin producing cells increases while AFP 
positive cells show a continuous decline (Kuhlman, 1979; 
Nayak and Mittal, 1977). After two weeks of postnatal 
life a tremendous decrease in AFP positive cells in the 
liver occurs corresponding to a rapid maturation of hepato-
cytes and after 4 weeks AFP containing cells could no 
longer bo detected (Kuhlman, 1979; Nayak and Mittal, 1977)» 
It appears that as the maturation of hepatocytes occurs, 
u 
the hepatocytes switches from APP to albumin producing one. 
The regulation of APP and albumin siynthesis is directly 
governed by the amount of mRNA. The albumin mENA levels 
increase while APP mRNA levels in the liver decline during 
postnatal development (Liao et al, 1980; Hoffer et al, 
1979; Salatrepat et al, 1979; Sell et al, 1979; Koga and 
Tamaoki, 1974). In the adult hepatocytes, no AFP producing 
cell could be observed (Kuhlman, 1979; Nayak and Mittal, 
1977). The presence of small amounts of APP in normal 
human sera (Ruoslahti and Seppala, 1971b) and adult sera 
of other species, suggests that AFP gene is not completely 
turned off and AFP may be produced by many cells and not 
by a specialised population cells (Ruoslahti and Seppala, 
1979). 
In normal adult rat liver only 10?^  hepatocytes 
produce albumin at any given moment and this seems to arise 
primarily from the cyclic activity of the hepatocytes 
rather than any specialised hepatocyte being albumin 
producer (Maurice et al, 1979; Guillouzo et al, 1976). The 
synthesis and secretion of AFP by fetal rat hepatocytes 
iJL yityo is related to alterations in the state of its 
grojfrth while albumin synthesis is probably independent of 
growth cQTcle (Sell et al, 1975). AFP appears to be 
synthesized before S phase and secreted just prior to 
mitosis (Sell et al, 1975) and no synthesis occurs during 
SI, & or M phases of the cell cycle (Guillouzo et al, 1979, 
1978). Albumin is synthesized from the middle period of S 
phase to early G phase or to late G phase (Tsukada and 
Hirai, 1975). Thus, albumin synthesis occurs at a later 
stage of the cell cycle and last for a much shorter period 
of time than AFP synthesis. 
INTRACELLULAR TRANSPORT OF ALBUMIN ANT) AFP 
Studies on biosynthesis of albumin have shown that it 
is synthesized on membrane bound polysomes (Garland and 
Cori, 1981J Peters and Reed, 1980j Peters, 1977? 
Zahringer et al, 1977; Yap et al, 1977). Following its 
synthesis, albumin (or its precursor) is passed successively 
into the channel of rough endoplasmic reticulum (RER), 
smooth endoplasmic reticulum (SER), and golgi apparatus 
(GA), and finally out of the coll (Peters and Reed, 1980; 
Peters, 1977j Edwards et al, 1976). Intracellular albumin 
has been found to exist in two forms-mature serum albumin 
and its precursor (prealbumin)• The prealbumin possesses 
an additional hexapeptide at the NH -terminus with a sequence 
of NH -Arg-Gly-Val-Phe-Arg-Arg-serum albumin (Peters and 
Reed, 1980; Strauss et al, 1977; Edwards et al, 1976). The 
proalbumin is cleaved to albumin by an intracellular 
membrane bound cathepsin B typo enzyme and the process takes 
place in the golgi vesicles (Algranti and Sabatini, 1979; 
Judah and Quinn, 1978; Redman ct al, 1978; Oda et al, 1978\ 
C) 
The golgi vesicles, filled with the secretory proteins, then 
fuse in a controlled manner forming secretory vesicles, 
which in turn is able to recognize and fuse with the plasma 
membrane to allow exocytosis of the proteins. The 
prealbumin and albumin do not differ in binding properties 
to bilirubin and palmitate (Peters and Reed, 1980). The 
role of the pro-form is not clear. It may serve in. vivo,, 
as the cationic propeptide to channel the nascent albumin 
through the liver cell in lieu of the glycosyl groups which 
become attached to most secreted proteins (Peters and 
Reed, 1980). 
The product of translation of mRNAs for albumin and 
other secretory proteins are larger than either the intra-
cellular form or serum form of albumin. These initial 
translation products are called preproteins and contain an 
extension (prepiece) of 15-29 amino acid residues (24 and 
20 amino acid for albumin and AFP respectively) at the NHp-
terminus, popularly known as 'signal peptide' or 'signal 
sequence' or'leader sequence' (Steiner et al, 1979; 
Strauss ot al, 1977; Blobel and Dobberstein, 1975). The 
signal peptide contains a high percentage of hydrophobic 
amino acids and helps in the binding of nascent polypeptide 
chain to RBR membrane bilayer and transports the protein 
across the membrane. The signal peptide is probably 
removed before the entire secretory protein has been 
9 
synthesized by a RER membrane bound endopeptidase cleaving 
at a ser-Arg peptide bond yielding proform - the proalbumin 
(Habener et al, 1979; Dobberstein and Blobel, 1979; Strauss 
et al, 1978; Shields and Blobel, 1978; Blobel and 
Dobberstein, 1975). 'The preform of albumin and the signal 
peptide are discharged together into the cistemae of RER, 
and apparently destroyed. 
Essentially the same secretory pathway has also been 
recognized for APP (Peters et al, 1979; Miura et al, 1979; 
Belanger et al, 1979a; Guillouzo et al, 1978). However, AFP 
is glycosylated as the peptide chain passess through the 
channels of ER and GA (Belanger et al, 1979a). AFP is 
released from membrane bound ribosomes in a nonglycosylated 
form. It becomes glycosylated as it moves into RER, where 
it receives, at least part of the core structure (N-Acetyl-
galactosamine and mannose) of its oligosaccharide Unit(s). 
When the growing peptide enters the G-A, it receives a 
variable number of peripheral carbohydrate residues 
(galactose and sialic acid) and apparently achieves a terminal 
lectin reactivity and microheterogeneity. The entire process 
is completed within I5 minutes (Belanger et al, 1979a). 
PHYSIOLOGICAL PROFILES OF AFP IN BODY FLUIDS 
FETAL SERUM - During human gestation, the highest AFP 
concentration (1-5 mg/ml) in fetal serum occurs at 12-14 weeks 
of gestation duo to the high rate of AFP synthesis in the 
JLJ 
liver (Seppala, 1977; Gitlin, 1975). After 14th week AFP 
level declines attaining very low level (I3-86 |ag/inl) at 
birth. This fall in APP content probably reflects a large 
increase in volume of the blood and fetal growth rather than 
to a decrease in rate of AFP synthesis in liver. After 32 
weeks the liver production of AFP declines sharply resulting 
in low level of serum AFP (Seppala, 1977; Gitlin, 1975). 
In rat, the fetal serum AFP concentration at birth is 
in excess of 5000 \ig ml" which remains high ( 1000 |ag ml ) 
for about 4 weeks when there is abrupt decline to adult level 
(Stillman and Sell, 1979; Sell ct al, 1974). This is about 
the time when liver proliferation ceases, and weaning and 
gluconeogenesis begin (Sell et al, 1975; Leffert and Sell, 
1974). 
AMNIOTIC FLUID 
In human amniotic fluid, the AFP concentration is 
100-300 times smaller than in fetal serum, but the decreasing 
slope with advancing gestation parallels that of fetal scrum 
AFP profile (Seppala, 1977). It is assumed that AFP enters 
amniotic fluid via fetal urine (Seppala and Ruoslahti, 1972b) 
but skin, amnion, chorion, umblical cord, gastrointestinal 
tract, buccal and bronchial secretions may also contribute 
(Seller and Berry, 1978; Sutcliffo, 1975). 
MA.TERNAL SERUM 
During human pregnancy, peak level of AFP (150-250 ng 
ml in maternal serum are obtained at 32 weeks of gestation. 
At birth, the maternal APP level is 200-600 times lower than 
fetal serum level and correspond well with placental size 
(Seppala, 1975). During the postpartum period, maternal AFP 
concentration decreases at a rate corresponding to a half life 
of 4-5 days (Seppala and Ruoslahti, 1973)• It has been 
demonstrated that AFP in maternal serum is of fetal origin 
and maternal tissues are not capable of synthesizing AFP 
(Sell and Skelly, 1976; Sell, 1974). The increase in 
maternal serum AFP during pregnancy is probably due to the 
transplacental and transamniotic passage of AFP from fetus to 
mother. 
NEWBORN MD NORMAL SERUM 
The average AFP level in human cord blood (50 ng ml ) 
decreases with a half life of 3-5 days and a normal adult 
level (4-25 ng ml~ ) is attained after 1-2 yrs (Masseyeff et 
al, 1975). In rats, there is a fall of serum AFP level owing 
to loss of yolk sac at birth (Gitlin, 1975; Sell et al, 1974). 
AFP concentration decreases gradually during postnatal life 
(t 1/2 = 24 hrs) and normal adult basal level is attained 
after about 10 weeks (Olsson et al, 1977; Sell et al, 1974, 
Masseyeff ot al, 1974). 
1. 
PURIFIOi^TION AM) IMUNQASSAYS OF AFP 
Ear ly a t t e m p t s t o p u r i f y iJ*P were mainly f r u s t r a t i n g 
by t h e s i m i l a r i t y of the p h y s i c a l and chemical p r o p e r t i e s of 
AFP and a lbumin . Human AFp i n amounts s u f f i c i e n t for 
b i o l o g i c a l c h a r a c t e r i z a t i o n was f i r s t ob ta ined from t h e AFP-
a n t i AFP immunoprec ip i t a te by g e l f i l t r a t i o n a t low pH 
( N i s h i , 1970; R u o s l a h t i and Seppala , 1 9 7 1 a ) . Since then a 
g r e a t v a r i e t y of p rocedures have been desc r ibed wi th l i m i t e d 
success (Howard e t a l , 1980j Kapadia e t a l , 1979; Mizejewski , 
1979; Gold e t a l , 1978; Hassoux c t a l , 1977; Benassayag e t 
a l , 1975; Page , 1973; S e l l e t a l , 1 9 7 2 ) . However, t h e 
immunoaffini ty or immunoadsorbent p rocedure h a s been more 
succes s fu l ( R u o s l a h t i , 1976; F i s h i and H i r a i , 1972; N i s h i , 
1972) , e s p e c i a l l y on immunoadsorbent employing low a f f i n i t y 
a n t i b o d i e s ( R u o s l a h t i , 1 9 7 8 ) . 
A l l c u r r e n t l y used methods for AFP measurement r e l y on 
i t s a n t i g e n i c i t y and d i f f e r i n s e n s t i v i t i e s (Tabic 1 ) . Only 
radioimmunoassay (RIA) and enzyme immunoassays a r e s e n s t i v o 
enough t o d e t e c t AFP i n a d u l t r a t or human s e r a . However, 
a t high c o n c e n t r a t i o n of AFP i n the t e s t sample , L a u r e l l ' s 
r ocke t assay has many advan tages over RIA ( R u o s l a h t i and 
Seppala , 1 9 7 9 ) . 
PHYSICO-GHEMICiAL PROPT^RTIES OF / J P 
The main p h y s i c a l and chemical c h a r a c t e r i s t i c of 
AFp's from v a r i o u s s p e c i e s a r e l i s t e d i n Table I I . Extens ive 
Method 
Double d i f f u s i o n 
Counter e l e c t r o p h o r e s i s 
Rocket immunoassay 
Latex a g g l u t i n a t i o n 
i n h i b i t i o n 
Immunoaut©radiography 
S e n s t i v i t y 
2 .5 -5 i^g ml""^ 
0 , 2 5 - 0 . 5 \ig ml~ 
0 . 5 - 1 |ig m l " 
250 Jig ml"-"-
50 ng ml 
l ad io immunoe l ec t ropho re s i s 20 ng ml 
Reference 
Abelev , e t a l , 
1963^ 
Smith, 1971 
Norgaa rd -
Pedersen and 
Gaede, 1975 
C a h i l l e t a l , 
1974 
Abelev, 1971 
Norgaa rd -
Pede r sen , 1976 
Enzyme immunoassay (EIA) 3 ng ml -1 
Radioimmunoassay (RIA) 0.5 ng ml -1 
Belanger et al, 
1973; Masseyeff 
et al, 1976 
Ruoslahti and 
Seppala, 1971b, 
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comparison of f e t a l iiPp wi th AFP ob ta ined from hepatoma 
serum u s i n g immunological methods , e l e c t r o p h o r e s i s , mo lecu la r 
weight d e t e r m i n a t i o n , amino a c i d a n a l y s i s , ca rbohydra te 
con ten t ( R u o s l a h t i and Engva l l , I 9 7 8 j H i r a i e t a l , 1973; 
Gousev e t a l , 1971 ; R u o s l a h t i e t a l , 1 9 7 1 a , b ; N i s h i , 1970) 
and N - t e r m i n a l sequencing (Aoyagi e t a l , 1977 J R u o s l a h t i e t 
a l , 1974) has not d i s c l o s e d any s i g n i f i c a n t d i f f e r e n c e s 
except i n e l e c t r o p h o r e t i c h e t e r o g e n e i t y ( L e s t e r e t a l , 1976) 
and a d i f f e r e n c e in e s t r o g e n b i n d i n g (Benassayag e t a l , 1 9 7 5 ) . 
The amino ac id composi t ions of human, r a t , mur ine , 
b o v i n e , p o r c i n e , ov ine , dog, r a b b i t and chicken AFP show 
s i g n i f i c a n t i^esemblance t o one a n o t h e r and t o albumin 
( R u o s l a h t i and Seppa la , 1979; R u o s l a h t i and Engva l l , 1978) . 
However, cDNA, j,p cannot h y d r i d i z e wi th mRNA^^ ^^  (Belanger 
e t a l , 1978; Tamaoki e t a l , 1978; I n n i s and M i l l e r , 1 9 7 7 ) . 
I t appears t h a t r e l a t i o n s h i p between AFP and albumin i s 
s i m i l a r t o t h a t of f e t a l and a d u l t hemoglobin (Abelev, 1971) . 
MICROHETEROCxENEITY OF AFP 
ilFp was o r i g i n a l l y though t t o be a r e l a t i v e l y simple 
p r o t e i n molecule ranging i n m o l e c u l a r weight from 6 5 , 0 0 0 -
70,000 and i n e l e c t r o p h o r e t i c m o b i l i t y from a, - p r e g i o n 
depending upon i t s source (Abelev , 1 9 7 1 ) . In t h e pas t 15 y e a r s , 
however, I^FP h a s been shown t o e x i s t a s a group of c l o s e l y 
r e l a t e d mo lecu l a r v a r i a n t s and to bo p r e s e n t i n se ra of 
humans and an imals wi th a v a r i e t y of AFP i n d u c i n g c o n d i t i o n s . 
l i 
An extensive and excellajat review has recent ly appeared on 
the heterogenei ty of AFP and i t s physiological and patho-
l o g i c a l co r r e l a t i ons (Smith and Kel leher , 1980). 
AFP i s heterogeneous with respec t to charge, s i ze and 
l e c t i n binding (Table I I I ) , Depending upon the methods of 
f rac t iona t ion two, four or nine molecular v a r i a n t s of r a t 
AFP could be obtained (Bayard and Kerckaert , 1977; 
Kerckaert e t a l , 1977; Savu e t a l , 1977; Nunez et a l , 1976; 
Benassayag et a l , 1975; Smith and Kelleher , 1973). F rac t ion -
a t ion of these charge v a r i a n t s on Con-A and Ricinus communis 
l e c t i n s allows even fur ther sub-divis ions of AFP v a r i a n t s 
(Smith and Kel leher , 1980). A scheme i s depicted in F i g . l 
which shows the heterogenei ty of AFP with respect t o various 
procedures. 
S t r u c t u r a l s tudies published to date have shed l i t t l e 
l i g h t on the bas i s of charge and molecular he te rogene i ty . No 
major difference have been de tec ted in amino acid composition 
(Peters e t a l , 1978; Kerckaert et a l , 1977, 1975), p a r t i a l 
amino ac id sequence (Peters e t a l , 1978). C-terminal amino 
acid res idue (Kerckaert e t a l , 1977), c i r c u l a r dichorism 
spect ra (Aubert et a l , 1977; Vorsoe and Barel , 1976) in the 
two charge v a r i a n t s of r a t AFP, Only s i a l i c acid content has 
been found to be d i f ferent in the two va r i an t s (Kerckaert 
et a l , 1977). However, f a c t o r s other than s i a l i c acid are 
thought t o involved in the observed heterogenei ty due t o 
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charge (Kerckaert et a l , 1977; Zimmerman, 1976; Watanabe et 
a l , 1975; Alpert e t a l , 1975; Aussel e t a l , 1973). 
The dif ference in the terminal sugars on AFP molecule 
gives r i s e t o i t s heterogenei ty on r e a c t i v i t y with l e c t i n s 
having d i f fe r ing carbohydrate s p e c i f i c i t i e s . Affinity 
chromatography of mouse, r a t and human AFP (Bayard and 
Kerckaert , 1981; Smith and Kelloher, 1980; Kerckaert et a l , 
1979; Ruoslaht i and Adamson, 1978; Ruoslaht i et a l , 1978; 
Dambuyant et a l , 1978; Bayard et a l , 1977; Savu et a l , 1977; 
Smith et a l , 1977) on Con-A sepharoso yielded Con-A non-
r e a c t i v e , weakly r eac t ive and reac t ive molecular v a r i a n t s , 
Gon-A nonreact ive AFP va r i an t contains more N-Acetylgluco~ 
samine, ga lac tose and s i a l i c acid than does Con-A reac t ive 
one and may fu r the r d i f fe r in the s t r uc tu r e of carbohydrate 
chain (Fig.2) (Bayard and Kerckaert , 1981). I t has been 
demonstrated tha t Con-A a f f i n i t y molecular v a r i a n t s are 
glycosylated d i f fe ren t ly (Ruoslahti and Adamson, 1978; Smith 
and Kcl leher , 1978; Wilson and Zimmerman, 1976) and have 
di f ferent o r i g i n s . The yolk sac synthesizes Con-A nonreact ive 
while l i v e r exclusively synthes izes and sec re tes Con-A 
reac t ive ilFP v a r i a n t . 
Heterogeneity of AFP observed on Ricinus comraunis 
agglu t in in (RCA) depends on the presence of external 
D-galactose residue (Bayard and Kerckaert , 1981). However, 
difference in s i a l i c acid content may pa r t l y account for the 
Con A - r e a c t i v e A F P 
Kidn 
N e u N A c - 6 a l - 6 l c N A c - M a n 
Con A.^nonreact ive A F P 
NeuNAc-Gal-GlcNAc-Man 
y-Man-GlcNAc-GlcNAc-Asn 
., . . . ^ , p, . . . .- ^ />-Man-GlcNAc-GlcNAc-Aan NcuNAC'Ga' -GlcNAc-Man -^ 
^ " ^ 2 . S t ' u c t u r o of oligosaccharide units of the AFP Con A 
a f f i n i t y molecular var iants(Bayard and Kt.ickaert,19Ql) 
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RCA-aff ini ty molecular v a r i a n t s . Not much i s known about t h e 
h e t e r o g e n e i t y of AFP due to o t h e r l e c t i n s (Smith and 
K e l l e h e r , 1980; Kerckae r t e t a l , 1979) . 
R e l a t i v e p r o p o r t i o n of l e c t i n (Con-A, RCA and LCA) 
a f f i n i t y molecu la r v a r i a n t of r a t and human AFp may d i f f e r 
du r ing n e o n a t a l growth i n f e t a l serum, a m n i o t i c f l u i d , and 
materna l serum (Smith and K e l l e h e r , igsO; K e r c k a e r t e t a l , 
1979; F o u m i e r e t a l , 1979; Smith and K e l l e h e r , 1978; Smith 
e t a l , 1977; Bayard e t a l , 1977) and i n s e r a of hepatoma 
b e a r i n g r a t s , mice and human (Ke l l ehe r e t a l , 1979; 1978; 
McMahon e t a l , 1979; Smith e t a l , 1979, 1 9 7 7 ) . Con-A 
n o n r e a c t i v e AFP v a r i a n t has a l s o been found t o dec rease i n 
c e r t a i n abnormal p r e g n a n c i e s (Brock, 1979; K e l l e h e r e t a l , 
1979; Smith et a l , 1 9 7 9 ) . I t appears t h a t l e c t i n a f f i n i t y 
molecular v a r i a n t s may be u s e f u l i n the d i f f e r e n t i a l 
d i a g n o s i s of v a r i o u s d i s e a s e s or abnormal p r e g n a n c i e s where 
AFP l e v e l s a r e known t o be a f f e c t e d (Smith and K e l l e h e r , 
1980 ) . 
PHYSIOLOGICAL ROTS OF AFP: CORRBIATION WITH MOLECUMR 
HETEROGENEITY 
The p h y s i o l o g i c a l f u n c t i o n ( s ) of AFP have no t been 
e s t a b l i s h e d wi th c e r t a i n i t y . Severa l i n v e s t i g a t o r s have 
shown evidence fo r ( I n n i s and M i l l e r , 1980; R u o s l a h t i and 
En g va l l , 1978; Vorsee and B a r c l , 1978b; Grigorova ot a l , 
1977; R u o s l a h t i and Terry^ 1976) or a g a i n s t ( S e l l e t a l , 
I 
1979; Belanger e t a l , 1978; P e t e r s e t a l , 1 9 7 8 a , b ) . AFP's 
homology wi th serun a lbumin. I t i s thought t h a t AFP may be 
a s u b s t i t u t e for t h e l a t t e r , and t h a t albumin r e p l a c e s AFP 
i n much t h e same way a s a d u l t hemoglobin r e p l a c e s f e t a l 
hono./^lnbin (Abelev, 1 9 7 1 ) . J^ VFP may a l s o sha re some of t h e 
b i n d i n g and t r a n s p o r t i n g f u n c t i o n s of albumin (Berde e t a l , 
1979 ) . 
BINDING OF ESTROGENS /iJID OTHER SUBSTikNCE 
The es t rogen b i n d i n g p r o p e r t y of roden t AFP's a r e 
f i rmly e s t a b l i s h e d ( U r i e l , 1979; Nunez et a l , 1979; Vorsoe 
and B a r e l , 1978; A t t a r d i and R u o s l a h t i , 1 9 7 6 ) . AFP may a l s o 
b ind d i e t h y l s t i l b o e s t e r o l (Savu e t a l , 1979; Ausse l e t a l , 
1973) and o t h e r norandrogens which do not p o s s e s s e s t r a t r i o n e 
ske l e ton (Versee and B a r e l , 1 9 7 8 ) , The a s s o c i a t i o n cons tan t 
of AFP fo r e s t r a d i o l i s of the o r d e r of 10 M (Aussel and 
Masseyeff, 1977; Benassayag e t a l , 1975; Raynaud e t a l , 
1971 ) . S to ich iomet ry of r a t AFP-estrogen i n t e r a c t i o n i s 
c o n t r o v e r s i a l . One group f i n d s two t y p e s of b i n d i n g s i t e s 
wi th d i f f e r e n t a f f i n i t i e s and b i n d i n g s i t e s l e s s than one 
( V a l l e t t e t a l , 1977; Benassayag e t a l , 1975) whi le o t h e r s 
(Versee and B a r e l , 1978; Ausse l and Masseyeff, 1977; Soloff 
e t a l , 1976) have found no h e t e r o g e n e i t y and one b i n d i n g s i t e 
pe r mole of AFP. S i m i l a r d i s c r e p a n c i e s e x i s t i n case of the 
e s t rogen b i n d i n g with v a r i o u s charge and l e c t i n a f f i n i t y 
molecu la r v a r i a n t s of AFP. One group has demonst ra ted t h a t 
l o 
AFP molecular v a r i a n t s d i f fe r in the estrogen binding and 
possess f r a c t i o n a l binding s i t e s (Val le t t e t a l , 1979, 1977; 
Nunez et a l , 1976; Benassayag e t a l , 1975) and propose tha t 
ol igosaccharide uni t has a r o l e in estrogen binding. While 
several other i nves t i ga to r s found no difference in estrogen 
binding by var ious AFP molecular v a r i a n t s and reported one 
binding s i t e and propose t h a t ol igosaccharide moiety i s not 
important for estrogen binding (Aussel et a l , 1979, 1978, 
1977; Soloff et a l , 1976). The source of these d iscrepancies 
have not yet been c l a r i f i e d . 
According to most s tud ios human, guinea p ig , hamster, 
bovine, r abb i t and chicken AFP's are devoid of demonstrable 
estrogen binding a c t i v i t y (Ruoslahti and Seppala, 1979; 
Kiang et a l , 1978; Nunez et a l , 1976, 1974; Swartz and 
Soloff, 1975; Savu et a l , 1974) . I t i s proposed tha t lack 
of e s t r o p h i l i c i t y of human AFP may be due to very low 
proport ion of Con-A nonrcact ivc AFP var iant (Va l l e t t et a l , 
1977) which i s high a f f i n i t y e s t r a d i o l binding component of 
r a t iiFP. 
The physio logica l s igni f icance of estrogen binding i s 
not known. Although speculat ion on a possible role of AFp 
in p r o t e c t i n g the ra t or mouse f e t a l brain against excessive 
maternal es t rogens have been popular , only a few aspects 
have been experimentally i nves t i ga t ed . The f i r s t one deal 
with the p a r t i c i p a t i o n of I^FP in the act ion of estrogen on 
1J 
uterus (Uriel et al, 1976; Raynaud et al, 1971). Secondly, 
rat AFP has been shown to compete with the estrogen 
metabolizing tissue enzymes for the estrogens (Aussel et al, 
1976). The overall result of this effect is likely to be 
inhibition of estrogen metabolism and to decrease tissue 
uptake of estrogens (German et al, 1978j Pool et al, 1978), 
Finally, the presence of AFP in the serum may influence the 
concentration of hormones with estrogen dependent expression 
in the circulation of neonatal rat (Aussel et al, 1980; 
Nunez et al, 1976). 
AFP AND IMMUNOREGUIATION 
The idea that AFP would be immunosuppressive originates 
with the report of Parmely and Hsu (1973) and found 
confirmation in case of mouse, rat and human by several 
authors (Lester and Yachnin, 1979; Auer et al, 1979; Gupta 
and Good, 1977; Keller and Tomasi, 1976). Mouse AFP strongly 
suppresses the plaque forming cell response to sheep RBC in 
spleen cell cultures. Primary IgM, secondary IgM, IgA and 
IgG response were all inhibited (MurgLta and Tomasi, 1975a,b). 
AFP suppresses certain T lymphocyte functions in vitro but 
does not directly inhibit B cell function and acts probably 
through induction of T cell with capacity to inhibit helper 
T coll (Alpert et al, 1978; Murgita ot al, 1977). The 
significance of immunosuppressive activity of AFP is not 
clear. Although, immunosuppression of the mother by fetal 
Zj 
AFP would offer a convenient explanation for the survival of 
the fetus as an allograft, there is no direct evidence that 
AFP would be immunosuppressive in_ vivo. Evidence to the 
contrary has been presented (Sheppard et al, 1977j Sell et 
al, 1977; Belanger et al, 1976), Further, immunosuppression 
by human, rat and mouse AFP is also controversial, Sheppard 
et al, (1977) and Sell et al (1977) in extensive studies on 
the effect of mouse ?ind rat AFP on immune response, could not 
confirm the findings reported by Murgita, Tomasi and 
co-workers. Several others (Littman et al, 1977| Charpentier 
et al, 1977j Gooken and Thompson, 1977) found no consistent 
immunosuppression by human AFP and propose that immuno-
suppressive activity is likely to be of no biological 
significance. 
AFP has been demonstrated to inhibit the binding of 
mysthonia gravis antibody to acetylcholine receptor and thus 
provide clinical remission from the symptoms of the disease 
during pregnancy (Brenner et al, 1980). It is also proposed 
to perform similar role in other autoimmune diseases. 
Human and rat AFp can also bind a variety of biolo-
gically active small molecular weight ligands (Table IV). 
It is proposed that AFP play a role in the transport of these 
biologically active substances (Ruoslahti and Seppala, 1979). 
TABLE IV! LIG/JgP BINDING PROPERTIES OP AFP 
LIGANDS SPECIES REFERENCE 
Estradiol 
Bilirubin 
Fatty acid 
Pr ostaglandin 
Aflatoxin B^  
Rat,Mouse only-
Rat, Human, 
Bovine 
Rat,Human 
•Rat,Human 
Rat 
Kiang et al, 1978; 
Swartz and Soloff, 
1975. 
Berde et al, 1979; 
Versee and Barel, 
1979. 
Benassayag et al, 
1979; Parmelee 
et al, 1978. 
Grose and Bclanger, 
1979; Yachnin et al, 
1979. 
Bvrain et al,l978. 
Retinoic acid 
Deoxy chelate 
Rat 
Mouse,Human, 
Bovine 
Ruoslahti, 1979. 
Ruoslahti, 1979. 
Dyes 
Copper and nickle 
Human 
Human 
Endo et a l , 1974. 
Aoyagi e t a l , 1978 
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MOLECULAR BASIS OF REGUMTIOIir CF AFP AI^ D ALB[JMII^  SYIfTHESIS 
The striking variation of AFP and albumin production 
accompanying cell differentiation and cacinogenesis indicate 
that effective mechanisms of turning the AFP synthesis on 
and off must exist. However, very little is known about the 
exact molecular nature of the events that are behind the 
expression of AFp production. 
Various hormones markedly suppress serum AFP levels 
in newborn rats and in hepatocyte culture in vj_trQ 
(Belanger et al, 1978a, 1975). Glucocorticoids (prednisolone, 
dexamothasone, hydrocortisone) induces a dramatic decrease 
in serum AFp level while insulin, glucagon, deoxycorticost-
erone, testosterone, progesterone and estradiol revealed no 
consistent effects. Suppression of AFP synthesis by 
glucocorticoids is mediated by a direct decrease in the 
amount of AFP mRFA (Commor et al, 1979). Conversly, in 
animals submitted to AFP inducing condition (CCl. intoxi-
cation, 3'-DAB carcinogenesis) corticoids increased the AFP 
levels (Belanger et al, 1978a). ACTH, dbcAMP, thyroxine and 
epinephrine may also induce an accelerated decrease of serum 
AFP in newborn rat, while iron deficiency has an opposite 
effect. The accelerated decrease of AFp from serum by a 
factor present in adult mouse organ (Tumyan et al, 1975) 
might have contained more of hormones known to suppress serum 
AFP levels. It has been observed that experimental induction 
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of AFP is accompanied by an increase in methionine levels 
with a depletion of ATP pool (Belanger et al, 1978b, 1976) 
and ATP administration may prevent induction of AFP 
(Taketa et al, 19"^). This hypothesis implies that 
methionine activation and AFP expression are functionally 
related and altered transmethylation event might determine 
a modification of gene expression towards incomplete 
differentiation which includes re-expression of AFP. 
Genetic experiments on the regulation of AFP gene 
have revealed that AFP is controlled by a single Mendelian 
gene, the Raf gene (Rat AFP gene) (Olsson et al, 1979; 
Lindahl et al, 1978), How direct the regulation of AFP 
by this gene is, remains to be elucidated. 
Several laboratories have, during the past couple of 
years, been tooling up to study the regulation of the AFP 
gene using methods of molecular biology. The mRNA for AFP 
has been isolated and cDNA probe prepared (Law et al, 1980; 
Innis and Miller, 1980, 1979; Simon et al, 1980; Gorin and 
Tilghman, 1980; Miura et al, 1979). Using this AFP cDFA 
probe it has been demonstrated that the control of AFP 
synthesis takes place at the transcription level. The 
change in AFp levels during normal fetal development (Liao 
et al, 1980; Nishi et al, 1979; Miura et al, 1978; lio et al, 
1976; Tamaoki ot al, 1976; Koga and Tamaoki, 1974) and in 
carcinogenesis or liver regeneration (Atryzek et al, 1980; 
Salatrepat et al, 1979; Chiu et al, 1979; Miura et al, 1979; 
2o 
Sell et al, 1979j Innis and Miller, 1979) is directly 
related to the amount of AFP mRNA and does not arise from 
any change in the translation activity, 
REGULATION OF ALBUMIN STOTHESIS 
Albumin concentration in serum is the net result of 
its synthesis, degradation and distribution. Several 
factors are responsible for modulation of albumin metabolism 
(Rothschild et al, 1977). The most important factor is 
nutrition. Deficiency of dietary protein results in the 
decrease of albumin synthesis (Pain et al, 1978; Morgan and 
peters, 1971) with a corresponding decrease in albumin 
synthesizing cells (Chandrashekharan, 1967) and a decrease 
in albumin mRKTA (Pain et al, 1978). Fasting also decreases 
albumin synthesis (Yap et al, 1978), Thyroid hormone and 
cortisone increase albumin synthesis by a direct increase 
in albumin mRNA level (Keller and Taylor, 1979). Similarly, 
hypophysectomy results in 50'/^  decrease in albumin 
synthesis with a corresponding decline in its mRNA (Keller 
and Taylor,1979; Feldhoff et al, 1977). Growth hormone 
treatment may restore albumin mRNA level and normal rate of 
albumin synthesis in hypophysectomized rats. 
Several conditions like CCl. intoxication, ethanol 
administration partial hepatectomy or alloxan induced 
diabetes decrease albumin synthesis due to disaggregation 
of polysomes from RER and a decrease in albumin mRNA level 
2. 
(Kreig et al, 1980; Peavy et al, 1978). Certain 
hereditary disorders of albumin metabolism like analbuminemia 
(complete absence of albumin in serum) has been shown to be 
due to the complete absence of functional albumin mRNA in 
liver (Sugiyama et al, 1980). Thus there appears to be a 
close resemblance in the amount of albumin mRNA, albumin 
synthesizing polysomes, and albumin synthesis in liver. 
The exact mechanism or site(s) for the oatabolism of 
albumin are not known. Since, no single organ has yet been 
identified as the major site of albumin catabolism, the 
possibility of diffused catabolism throughout the body 
involving reticuloendothelial system or the vascular endo-
thelium may be the major site of albumin catabolism 
(Baynes and Thorpe, 1981; Waldman et al, 1977), 
AFP IN LIVER DISKASBS M P GERM CELL TUMORS 
LIVER CELL PROLTEERAT TOW 
The proliferation of hepatocytes in adult liver is 
generally associated with AFP production (Abolev, 1974). 
This has been demonstrated in animal experiment following 
CCl^ intoxication, partial hopatectomy and chemically 
induced liver necrosis (Chiu et al, 1981; Ruoslahti and 
Seppala, 1979; Stillman and Sell, 1979; Engelhardt, 1976; 
Sell et al, I974), AFP production during regeneration takes 
place in mature hepatocytes due to derepression of AFP gone 
resulting in increased level of AFP mRNA (Chiu et al, 1981; 
2.J 
Abelev, 1979). In humans, elevated serum AFP levels are 
found in hepatitis, liver necrosis or cirrohosis and tend 
to occur in regeneration phase (Lehman and Wegner, 1979j 
Ruoslahti et al, 1974; Silver et al, 1974). Elevation of 
kFB levels in serum after ligation of the common bile duct 
is proposed to be due to the ductular cell proliferation 
(Wu et al, 1981). 
HBPATOGARCINOGENESIS 
Feeding of various hepatocarcinogens (3'-methyl-DAB, 
AAF, ethionine, DEN etc) results in the elevation of AFP 
level (Stillman and Sell, 1979). An early rise occurs 
within a few weeks or even hrs after the initiation of the 
treatment or with a subcarcinogcnic, nontoxic dose of 
carcinogen without any apparent liver injury (Stillman and 
Sell, 1979; Kroes et al, 1975; Becker and Sell, 1974). The 
final elevation of AFP is usually followed with the appear-
ance of malignant cells with increasing size of the tumor 
and with metastatic spread. There seems to be a general 
agreement that 'Oval cells' or transitional basophilic 
hepatocyte like cells are responsible for early rise of AFP 
and may give rise to cancer colls (Atryzek et al, 1980; 
Guillouzo et al, 1978; Kuhlman, 1978a). Whether all tumor 
cells go through a stage of AFP production some time during 
their life span, or whether AFP production is a function of 
differentiated subpopulation of tumor cells, is not clear 
(Abelev, 1979). 
HEPATOCELLULAR GMCER 2G 
Highly elevated levels of AFP in serum have been 
found to be specific for PEG (Ruoslahti and Seppala, 1979; 
Ruoslahti et al, 1974; Abelev, 1974; Mclntire, 1972). The 
occurrence of APp in serum of patients with PHC shows a 
striking geographical variation. The highest positive rates 
are found in those areas where tumor occurs most commonly 
e.g. Indonesia 8770, South Africa 78/% Taiwan 73/", compared 
to 2^1" in Britain and 28-50^ in USA (Ruoslahti and Seppala, 
1979). The reason for this variation is not known but it 
may reflect the difference in the etiology of the tumor in 
endemic and nonendemic parts of the world. A survey of 
500,000 individuals in China revealed sovor'il nov caso-C oS. 
PHC (Dfature editorial, 1911 ^ coordinating group for Res, on 
liver cancer, 1974). Malignant cells or hepatocytes grown 
in culture synthesize AFP (Suganuma et al, 1980; Kuhlman, 
1978a,b; Masseyeff et al, 1973). AFP producing cells 
(malignant) have been found to be situated near vessels 
surrounding the central veins or scattered throughout the 
tumor (Nishioka et al, 1972; Gousse et al, 1971). As might 
be expected, serum AFP level falls rapidly after resection 
of the tumor (Stillman and Sell, 1979; Sugahara et al, 1973; 
Alpert et al, 1971). 
It is apparent that AFP assays can be used for the 
detection and localization of PHC and to assess completeness 
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of surgical resection of the tumor and for the subsequent 
surveillance of the patients with regard to recurrence or 
growth of metastasis. 
CrEip CELL AND EmODERML CELL TUMORS 
The association of elevated serum AFP level with 
teratocarcinomas of the ovary and testis is now well 
documented (Eyben et al, 1980j Kurman et al, 1977; Grigor 
et al, 1977; Kohn et al, 1976j Tsuchida et al, 1975; Wahren 
et al, 1974). Yolk sac tumors produced in mice by murine 
sarcoma virus also produce AFP (Hooghe and Zeicher, 1974). 
Immunohistochemical studies have shown that AFP is localized 
in the yolk sac tumor (Kurman et al, 1977; Teilum et al, 1974). 
In patients with yolk sac tumor, the serum AFP concentration 
reflects the activity of the disease and proved to be useful 
in monitoring of the treatment (Norgaard-Pederson, 1978; 
Lange et al, 1977). AFP has also been reported to occur in 
a wide range of endodermal tumors without hepatic metastasis. 
Gastrointestinal tract tumor seems to be common site for AFP 
production (Akai and Kato, 1973; Montplaisis et al, 1973). 
Germ cell tumors, developing primarily in the skull, 
comprise about 5% of all brain tumors. Several patients 
with primary intracranial germ cell tumors have been found 
to have elevated serum AFp level (Arita et al, 1980; 
Norgaard-Pedersen, 1978). Several other kind of tumors 
like dysgerminomas, retinoblastomas and various carcinomas of 
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breast, lung, basal cell carcinoma of nose (Lie-Injo et al, 
1976; Mchelson et al, 1976; Tsuchida et al, 1975) and in 
the epidermal cell tumor (Bowen's disease) (Soltani et al, 
1978) may shows high levels of AFP. 
AFP m OTHER LIVER DISEASES 
AFP is elevated in about lO/o of the patients with 
liver diseases other than PHC. These include acute viral 
hepatitis, toxic hepatitis, chronic active hepatitis, 
cirrhosis, liver trauma, congenital biliary artresia and 
neonatal hepatits (Ruoslahti and Seppala, 1979; Lehman and 
Wegner, 1979) with an elevation of AFP level from slight to 
moderate. A strong association has been observed between 
PHC and evidence for a contact with hepatitis B virus 
(Tabor et al, 1977). Vaccination against the virus may prove 
to be an effective measure to prevent liver cancer (ziegler 
et al, 1978). Tyrosinemia, which is also associated with 
elevated AFP levels, often leads to the development of PHC 
and repeated testing of such individual may reveal patients 
at a curable stage (Belanger et al, 1976), 
AFP AS A POSSIBLE TARGET MOLECULE FOR TUMOR IMMJNOPREVENTION 
AITO IMMUNOTHERAPY 
Several reports indicate that heterologous antibodies 
to AFP inhibit the growth of hepatoma cells in vitro, 
inhibit the growth of hepatoma transplanted in rat and 
human testicular tumor transplanted into nude mice, and 
23 
inhibition of tumor development in hepatocarcinogenesis 
(Hirai, 1979). It has been proposed that anti-AFP may coat 
tumor cells and in this way increases their immunogeneclty 
to the host or in some way facilitate recognition of their 
foreigness to the host. Small amount of AFP may be bound 
to the cell surface and binding of antibody induce a 
cytostructural alteration of the cell membrane which would 
eventually lead to the death of the tumor cell (Wepsic et al, 
1980). 
Effect of anti-AFP on pregnancy is controversial. 
Degenerative changes have been reported to occur in the fetal 
liver of rabbit with autologous antibodies. However, 
production of homologous antibodies did not elicit any 
abnormality (G-oussev et al, 1974). Injection of heterologous 
antiserum into pregnant animal have been aruged to have an 
abortogonic effect (Mizejewski and Grimley, 1976; Slade, 
1973), but this has not been confirmed by several investigat-
ors (Hirai, 1979; Ruoslahti and Seppala, 1979; Leung et al, 
1977). 
The use of radiolabelled antibodies against AFP has 
proved to be useful in tumor localization (G-oldenberg, 1980). 
The possibility of a clinical application of the antiserum 
treatment, either heterologous or homologous, to the 
patients with hepatoma, yolk sac tumor or cirrohosis may 
prove very useful and needs further clinical trials. 
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AFP IN THE DIAGNOSTS OF FT^ .TAL PATHOLOGY 
The AFP assays have recently become important in the 
prenatal diagnosis of certain fetal defects and a number of 
other situations in which it is necessary to monitor the 
fetal condition. Some excollant reviews have recently 
appeared on these aspects (Ruoslahti and Seppala, 1979; 
Brock, 1979, 1977; Seppala, 1977; Kjessler and Johansson, 
1977). Table V summarizes the possible diagnostic value 
of AFP in different tirmester of pregnancy (Lau and Linkins, 
1976). 
Normal levels of APP in amniotic fluid, maternal 
serum and fetal serum at various stages of pregnancy has 
already been established (Seppala, 1977). Abnormal values 
of AFP in these compartments may arise due to abnormal 
development of pregnancy and presence of various fetal 
morphogenetic defects, such as open neural tube defect (NTD), 
hereditary congenital nephrosis (Finnish type), omphalocele, 
pitonidal sinus, esophageal artresia and others 
(Ruoslahti and Seppala, 1979). 
The classic observation of Brock and Sutcliffe (1972) 
that great majority of pregnancies with fetuses affected by 
open NTD (anencephaly, myelocoele, cervical meningocoele 
hydrocephaOun) are associated with elevated levels of AFP in 
amniotic fluid, is now extremely valuable in obstetric 
TABLE V: AFP IN THE DMGMOSIS OF FETAL PATHOLOGY 
FIRST, TRimgj;PR 
Predict outcome of threatened abortion 
Select cases of cervical incompetence 
Screen for early birth defects 
Differentiation of male and female pregnancy 
Detection of missed abortion and incomplete 
abortion. 
SECOND TRIMESTER 
Assessment of severity of diabetes, 
Rh-immunization and toxaemia 
Detection of late congenital defects 
Screening for twins 
THIRD TRIMESTER 
All the above conditions 
Determination of gestational age 
Detection of fetal distress and impending 
fetal death 
Assessment of uterine bleeding 
Detection of cancer in pregnancy 
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practice. The frequency of open NTD in various countries 
is as follows:-
North Ireland 
Wales 
Scotland 
England 
USA 
India 
India (North) 
7 .2 
5 .8 
5 .6 
4 .0 
4.5 
5.7 
6.7 
per 1000 pregnancies 
11 
1 \ 
»t 
II 
11 
II 
The presence or absence of certain cells (neural, 
epithelial, peritoneal, and placental cells) in amniotic 
fluid originating from fetal brain and spinal cord may-
further prove to be helpful in more precise detection of 
various fetal abnormalities. 
Determination of AFP in maternal serum in symptom 
free pregnancies, not known to be at increased risk of 
having affected off spring, may provide valuable information. 
Maternal serum AFP levels may generally be increased in twin 
pregnancies and NTD (Brock, 1977, 1975; Collaboratire 
report of UK, 1977) hereditary congenital nephrosis. 
Heckle's syndrome and intrauterine fetal death (Kjesslcr and 
Johansson, 1977, 1975; Seppala, 1977). 
Screening of all pregnancies by maternal serum AFP 
is now contemplated in several countries. Such screening 
3, 
would y i e ld about 3OOO cases vrith elevated values per 
100,000 pregnancies . In a repeat serum sample, the number 
would be reduced to 50O requ i r ing aminocentesis and l i k e l y 
t o reveal a t l e a s t 50 cases of NTD (report of the UK 
co l labora t ive study, 1977) along with severa l cases of 
congeni ta l nephros is , twin pregnancies, low b i r t h weight 
in fan t s and i n t r a u t e r i n e f e t a l death . 
M A T E R I A L S & M E T H O D S 
O t J 
DEAJl-cellulose (DE-52), bovine serum albumin, 
human serum albumin (Cohn f r ac t i on IV), r ibonuclease , 
cytochrome C, polyethylene glycol-6000, collagenase (type 
6 ? IV), t r y p s i n , i n s u l i n , cycloheximide, N , 0 , d ibutyryl 
3 ' f 5 ' - c y c l i c adenosine monophosphoric ac id (dbcAMP), 
dexamethasone, estrone ( K ) , e s t r ad io l -17 p (E ) , d i e t h y l -
s t i l b o e s t e r o l (DES) sodium dodecyl sulphate (SDS) and 
p-mercaptoethanol were procured from Sigma Chemical Company, 
St . l o u i s , MO, USA. Agarose, commassie b r i l l i a n t blue, 
4-(2-hydroxyethyl)- l -piperazine-N*-2-ethane sulphonic acid 
(HEPES), sepharose-4B and 6B, sucrose , 2,5-cliphenyloxazole 
(PPO), l ,4 -b i s - (5-phenyloxazoly l ) benzene (POPOP), t r i s 
(hydroxymethyl)-aminomethane ( T r i s ) , g lyc ine , amino ac ids 
were purchased from SISCO Research Labora to r i es , Bombay, 
India . Acrylamide, bisacrylamide ( b i s ) , ammonium persulph-
a t e , ethylene diamine t e t r a a c e t i c acid (EDTA), N,N,N' ,N'-
tetramethylene diamine (TEMED) were products of Eastman, 
Kodak, Rochester, New York, USA. Ie ibowitz-15 (L-15) 
medium, leuc ine f ree Eagle ' s MEM-199, p e n i c i l l i n , s t r e p t o -
mycin, fungizone, were obtained from GIBCO, USA, 
Concanavalin-A was a product of PL Biochemicals, USA. 
Lysozyme, pepsin , and amido black -lOB were procured from 
E.Merck, Daimstadt, Germany. Complete Preund 's adjuvant 
(CFA) was supplied by Difco, England. Cibacron blue -F3GA 
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and epichlorohydrin were a generous g i f t from Mr.Mohd.Akhlaq, 
Department of Biophysics, C,D.R.I . , Lucknow. 6,7-[ H ] -
e s t r a d i o l ( spec i f ic a c t i v i t y 44.0 Ci/m mol) was procured from 
New England Nuclear, Boston, USA, while DL-l-[ C]-leucine 
( spec i f i c a c t i v i t y 28.9 mCi/m mol) was supplied by Bhabha 
Atomic Research Centre (BARC), Bombay, Ind ia . All other 
chemicals and reagent were of AR grade. 
Inbred a lbino r a t s (Charles Foster s t r a i n ) were 
drawn from Central Drug Research I n s t i t u t e animal colony. 
The animals were housed in a i r -cond i t ioned quar te r s and 
and fed standard balanced p e l l e t d ie t (Hind Lever, Bombay, 
India) and water g^ l ibi tum throughout the experiments. 
Adult a lbino r a b b i t s and guinea pigs were a l s o drawn from 
our i n s t i t u t e animal colony. 
Fe t a l and neonatal r a t s of known ages were obtained 
from timed pregnancies. The female r a t s were mated in the 
p r e - e s t ru s phase of es t rus cycle as determined by vaginal 
smears. The day a f t e r mating was designated as day zero of 
pregnancy. The fe tuses were removed from the pregnant 
females on day 16, 18 and 20 of ge s t a t i on . Pos tna ta l r a t s 
a f t e r 1, 3 , 7, 14, 21, 28 days were a l so used tak ing day of 
b i r t h as day 1 of pos tna ta l l i f e . 
So 
NORMAL RAT SmXJJJl (ms) AND PREGNMT RAT SERUM (PRS) 
Blood was withdrawn th rough h e p a t i c p o r t a l ve in 
from s e v e r a l a d u l t r a t s and from pregnant r a t s (20 d 
g e s t a t i o n ) . Sera obta ined were pooled s e p a r a t e l y and l a b e l l e d 
a s NRS and PRS and s to red f r o z e n . 
AMMIOTIG FLUID (AF) AND FETAL SERUM (FS) 
I n t a c t f e t u s e s a t 1 6 , 18 and 20 d g e s t a t i o n were 
removed from the u t e r u s and washed i n normal s a l i n e . 
Amniotic f l u i d was c o l l e c t e d by punc tu r ing the amnio t i c 
membrane. The f l u i d o b t a i n e d was c e n t r i f u g e d a t 4000 rpm 
fo r 15 min. a t 4 C and s t o r e d f r o z e n . F e t a l blood was 
c o l l e c t e d from the d e c a p i t a t e d f e t u s e s . Sera ob ta ined from 
s e v e r a l f e t u s e s of each age group were pooled s e p a r a t e l y 
and s t o r e d f rozen . 
The f e t u s e s removed from pregnant r a t s a t 16 d of 
g e s t a t i o n were washed i n phosphate buf fe red s a l i n e , pH 7 . 4 
and homogenized. The homogenate (505^ v / v ) was c l e a r e d a t 
40,000 rpm a t 4 C. The s u p e r n a t a n t was termed a s f e t a l 
e x t r a c t and s t o r ed f rozen i n smal l a l i q u o t s . 
PURIFICATION OF RAT AND HUMAN SERUM ALBUMIN 
PREPARATION OF BLUE-SEPHAROSE 
Ep ich lo rohydr in c r o s s - l i n k e d sepharose-6B was 
p repa red a c c o r d i n g t o the p rocedure of P o r a t h e t a l (1971) . 
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20 g of sepharose 6B was t r e a t e d with 18 ml of IM NaOH and 
2 ml of epichlorohydrin a t room temperature in the presence 
of 40 mg of sodium borohydride. The suspension was heated 
t o 60°C with s t i r r i n g and the reac t ion was stopped a f t e r 2 
h r . The gel was washed free of a l k a l i with d i s t i l l e d water . 
Blue-sepharose-6B was synthesized by coupling cibacron 
Blue-F3 GA t o epichlorohydrin cross- l inked sepharose-6B 
e s s e n t i a l l y according t o the procedure of Bohme et a l (1972). 
A so lu t ion of 200 mg of cibacron Blue-F3 GA in 50 ml of water 
was added dropwise with vigorous s t i r r i n g to a 10 g suspension 
of epichlorohydrin cross l inked sepharose-6B in 350 ml of 
water a t a temperature of 60 C. After s t i r r i n g for 30 min 
45 g of NaCl was added and the s t i r r i n g continued for 1 h r , 
4 g NaoCO„ was added to the mixture heated t o 80 C, I t was 
then s t i r r e d at t h i s temperature for 2 h r s . After cooling 
t o room temperature the gel was f i l t e r e d by suction on a 
BUchner funnel and washed repeatedly with 0,02 M ace ta t e buffer , 
pH 4 .5 , and 0.02 M bicarbonate buffer , pH 9.0 containing 2 M 
NaCl. After washing at pH 9 .0 , the gel was washed t h o r o u ^ l y 
with water . The extent of dye binding was determined by 
hydrolyzing the gel in 6M HCl a t 40*^ 0 for 30 min, reading 
the absorbance a t 65O nm and comparing the values t o a 
standard curve prepared with the pure dye. The dye concent-
r a t i o n was 0,69 |i mol/ml of packed gel volume. 
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PURIFICATION OF BAT SERUM ALBUMIN FROM NRS BY PEG 
PRECIPITATION AND AFFTUITY CHROMATOGRAPHY ON BLUE SEPH/.ROSE 
Rat albumin was partially purified from NRS by-
polyethylene glycol precipitation procedure of Jimenez et 
al (1974). NRS was treated with 25/" polyethylene glycol 
(mol, wt, 6000) at 4 C with constant stirring for 30 min. 
The precipitate was discarded and to the supernatant, 
ethanol was added to a final concentration of 40^ at -5 C. 
After keeping it for 4 hrs at 4°C it was centrifuged and 
supernatant discarded. The precipitate was dissolved in 
water and ethanol added to a final concentration of 40^ at 
pH 5.0 and -5 C. This process was repeated thrice and the 
precipitate was finally dissolved in 0.05 Tris-HCl, pH 7.4 
containing 0,1 M KCl, This preparation showed a minor band 
along witha major band of albumin on PAGE and was further 
purified by affinity chromatography on blue sepharose 
(Smith and Kelleher, 1979). 
Partially purified rat serum albumin (20 mg) was 
applied on blue-sepharose column (1.0 x 15.0 cm) equili-
brated with 0.05 Tris, pH 7.0, containing 0.1 M KCl and 
washed thoroughly with this buffer. Albumin was eluted 
with the starting buffer containing 1.5 M KCl. Elution of 
the protein was followed by measuring absorbance at 280 nm. 
Protein rich fractions were pooled and dialysed against 
water for 24 hrs and lyophillized. The purity of albumin 
3:> 
was checked on polyacrylamide gel electrophoresis, 
immunoelectrophoresis, and douhle diffusion. 
PURIFICATION OF HUMN SERUM ALBUMIM (HSA) 
Human serum albumin was purified from its crude 
preparation (Cohn fraction IV) hy affinity chromatography 
on blue sepharose as described above, 
ANTISERA 
RABBIT ANTI-NORM/.L ADULT RAT SERUM (ANTI-URS) 
Anti-NRS was o b t a i n e d by immunizing r a b b i t s four 
t imes wi th 1.0 ml of normal a d u l t r a t serum mixed with an 
equal volume of complete F r e u n d ' s ad juvan t (CFA) a d m i n i s t e r e d 
subcutaneous ly a t one week i n t e r v a l . The an ima l s were 
admin i s t e r ed two b o o s t e r doses of 1.0 ml NRS i n t r a m u s c u l a r l y 
a t 10 days i n t e r v a l s and were b l e d a f t e r 10 th day of l a s t 
i n j e c t i o n when an t ibody t i t r e was maximum. Antibody t i t r e 
was e v a l u a t e d by double d i f f u s i o n . 
RABBIT ANTI-NORMAL ADULT HUMTJT SERUM (ANTI-IffiS) 
Anti-NHS was ob ta ined by immunizing r a b b i t s wi th NHS 
us ing t h e same p r o t o c o l a s d e s c r i b e d for an t i -NRS. 
QUINBA PIG /LNTI-NORMAL RABBIT SERUM (ANTI-NRbS) 
Immunization schedule fol lowed t o r a i s e an t ibody 
a g a i n s t normal a d u l t r a b b i t serum (NRbS) i n guinea p i g s was 
s i m i l a r t o t h a t used f o r anti-NRS except t h a t 0.5 ml NRbS 
was used fo r i n i t i a l immuniza t ion . 
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RfiBBIT iil^TI-NORML ADULT MT SERUM ALBUMIJT (AMTI-RSA) 
P a r i f i e d RSA ob ta ined by a f f i n i t y chromatography on 
blue sepharose was used for immunizing r a b b i t s . Four 
subcutaneous i n j e c t i o n s of 2 , 4 , 4 and 6 mg each of 
p u r i f i e d RSA i n 1,0 ml normal s a l i n e mixed w i t h an equal 
volume of CFA were admin i s t e r ed weekly . Then t h r e e b o o s t e r 
doses , 6 mg each of RSA, were a d m i n i s t e r e d i n t r a m u s c u l a r l y 
a t 10 day i n t e r v a l s . The animals were b l e d when an t ibody 
t i t r e reached peak value a s ana lyzed by double d i f f u s i o n , 
RABBIT AUTI-NORML ADULT HUMilN SERUM ALBUMIN (AUTI-HS/O 
Anti-HSA was obta ined by immunizing r a b b i t s wi th 
HSA p u r i f i e d by a f f i n i t y chromatography on b lue s e p h a r o s e . 
The immunizat ion schedu le was s i m i l a r t o t h a t used for 
ant i -RSA. 
RABBIT ANTI-R/iT AMNIOTIC FLUID SERUM (ANTI-AF) 
Antibody a g a i n s t pooled r a t amnio t i c f l u i d was r a i s e d 
i n r a b b i t s by fo l lowing the immunization p r o t o c o l s i m i l a r 
t o t h a t used f o r ant i -NRS. 
PREPARATION OF ANTI-AP-^ 
Anti-AF serum was made s p e c i f i c for /^Fp by r e p e a t e d 
a b s o r p t i o n w i th l y o p h i l i z e d NRS ( 0 . 3 mg/ml an t i -AF) t i l l 
no v i s u a l i m n u n o p r e c i p i t a t i o n o c c u r r e d . The a n t i - s e r u m 
thus p repa red did not r e a c t e d wi th any a d u l t r a t serum 
p r o t e i n s and was s p e c i f i c f o r I^FB. I t was termed a s 
anti-AFP . 
R/lBBIT ANTI-HUMN AMNIOTIC FLUID SERUM (ANTI-HAF) 
The r a b b i t s were immunized wi th human amnio t i c 
f l u i d (14th week of g e s t a t i o n ) a s d e s c r i b e d f o r ant i -NRS. 
Anti-HAF was a l s o adsorbed wi th l y o p h i l i z e d a d u l t 
human serum and made s p e c i f i c f o r AFP and termed as 
anti-HAFP^. 
ISOLATION OF IMMUNOGLOBULINS (IgG) FROM ANTI-NRS AND 
ANTI-NHS BY DEAE-CELLULOSE CHROMATOGRAPHY 
Antiserum (anti-NRS o r anti-NHS) was p r e c i p i t a t e d 
a t 4 G by a d d i t i o n of ammonium s u l p h a t e a t a f i n a l concen-
t r a t i o n of 40?^. The p r e c i p i t a t e was washed t w i c e wi th 40?^  
ammonium s u l p h a t e s o l u t i o n and d i s s o l v e d i n 0»01 M 
phosphate b u f f e r , pH 8.0 (one t h i r d volume of i n i t i a l 
an t i s e rum) and d i a l y z e d a g a i n s t the same bu f fe r f o r 24 h r s 
a t 4 C wi th s e v e r a l changes of the d i a l y z i n g b u f f e r . 
The crude immunoglobulin sample (300 mg p r o t e i n ) was 
a p p l i e d t o DEAE-cellulose column (2 .5 x 30 cm) p r e -
e q u i l i b r a t e d wi th 0 ,01 phospha te b u f f e r , pH 8 .0 (buf fe r I ) . 
Unadsorbod p r o t e i n s were washed through the column with 
bu f fe r I a t a flow r a t e of 50 m l / h r . P r o t e i n con ten t i n t h e 
e f f l u e n t was followed by measur ing t h e absorbance a t 280 nm. 
IgG- which does n o t b ind to t h e adsorbant column, under 
these conditions, was collected in the unadsorbed peak, 
Inununological activity of the protein rich fraction (IgG-) 
was checked on double diffusion against NRS. IBP of the 
isolated immunoglobulins and subsequent diffusion with 
guinea pig anti-normal rabbit serum did not revealed any 
precipitin arc in a or p region. This indicates that the 
immunoglobulins preparation contain proteins with y'^ io^ ili'^ 'y 
only (Ig&). The IgG was concentrated by lyophilization and 
stored frozen in small aliquots. 
ANALYTICAL TECHNIQUES 
OUCHTERLONY'S DOUBLE DIFFUSION 
Double immune diffusion method was basically according 
to Ouchterlony (1958), Hot agarose solution (l/o in PBS 
containing 0,025^  sodium azide) was poured on microscopic 
slides or glass plates placed on levelling table and kept 
at room temperature for 15 minutes to allow the formation of 
gel. Wells of appropriate sizes were punched out. Antigen 
and antibody were then filled in appropriate wells and 
allowed to diffuse at room temperature for 24 hrs in a 
humid chamber. After formation of precipitin lines, the 
gel plates were washed in normal saline for several days at 
4 C and stained with amido black (0.25/° in 7/° glacial 
acetic acid and 5^ methanol) to visualize the precipitin 
lines. 
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IMMJNOELEGTROPHORESI3 (lEP) 
The p rocedure developed by Grabar and Wil l iams 
(1955) was used t o perform immunoe lec t rophores i s on ifo 
agarose p l a t e s buf fered a t pH 8,3 wi th 0 .05 M b a r b i t a l - H C l 
b u f f e r . Ant igens were f i l l e d i n the w e l l s and e l e c t r o -
phoresed a t c o n s t a n t c u r r e n t of 2 mA/sl ide f o r 2 h r s a t 
room t e m p e r a t u r e . Bromophenol b lue was used a s i n d i c a t o r 
dye . Af ter e l e c t r o p h o r e s i s , a p p r o p r i a t e a n t i s e r a were 
f i l l e d i n the t r o u g h s and a l lowed t o d i f f u s e a t room 
tempera tu re f o r 24 h r s i n a humid a t m o s p h e r e . The p l a t e s 
were washed and s t a i n e d a s d e s c r i b e d above . 
Immunological i d e n t i t y of the a n t i g e n samples was 
r evea led by d i f f u s i n g the a n t i g e n s ( a f t e r e l e c t r o p h o r e s i s ) 
between the two p a r a l l e l t r o u g h s ; one c o n t a i n i n g the known 
a n t i g e n ( w i t h which t h e immunological i d e n t i t y i s be ing 
i n v e s t i g a t e d ) and the o t h e r c o r r e s p o n d i n g an t i se rum 
(Osserman, 1 9 7 0 ) . 
POLYACRyLi^ MlDE GEL ELECTROPHORESIS (PAGE) 
/Lnalysis of t he p r o t e i n s on po lyacry lamido ge l 
e l e c t r o p h o r e s i s was performed on 10% g e l s a s d e s c r i b e d by 
Benassayag e t a l (1975) wi th the f o l l o w i n g ge l compos i t ion : 
8 g a c r y l a m i d e , 0.16 g b i s , 56 mg ammonium p e r s u l p h a t e , 
and 0.023 ml TBJIBD i n 80 ml of T r i s ( 0 . 5 M)/HCl (0 .06 M) 
b u f f e r , pH 8 . 9 . The m i g r a t i o n of the p r o t e i n s was 
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performed a t room t e m p e r a t u r e , u n l e s s othei*wise s t a t e d , i n 
a T r i s (0 .025 M)/glycine ( 0 . 2 M) b u f f e r , pH 8 . 3 , ^or 3 h r s 
a t a c o n s t a n t c u r r e n t of 1.5 mA pe r t u b e . Af ter e l e c t r o -
p h o r e s i s , t h e g e l s vrere s t a i n e d wi th coomassie b r i l l i a n t 
b l u e (0,25/" coomassie b l u e i n Ifo g l a c i a l a c e t i c a c i d and 
5^ methanol) fo r 30 min. D e s t a i n i n g of the g e l s was 
performed i n 7fo g l a c i a l a c e t i c a c i d and 5^ ° methanol s o l u t i o n . 
DETERMimTIQN OF MOLECULAR WEIGHT BY SDS-PAGE 
Molecular w e i ^ t of t he pure p r o t e i n was de termined 
by the procedure of V/eber and Osborn ( 1 9 6 9 ) . Cyt C ( 1 1 , 7 0 0 ) , 
RNase ( 1 3 , 7 0 0 ) , lysozyme ( 1 4 , 3 0 0 ) , p e p s i n ( 3 5 , 0 0 0 ) , and BSA 
(66,000) were used as known molecu la r weight p r o t e i n m a r k e r s . 
In some exper iments AFP and albumin were immuno~ 
p r e c i p i t a t e d from c u l t u r e medium us ing s p e c i f i c a n t i s e r u m . 
The immunoprec ip i t a t e s were p rocessed fo r t h e d e t e r m i n a t i o n 
of molecu la r weight of d i s s o c i a t e d a n t i g e n s (APP and albumin) 
a c c o r d i n g t o Schapiro e t a l ( 1 9 6 7 ) . 
ESTRADIOL BINDING ASSAY OF R/iT AFP 
I n t e r a c t i o n of [ H ] - e s t r a d i o l wi th AFP was s t u d i e d a s 
d e s c r i b e d by P l a p i n g e r e t a l ( 1 9 7 3 ) . A l i q u o t s of AFP (5 |ig) 
i n 0 . 1 M phosphate b u f f e r , pH 7 . 4 , i n t r i p l i c a t e s were 
i n c u b a t e d wi th [\]-E^ (2-100 nM) wi th or w i t h o u t 1000 fo ld 
excess of co ld Ep f o r 3 h r s a t 4°C. After i n c u b a t i o n , 50 \il 
d e x t r a n coated cha rcoa l (DGC)ri/o dex t ran (T-70) and 105^ 
c h a r c o a l (Nor i t A)] was added t o each tube and mixed 
v i g o r o u s l y followed by c e n t r i f u g a t i o n a t 800 x g fo r 10 min. 
R a d i o a c t i v i t y was measured i n the supernatsuats i n a T r i c a r b 
l i q u i d s c i n t i l l a t i o n coun te r w i th an e f f i c i e n c y of 5 0^ . 
4 g PPO and 100 mg POPOP d i s s o l v e d i n one l i t r e 1;1 mix ture 
of t o luene and 2-methoxy e t h a n o l was used as a s c i n t i l l a t i o n 
c o c k t a i l . A s s o c i a t i o n c o n s t a n t and number of b ind ing s i t e s 
f o r B^ per mol of APP were c a l c u l a t e d from Sca tchard p l o t 
( 1 9 4 9 ) . 
QUANTITATION OF AFP AND ALBUMIN BY ROCKET IMMJNOASS/iY 
AFP and albumin were q u a n t i t a t e d in v a r i o u s samples 
by L a u r e l l ' s rocke t immunoassay (1965) , Agarose (2?^ i n 
0.05 M b a r b i t a l - H C l b u f f e r , pH 8 . 3 , c o n t a i n i n g 0.02/^ 
sodium a z i d e ) was mel ted in a water ba th and main ta ined a t 
45 0, S u i t a b l y d i l u t e d s p e c i f i c an t i se rum ( a n t i - r a t AFP or 
a n t i - r a t a lbumin, or ant i -human APp) was mixed w i t h e q u a l 
volume of 2f° agarose s o l u t i o n and mixed t h o r o u g h l y . A n t i b o d y 
aga rose s o l u t i o n was then poured on pre-warmed g l a s s p l a t e s 
kep t on a l e v e l l i n g t a b l e . Amount of aga rose p l a t e d was 
a d j u s t e d t o give a uniform gel t h i c k n e s s of 1.5 mm. Af te r 
format ion of the g e l , s e r i e s of w e l l s were punched out and 
kep t in humid atmosphere a t 4 C. 
S e r i a l d i l u t i o n s of a p p r o p r i a t e samples (10 p,l) were 
f i l l e d i n t h e w e l l s and e l e c t r o p h o r e s i s was c a r r i e d out a t 
room t empera tu re f o r 4 h r s u s ing 0,05 M b a r b i t a l - H C l b u f f e r , 
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pH 8 . 3 , a t a c o n s t a n t v o l t a g e of 5 V/cm of aga rose g e l . 
Af ter e l e c t r o p h o r e s i s immunoprec ip i t in r o c k e t h e i g h t was 
measured under a magnifying l e n s . Amount of AFP or albumin 
i n unknown sample was determined from t h e s t anda rd curve fo r 
t h a t p a r t i c u l a r a n t i g e n . P u r i f i e d r a t serum albumin and 
AFP served aa t h e s t a n d a r d s . Standard human AFP was a 
72/225 p r e p a r a t i o n of cord serum (WHO, Lyon, F r a n c e , 1 9 7 5 ) . 
This p r e p a r a t i o n has 50,000 i n t e r n a t i o n a l u n i t s (lU) of AFP 
per ml of s t a n d a r d cord serum. One I .U , corresponded t o 
1.18 ng human AFP. S e n s t i v i t y of t h i s a s s a y , i n our hands , 
i s 2-5 |ig/ml f o r r a t AFP, 3-5 |J.g/ml f o r r a t albumin and 
1-2 |j,g/ml f o r human AFP. 
A t y p i c a l s t a n d a r d curve for r a t AFP i s shown i n 
Fig*3A. I n s e r t i n Fig.^A shows t h e r o c k e t p a t t e r n ( i n 
d u p l i c a t e ) of t h r e e s e r i a l d i l u t i o n of r a t AFP. Fig ,3B 
shows a t y p i c a l r o c k e t assay p l a t e used f o r q u a n t i t a t i o n of 
r a t AFP i n samples c o n t a i n i n g v a r i a b l e amounts of t h e p r o t e i n . 
Large r o c k e t s (open peaks) a r e due t o t h e h i g h c o n c e n t r a t i o n 
of t h e p r o t e i n . 
ESTIMATION OF PROTEIN 
P r o t e i n e s t i m a t i o n was c a r r i e d out a c c o r d i n g to Lowry 
e t a l (1951) u s i n g bovine serum albumin as s t a n d a r d . 
FIG.3 QUANTITATION OF AFP BY ROnTTF^T TMMimOASSAY 
3A. Standard curve fo r r a t AFP, I n s e r t 
i n Fig.3A shows a t y p i c a l p a t t e r n of 
r o c k e t s f o r a s e r i e s of t h r o e s t andard 
c o n c e n t r a t i o n ( i n d u p l i c a t e ) of r a t 
AFP. 
3B. A t y p i c a l rocke t a s say p l a t e for the 
q u a n t i t a t i o n of r a t AFP. Sample 
w e l l s con t a in v a r y i n g c o n c e n t r a t i o n 
of AFP (open r o c k e t s a r e due t o 
t h e h igh c o n c e n t r a t i o n of AFP), 
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PREPARiiTION OF ViJlIOUS AFFINITY MTRICBS 
PREPiJliiTIOKT OF CYANOGEN BROMIDE (CNBr) 
CNBr was S i m t h e s i z e d i n t h i s l a b o r a t o r y a c c o r d i n g t o 
t h e p r o c e d u r e d e s c r i b e d i n o r g a n i c s y n t h e s i s V o l , 2 . A 
w h i t e c r y s t a l l i n e p r o d u c t w i t h m e l t i n g p o i n t of 4 9 - 5 1 C 
and b o i l i n g p o i n t of 6 0 - 6 1 C was o b t a i n e d . C r y s t a l l i n e 
CNBr was d i s s o l v e d i n a c e t o n i t r i l e ( 2 g CNBr/ml CH_CN) and 
s t o r e d f r o z e n i n s m a l l a l i q u o t s , 
CNBr ACTIVATION OF SEPHAR0SE-4B 
S e p h a r o s e - 4 B was a c t i v a t e d u s i n g CNBr (200 mg CNBr/ 
ml of g e l ) e s s e n t i a l l y a c c o r d i n g t o March e t a l ( 1 9 7 4 ) . 
Amount of CN"*" i o n s l i n k e d t o t h e g e l was q u a n t i t a t ed by a 
c o l o r i m e t r i c p r o c e d u r e of Kohn and Wi l chek ( 1 9 7 8 ) . 
U s u a l l y 6 - 8 |j, m o l e s of c y a n i d e i o n s were bound p e r ml of 
t h e packed g e l v o l u m e , 
PREPARATION OF CONC/iNAVALIN A-SEPHAROSE (CON A-SEPHARQSE) 
Con-A was c o u p l e d to CNBr a c t i v a t e d s e p h a r o s e - 4 B 
a c c o r d i n g t o P o r a t h e t a l ( 1 9 6 7 ) . U s u a l l y a b o u t 5 mg Con-A 
was c o u p l e d p e r ml of packed s e p h a r o s e - 4 B v o l u m e . 
PREPAR/^TIOiT OF ANTI-RAT AFP SEPHARQSE 
R a b b i t a n t i - r a t AFP IgG- VTB-S i s o l a t e d from 20 ml of 
r a b b i t a n t i - r a t AFP serum a s d e s c r i b e d e a r l i e r . I t was 
s u b s e q u e n t l y c o u p l e d t o t h e CNBr a c t i v a t e d s e p h a r o s e - 4 B a s 
d e s c r i b e d a b o v e . 
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Anti-iiPP sepharose immunoadsorbent was used t o 
i s o l a t e r a t AFP from amniot ic f l u i d or f e t a l serum a s 
desc r ibed by Ruos l ah t i ( I 9 7 6 ) . iiPP p u r i f i e d by t h i s 
procedure was homogeneous by v a r i o u s c r i t e r i a used f o r AFP 
(see c h a r a c t e r i z a t i o n of r a t AFp), However, t h e coupled 
l i g a n d (IgG) showed a tendency t o l e a k out ( d i s s o c i a t e ) 
slowly from t h e column. 
PRBPAR/iTION OF FETO-NEONATAL Ri^ TISSUE EXTR/iCTS 
The f e t u s e s (18 and 20 E) and p o s t n a t a l r a t s ( 1 , 3» 
7 , 14 , 2 1 , 28 d old) were ob ta ined from t imed p r e g n a n c i e s . 
Neonata l r a t s were k i l l e d by p u t t i n g them on cracked i c e or 
by e the r a n a e s t h e s i a . Var ious f e t o - n e o n a t a l organs ( b r a i n , 
thsrmus, h e a r t , l u n g , l i v e r , stomach, i n t e s t i n e , s p l e e n , 
p a n c r e a s , kidney and a d r e n a l s ) were r a p i d l y exc ised from 
each r a t and washed wi th c o l d phosphate bu f f e r ed s a l i n e 
(PBS) (8 .0 g NaCl, 0,2 g KCl, 2.0 g Na2HP0 , O.4 g ^^2^^A 
per l i t r e ) . F u l l t h i c k n e s s d o r s a l sk in was d i s s e c t e d off 
and washed s e v e r a l t imes with PBS. The sk in was p laced on 
a p e t r i d i s h , s t r a t u m comoum s i d e down,and f reed off t h e 
subcutaneous t i s s u e s by s c r a p p i n g t o produce t h i n p i e c e s 
of s k i n . Homogenates of sk in ( a f t e r f r e e z i n g and thawing 
the t i s s u e t h r e e t imes) and of v a r i o u s o t h e r f e t o - n e o n a t a l 
t i s s u e s were p r epa red in PBS, pH 7 .4 and c l e a r e d a t 22000 x 
g . Clear s u p e r n a t a n t s ( t i s s u e e x t r a c t s ) from v a r i o u s 
t i s s u e s were c o l l e c t e d r.nl used f o r v a r i o u s a n a l y s e s . 
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PREPARATION OF HUMAN FETAL BRAIN EXTRACTS 
Human fetal brain samples were obtained from legally-
aborted fetuses and still births 2-4 hrs after abortion, 
with due consent from women undergoing treatment at Queen 
Marry Hospital, King George Medical College (KGMC), Lucknow. 
Fetal age was ascertained from menstrual age and from crown 
to lump length of the fetuses. Amniotic fluid and cord 
serum samples were also collected at KGMC, Lucknow. The 
brain samples were stored frozen at -20 C and used within a 
week after excision. Brain tissue homogenates were 
prepared in PBS in a Potter Elvehjem homogenizer using a 
motor driven teflon coated pestle. The homogenates were 
centrifuged at 22,000 x g for 1 hr at 4°C and the supernatants 
obtained were treated as brain extracts and used for various 
analyses. 
DBTER^IIWATION OF FETAL BLOOD CONTAMINATION IN VARIOUS RA.T 
AND HUMAN TISSUE EXTRACTS 
In order to determine whether serum like antigenic 
component (AFp and albumin) detected in rat and human brain 
as well as other tissue extracts reflected artifactual 
contamination, heme concentrations in the fetal blood and 
various tissue extracts was determined. For this experiment, 
various tissue extracts 100 mg wet tissue weight 0.1 ml 
were prepared in 10 mM Tris, 1.5 mM EDTA, pH 7.4 (TE buffer). 
The buffer used is hypotonic (low ionic strength) and was 
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chosen t o ensure hemolys is of r ed blood c e l l s t h a t might 
have been p r e s e n t i n the t i s s u e e x t r a c t s . Blood was 
d i l u t e d and homolyzed 1:100, 1:200, 1:400, 1:800 wi th TE 
b u f f e r . R e l a t i v e heme c o n c e n t r a t i o n s i n blood and t i s s u e 
e x t r a c t s were e s t ima ted from s p e c t r o p h o t o m e t r i c absorbance 
a t 414 nm. The minimal b lood c o n c e n t r a t i o n r e q u i r e d fo r 
d e t e c t i o n of an t igen (AFP and albumin) was e s t i m a t e d by 
c o r r e l a t i n g O.D. a t 414 nm wi th the development of p r e c i p -
i t i n l i n e s by double d i f f u s i o n method. When f e t a l blood 
was d i l u t e d t o y i e l d c o n c e n t r a t i o n of heme in v a r i o u s 
t i s s u e e x t r a c t s , i t f a i l e d t o form a d e t e c t a b l e p r e c i p i t i n 
l i n e a g a i n s t an t i - i iFp or a n t i - a l b u m i n on double d i f f u s i o n . 
This o b s e r v a t i o n i n d i c a t e s t h a t APP and albumin i n v a r i o u s 
t i s s u e e x t r a c t s a re not e n t i r e l y due t o the f e t a l blood 
con t amina t i on . The magnitude of blood contamina t ion i n 
v a r i o u s t i s s u e e x t r a c t s was c a l c u l a t e d by comparing heme 
c o n c e n t r a t i o n with t h e s t a n d a r d f e t a l blood samples . 
PREPARATION OF BRAU^ CELLS BY FIECHANICAL DISSOCIATION 
Mechanical d i s s o c i a t i o n procedure (Benda e t a l , 1975) 
f o r t h e p r e p a r a t i o n of b r a i n c e l l s was used wi th some 
m o d i f i c a t i o n s . The vAiole b r a i n s (18-20 f e t a l and 1-7 
p o s t n a t a l r a t s ) were e x c i s e d from the cranium a t t h e l e v e l 
of medulla oblongata and washed i n i s o t o n i c b u f f e r ( I57 mM 
NaCl, 5 .4 mM KCl, 0.17 mM lTa2HP0^, 0.22 mM KH^PO^, 5.5 mM 
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g l u c o s e , 59 .0 mM s u r c o s e , pH 7 . 2 ) . Bach b r a i n was c a r e -
f u l l y c leaned of p ia ma t t e r and blood v e s s e l s , washed 
twice with i s o t o n i c buf fe r and minced t o about 1-2 cubic 
mm p i e c e s wi th f i n e s c i s s o r . The minced t i s s u e (1 -2 g) 
was suspended in L-15 medium (supplemented wi th 25 QM 
HEPES bu f f e r and 6 mg/ml g lucose ) and mechan ica l ly 
d i s s o c i a t e d by p a s s i n g the t i s s u e s e v e r a l t i m e s through a 
f i ne t i pped P a s t e u r p i p e t t e . The s o l u t i o n was a l lowed t o 
s t and for 5 min and the procedure r e p e a t e d t h r i c e on 
decanted p e l l e t . The pooled s u p e r n a t a n t c o n t a i n i n g the 
c e l l suspens ion was c e n t r i f u g e d a t 50 x g fo r 3 min. The 
c e l l s were recovered and washed twice wi th L-15 medium. 
For demons t ra t ion of p r o t e i n s y n t h e s i s (AFP and a lbumin ) , 
b r a i n c o l l s were a l s o washed once w i th l e u c i n e - f r e e E a g l e ' s 
MEM medium c o n t a i n i n g 25 mM HEPES, 6 mg/ml g l u c o s e , 1 vM 
- 1 - 1 
g lu tamine , 100 ng ml p e n i c i l l i n , 100 \xg ml s t r ep tomyc in , 
and 0.25 p.g ml fung izone . The p rocedure r o u t i n e l y 
y i e l d e d suspens ion of 90-95f° v i a b l e c e l l s {Q.2'/° t r y p a n b lue 
exc lus ion ) wi th very few c l u s t e r s of 5-10 c e l l s . 
PREPAR/iTION OF BRADJ CELLS BY ENZYMATIC PROCEDURE 
Brain c e l l s were a l s o p repared from 7-14 d old 
p o s t n a t a l r a t s by t r y p s i n d i g e s t i o n p rocedure a s d e s c r i b e d 
by Raizada e t a l (1980) wi th a few m o d i f i c a t i o n s . B r i e f l y , 
t he minced b r a i n t i s s u e (1 -2 g) was suspended i n 50 ml of 
i s o t o n i c buf fe r c o n t a i n i n g 0.25/° w/v t r y p s i n a t 37°C fo r 
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15 min with a constant and gent le s t i r r i n g . After incuba t -
i o n , t i s s u e suspension was allowed to stand for 5 min. The 
undissociated t i s s u e was t r i t u r a t e d several t imes with a 
Pas teur p ipe t t e followed by t ryps in t reatment and subjected 
t o the above procedure. The c e l l suspension were pooled 
and the c e l l s col lected by cent r i fugat ion a t 50 x g for 3 
min. About 90/« of -tiie d i s soc ia ted b i^ in c e l l s seems t o be 
viable (0,2/°, trypan blue exc lus ion ) . 
RAT SKICT T^yPMl^ TT OtTLTURES 
C u l t u r e s of sk in e x p l a n t s from newborn r a t were s e t 
up a s d e s c r i b e d by H a l p r i n e t a l ( 1979 ) . F u l l t h i c k n e s s 
d o r s a l sk in was d i s s e c t e d off , washed f i r s t w i th 70/° 
a l c o h o l (2 min) and then t h o r o u ^ i l y wi th PBS. The sk in was 
p l aced on a p e t r i d i s h , s t r a t u m comium s i d e down, and f reed 
of the subcutaneous t i s s u e s by s c r a p p i n g t o produce t h i n 
p i e c e s of sk in and -then chopped i n t o smal l p i e c e s (2 mm ) . 
E igh t sk in e x p l a n t s were p l a c e d in each c u l t u r e f l a s k , 
dermal s i d e down, and al lowed t o s t and for 5 min and 
main ta ined i n l e u c i n e - f r e e MEM medium wi th supplement 
mentioned e a r l i e r . Skin e x p l a n t s c u l t u r e s of 7 , 14 , and 21 
d o ld r a t were a l s o s e t up by t h e procedure of H a l p r i n e t 
a l (1979) and Fusenig e t a l ( 1979 ) . 
PREPARATION OF HEPAQTOCYTES 
Hepa tocy tes were p r e p a r e d from r a t l i v e r by s l i g h t 
m o d i f i c a t i o n of the c o l l a g e n a s e p e r f u s i o n method of Berry 
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and Friends (1969) and Seglen (1976). The i n i t i a l wash oat 
perfusion, through the hepat ic p o r t a l ve in , was performed 
in the anaesthet ized animal (21 d old, 1 month old, and 
adult r a t s ) a t room temperature with Ca amd Mg free PBS, 
pH 7.4 supplemented with 25 mM HEPES buffer , O.l/o BSA and 
O.l/o glucose (buffer A). The l i v e r were then perfused with 
buffer containing Ca"^"*" (10 mM) and 0.04 mg/o collagenase 
for 10-15 min u n t i l the l i v e r began to d i s i n t eg ra t e v i s i b l y . 
The perfusion was repeated with buffer A for about 5 min. 
The l i v e r was then excised and dispersed with blunt forceps 
in buffer A. The c e l l suspension was passed through muslin 
cloth and the c e l l s recovered by cent r i fugat ion at 50 x g 
for 2 min. The c e l l p e l l e t was washed by resuspending in 
buffer A and recovering the c e l l s by cen t r i fuga t ion . 
F ina l ly , hepatocytes were washed xirith L-15 medium supplemented 
with 25 mN HEPES, 1 mM ^Lutamine, 7 mM glucose and 
a n t i b i o t i c s . The v i a b i l i t y of c e l l s was checked by trypan 
blue (0.2y0 exclusion. Usually 90-95?^ viable preparat ion of 
hepatocytes could be obtained. The hepatocytes were counted 
with the help of a henocytotometer and su i tab le quanti ty of 
c e l l s (1-3 X 10 ce l l s ) were used for the determination of 
the synthesis and secre t ion of AFP and albumin in short term 
cul ture of hepatocytes . 
Hepatocytes from f e t a l (18 and 20 E) and neonatal 
( l , 7, 14 d old) r a t l i v e r were prepared by d i s soc ia t ion of 
l i v e r s l i c e s by collagenase d iges t i on . 
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DETERMINATION OF INCORPOMTION OF r-'-'^ G]-LEUCTITE INTO AFP 
AND ALBUMPT BY BilT BRATN CELLf^  HTg'ATOCYTES AND SKIN 
EXPL/INT CULTURES 
I n c o r p o r a t i o n of [ C ] - l e u c i n e i n t o AFP and albumin 
by b r a i n c e l l s , h e p a t o c y t e s , and sk in exp lan t c u l t u r e s 
main ta ined i n l e u c i n e f r e e medium f o r 6 h r s was determined 
by f o l l o w i n g immunoprec ip i t a t ion of l a b e l l e d AFP and albumin 
i n c e l l l y s a t e s ( s y n t h e s i s ) and medium ( s e c r e t i o n ) . A l i q u o t s 
of the c e l l l y s a t e s or t h e c u l t u r e medium were mixed wi th 
100 ^1 of newborn r a t serum ( d i l u t e d t e n t imes ) t o p rov ide 
s u f f i c i e n t c a r r i e r /iFp and albumin f o r immunoprec ip i t a t i on 
of l a b e l l e d AFP and a lbumin . AFP was then p r e c i p i t a t e d by 
t h e a d d i t i o n of 0.5 ml anti-iLFP and the mix tu re was kept a t 
37 C f o r 1 h r and ove rn igh t a t 4 C. The fo l l owing day, t h e 
immunoprec ip i t a tes were ob ta ined by c e n t r i f u g a t i o n a t 4.OOO 
rpm fo r 15 min a t 4°0 . The s u p e r n a t a n t s ob t a ined were then 
used f o r immunoprec ip i t a t ion of albumin by a d d i t i o n of 0 ,7 
ml of an t i -RSA. The amount of a n t i - r a t AFP and anti-RSA 
used he re was determined by p r e l i m i n a r y t i t r a t i o n s t o g ive 
maximum p r e c i p i t a t i o n of l a b e l l e d AFP and a lbumin . I t was 
confirmed by the o b s e r v a t i o n s t h a t (a) a second a d d i t i o n 
of a n t i - r a t AFP or anti-RSA t o t h e s u p e r n a t a n t s ( a f t e r 
immunoprec ip i t a t ion of AFP and albumin) did not r e s u l t i n 
v i s i b l e immune p r e c i p i t a t i o n , and (b) a second a d d i t i o n of 
c a r r i e r f e t a l serum, fo l lowed by f u r t h e r a d d i t i o n of a n t i -
r a t AFP or ant i -RS/i t o t h e s e s u p e r n a t a n t s did not r e s u l t i n 
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t h e appearance of a d d i t i o n a l r a d i o a c t i v i t y i n e i t h e r AFP 
or albumin i m m u n o p r e c i p i t a t e s . The order of immunoprec ip i t -
i on of AFP and albumin was a l s o r eve r sed i n o r d e r t o s e e 
whether i t a f f e c t e d t h e amount of r a d i o a c t i v e AFP or albumin 
p r e c i p i t a t i o n . No s i g n i f i c a n t d i f f e r e n c e s were n o t e d . The 
immunoprec ip i t a tes were washed s e v e r a l t imes wi th PBS 
c o n t a i n i n g O.l/o l e u c i n e (PBS-leucine) t o remove n o n s p e c i f i c 
a d s o r p t i o n of [ H ] - l e u c i n e , F i n a l l y , t h e immunoprec ip i t a t e s 
were d i s s o l v e d i n O.3 ml /» 0 . 1 M NaOH and [ -^H] - rad ioac t iv i ty 
was determined i n a l i q u i d s c i n t i l l a t i o n coun te r (Packard 
model 3330) . 
DETERMIMTION OF TOTAL PRQTEM SYNTHESIS MD SECRETION 
Tot^ l p r o t e i n s y n t h e s i s ( i n c e l l l y s a t e s ) and 
s e c r e t i o n ( i n medium) was determined by fo l l owing t h e [ C ] -
l e u c i n e i n c o r p o r a t i o n i n t o TCA i n s o l u b l e f r a c t i o n s . 
A l i q u o t s (0 .5 ml) of c e l l l y s a t e s and t h e medium were mixed 
wi th 10 \xl NRS ( c a r r i e r p r o t e i n ) and the p r o t e i n s were 
p r e c i p i t a t e d by the a d d i t i o n of 0.5 ml 10/» TCA. The tubos 
were mixed and kept fo r 3 h r s a t 4°C. The samples were t hen 
c e n t r i f u g e d a t 4OOO rpm f o r 10 min a t 4°C. The p r e c i p i t a t e s 
were washed s e v e r a l t imes wi th co ld 5fo TCA c o n t a i n i n g 0,lfo 
l e u c i n e . F i n a l l y , t he p r e c i p i t a t e s were d i s s o l v e d in 0 .5 ml 
0 , 1 M NaOH and r a d i o a c t i v i t y was determined i n an a l i q u o t of 
0.25 ml i n a T r i c a r b l i q u i d s c i n t i l l a t i o n c o u n t e r . 
R E S U L T S 
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SPECIFICITY OF MTI-AFP^ 
Rabbi t anti~AF serum was absorbed s u c c e s s i v e l y wi th 
l y o p h i l i z e d NRS (O.3 mg/ml) , t i l l no v i s u a l immunoprec ip i t -
a t i o n occurred by f u r t h e r a d d i t i o n of NRS, and t h u s made 
s p e c i f i c f o r AFp. The s p e c i f i c i t y was confirmed by 
o b t a i n i n g s i n g l e p r e c i p i t i n a r c on IBP wi th a m n i o t i c f l u i d , 
f e t a l serum (FS) , f e t a l e x t r a c t (FE) and p regnan t r a t 
serum (PRS) (Fig.4A and 4B) and no r e a c t i o n w i th NRS. Double 
d i f f u s i o n a n a l y s i s of anti~AFP a l s o y i e l d e d s i n g l e l i n e 
showing complete l i n e of i d e n t i t y wi th AFP from r a t AF, FS 
and FE ( F i g . 5 A ) . Anti-AFP was used for i n i t i a l d e t e c t i o n 
of AFP dur ing the p u r i f i c a t i o n of r a t AFP by the procedure 
de sc r ibed below, 
AN IMPROVED PROCEDURE FOR ISOLATION OF Ri\T AFP 
DIRECT NEGATIVE IMMUNOABSORPTION OF AMNIOTIC FLUID (AF) 
Adult r a t serum p r o t e i n s were removed from amnio t i c 
f l u i d (18 d of g e s t a t i o n f e t u s e s ) by s u c c e s s i v e a d d i t i o n of 
r a b b i t anti~NRS IgG- a t o p t i m a l p r e c i p i t a t i o n p r o p o r t i o n . 
The mix ture (AF and IgG) was incuba ted fo r 2 h r s a t 37°C 
and overn ight at 4 C; fo l lowed by removal of t h e immuno-
p r e c i p i t a t e . The a b s o r p t i o n of AF wi th ant i-NRS IgG was 
cont inued t i l l no v i s u a l immunoprec ip i t a t ion occu r r ed . The 
F I G . 4 IMMJNQELECTROPHQRRTIG ( lEP^ ANALYSIS OF RAT 
AFP DURING ITS ISOLATION FROM AMNIOTIC FLUID 
PB, f e t a l e x t r a c t ; PRS, p r e g n a n t r a t serum; 
F S , f e t a l s e rum; AF, a m n i o t i c f l u i d } AFP, 
Y g l o b . , AFP-IgG m i x t u r e ; 
AFP, a l p h a - f e t o p r o t e i n ; Ant i -AFP , a n t i s e r u m 
made s p e c i f i c f o r AFP; A n t i - A F , a n t i -
a m n i o t i c f l u i d . 
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FIG.5 CHABiiCTERIZ/lTION OF RAT AFP 
5A.a: Double immunodiffusion a n a l y s i s of 
p u r i f i e d r a t AFP. 
P e r i p h e r a l w e l l 1 , p u r i f i e d r a t AFP; 
2, f e t a l serum; 5 , p u r i f i e d AFPj 
4, f e t a l e x t r a c t ; 5 , amniot ic f l u i d . 
C e n t r a l we l l con t a in an t i -AFP* . 
5A.b: Double immunodiffusion a n a l y s i s of AFP, 
Pe r iphe ra ] w e l l 1 , amnio t i c f l u i d ; 
2, AFP.y-g lobu l in m i x t u r e j 5 and 4, 
p u r i f i e d AFP; 5 , f e t a l serum. C e n t r a l 
wel l c o n t a i n a n t i - a m n i o t i c f l u i d ( a n t i - A F ) . 
5A.C! Double immunodiffusion a n a l y s i s of AF'P. 
P e r i p h e r a l w e l l 1 , anti-RS/v; 2, a n t i - A F ; 
3, an t i -AFP^; 4, anti-NRSj 5 , an t i -NRbS. 
C e n t r a l we l l con t a in p u r i f i e d AFP, 
5B s PAGE (107^) of i s o l a t e d ' s l o w ' ajid ' f a s t * 
v a r i a n t of r a t AFP. 
Gel a and c, ' s l ow ' and ' f a s t ' v a r i a n t 
of AFP (20 |ig each) ; b , t o t a l p u r i f i e d 
AFP (50 ^ig), 
5C 5 Double d i f f u s i o n a n a l y s i s of i s o l a t e d 
' s l o w ' and ' f a s t ' r a t AFP v a r i a n t s . 
5C,a: P e r i p h e r a l w e l l 1 , ' s l o w ' AFP v a r i a n t ; 
2, t o t a l AFP; 3 , ' f a s t ' AFP v a r i a n t ; 
4, amniot ic f l u i d . C e n t r a l w e l l c o n t a i n 
a n t i - r a t AFP. 
5 0 , b : P e r i p h e r a l wel l 1-4 s i m i l a r t o 5 0 , a . 
C e n t r a l w e l l c o n t a i n a n t i - r a t AFP 
' s l e w ' v a r i a n t . 
5D : Crossed- immunoelec t rophorGsis of 
p u r i f i e d r a t AFp. 
G, po lyac ry lamide gel ( a f t e r e l e c t r o -
p h o r e s i s of AFP). 
5B : Double immunodiffusion a n a l y s i s of Con A-
a f f i n i t y molecu la r v a r i a n t s of r a t AFP, 
P e r i p h e r a l w e l l 1 , p u r i f i e d AFP ( t o t a l ) ; 
2, Con-A r e a c t i v e ; 3 , Con-A n o n r e a c t i v e 
v a r i a n t ; 4 , amniot ic f l u i d ; 5 , f e t a l 
serum. C e n t r a l we l l c o n t a i n a n t i - A F P . 
5F : Molecular weight d e t e r m i n a t i o n of p u r i -
f i ed r a t Ai'P by SDS-PAGE. 
5G ; An e l ec t rophore tog ram (lO'/o PAGE) of 
amn io t i c f l u id p r o t e i n s . 
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immunoprecipitate thus formed wOr© removed by centrifugation 
at 10,000 rpm for 30 min at 4°C. The supernatant was then 
analysed for APP and its contaminants. Double diffusion 
analysis of the supernatant revealed no albumin or other 
adult rat serum proteins (Fig,5A.b) except AFP and IgG of 
rabbit origin ("Pig.JAb), Presence of excess of Igs in the 
supernatant was revealed by formation of several precipitin 
arcs around the wells on IBP due to cross reaction between 
anti-NRS Ig and anti-APP which contained excess of NRS 
(Fig.40). 
SEPARATION OF AFP FROM AFP AND IMMUNOGLOBULINS MIXTURE 
The supernatant (35O mg protein) containing AFP and 
rabbit immunoglobulins (IgG) was fractionated on DEAE-
cellulose column (2.5 x 10 cm) pre-equilibrated with 10 mM 
phosphate buffer, pH 8.0 (buffer I). Unadsorbed proteins 
were collected with two bed volumes of buffer I. The 
adsorbed proteins were eluted stepwise with buffer I contain-
ing 0.05 M NaCl and 0.2 M NaCl (Fig.6). The elution profile 
was monitored by following absorbance at 280 nm. Three protein 
peaks thus obtained were analyzed for AFP, albumin and 
rabbit IgG by double diffusion and IBP using appropriate 
antisera (Table VI), AFP was found to be present in the 
third peak only with no apparent contamination of the proteins 
of either rat or rabbit origin. Protein rich fractions from 
the third peak were pooled,dicily20d against water and 
lyophilized. 
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CHARAGTEfilZiiTION OF RI.T AFP 
P u r i f i e d APP y i e l d e d s i n g l e p r e c i p i t i n l i n e w i t h 
c o m p l e t e i m m u n o l o g i c a l i d e n t i t y w i t h o t h e r A F P ' s on d o u b l e 
d i f f u s i o n a g a i n s t a n t i - i i P o r a n t i - Z J ? ( F i g . 5 A , a and 5 A . b ) . 
I t a l s o formed a s i n g l e l i n e on lEP ( F i g . 4 D and 4 E ) . No 
a lbumin o r o t h e r serum p r o t e i n s of e i t h e r r a t o r r a b b i t 
o r i g i n c o u l d be d e t e c t e d by d o u b l e d i f f u s i o n ( F i g , 5 A . c ) , 
U n l i k e APP IgG m i x t u r e ( F i g . 4 0 ) , no p r e c i p i t i n a r c s a r o u n d 
t h e w e l l s w e r e o b t a i n e d w i t h p u r i f i e d AFP when t h e t r o u g h s 
were d e v e l o p e d w i t h a n t i - A P P , t h e r e b y , d e m o n s t r a t i n g 
c o m p l e t e e l i m i n a t i o n of i m m u n o g l o b u l i n s of r a b b i t o r i g i n 
( F i g . 4 F ) . 
PAGE OP R/.T AFP: ISOLATIOIT OF 'SLOW AND 'FAST' MOVCTG 
VARIANTS BY PREPARATIVE POLYACRYL/iMIDE SMB &EL ELECTRO-
PHORESIS 
Rat APP r e v e a l e d h e t e r o g e n e i t y on PAGE ( l O / O , 
y i e l d i n g ' s l o w ' and ' f a s t ' moving v a r i a n t s ( P i g . 5 B . b ) , The 
two v a r i a n t s of APP were i s o l a t e d by p r e p a r a t i v e p o l y a c r y l -
amide s l a b ( 5 mm) g e l (10%) e l e c t r o p h o r e s i s of APP f o r 6 h r s 
a t 4 G a t a c o n s t a n t v o l t a g e of 10 V/cm of t h e g e l . A f t e r 
c o m p l e t i o n of e l e c t r o p h o r e s i s , a p o r t i o n of t h e s l a b g e l 
was s t a i n e d w i t h coomass i e b r i l l i a n t b l u e . P o r t i o n s of t h e 
g e l c o r r e s p o n d i n g t o t h e two s t a i n e d b a n d s o f ' s l o w ' and 
' f a s t ' APp v a r i a n t were c u t s e p a r a t e l y a n d minced by p a s s i n g 
t h r o u g h a s y r i n g e . S u b s e q u e n t l y , t h e p r o t e i n ( ' s l o w ' and 
• f a s t ' iiPp v a r i a n t ) were s e p a r a t e l y e x t r a c t e d w i t h 0 . 0 2 M 
53 
p h o s p h a t e b u f f e r , pH 7 . 5 , d i a l y z e d i n t h e same b u f f e r and 
l y o p h i l i z e d . 
Each of t h e two v a r i a n t s i s o l a t e d by p r e p a r a t i v e 
PAGE was found t o be homogeneous on r e - e l e c t r o p h o r e s i s on 
PAGE u n d e r s i m i l a r c o n d i t i o n s ( E i g . 5 B . a and 5 B . c ) . The two 
v a r i a n t s of /tEP ( s l o w and f a s t ) a l s o m i g r a t e d w i t h t h e i r 
o r i g i n a l e l e c t r o p h o r e t i c m o b i l i t y on PAGE. 
PRODUCTION OF ANTI-AFP ATO ANTI-AFP 'SLOW VARI/iNT: 
IMMUNOLQGICJLL IDENTITY OF 'SLOW AND 'EAST' RAT AFP 
P u r i f i e d AFP was i n j e c t e d i n r a b b i t s t o s t u d y 
whe the r I t i n d u c e d AFP s p e c i f i c a n t i s e r u m . I n i t i a l l y 200 
[ig iiFP, c o n t a i n i n g b o t h s l o w and f a s t v a r i a n t s , was 
e m u l s i f i e d i n CFA and a d m i n i s t e r e d t h r o u g h f o o t p a d s . 
A f t e r onQ week, 200 [xg AFP i n CFA was i n j e c t e d i n t r a d e r m a l l y 
a t m u l t i p l e s i t e s a t 10 day i n t e r v a l s (3 i n j e c t i o n s ) . A f t e r 
t h e l a s t i n ; ; e c t i o n , t h e a n i m a l s r e c e i v e d two s u b c u t a n e o u s 
b o o s t e r d o s e s ( w i t h o u t CFA) of 500 \xg AFP. The a n i m a l s 
were b l e d a f - e r l a s t i n j e c t i o n , a n a l y z e d f o r a n t i b o d y 
t i t r e , and b l e d when t h e t i t r e was maximum. S p e c i f i c i t y 
of t h e a n t i s e r u m was a n a l y z e d by d o u b l e d i f f u s i o n and l E P , 
R a b b i t a n t i - A F P showed s i n g l e p r e c i p i t i n l i n e on 
d o u b l e d i f f u s i n v i t h r a t a m n i o t i c f l u i d and p u r i f i e d AFP 
w i t h a l i n e of f u s i o n ( F i g . 5 C . a ) , I t d i d n o t r e v e a l any 
r e a c t i v i t y w i t h no rma l a d u l t r a t se rum, i n d i c a t i n g t h e 
s p e c i f i c i t y of t h e a n t i s e r u m f o r AFP. 
5 J 
A n t i - r a t AFP 'slow' va r i an t (anti-AFP 'S ' ) was a lso 
ra i sed in r abb i t s following the immunization schedule 
described for t o t a l AFP. Both anti-AFP and anti-AFP ' S ' 
showed s imilar s p e c i f i c i t y . The two AFP va r i an t s ind iv idua l ly 
formed single p r e c i p i t i n l i n e against e i the r anti-AFP or 
anti-AFp ' S ' (Fig.5C.a and 5C,b) . A complete immunological 
i d e n t i t y was also displayed among AFP ( t o t a l ) , AFP ' s low ' , 
iiFp ' f a s t ' and AFp present in amniotic f l u i d . These obser-
vat ion c l ea r ly indica te t h a t two bands of AFp observed on 
107? PAGE were i t s charge v a r i a n t s which have common a n t i -
genic determinant s i t e . 
Heterogeneity of r a t AFP was also displayed on 
crossed Immunoelectrophoresis ca r r ied out according to Clark 
and Freeman (1967). Rat AFP was resolved on 10/« PAGE and 
a f t e r e l ec t rophores i s , the gel was cut long i tud ina l ly in to 
two halves* One half was placed on if" agarose p l a t e con ta in -
ing uniformly d i s t r ibu ted anti-ZiFP and electrophoresed in 2nd 
dimension a t r i gh t angle to the f i r s t (PAGE), AFP yielded 
two p r e c i p i t i n peaks fusing with each other (Fig.5D) 
ind ica t ing again that AFP i s heterogenous on PAGE y i e ld ing 
two v a r i a n t s which are immunologically i d e n t i c a l . Hetero-
geneity of rat ikFP on PAGE i s wel l documented and probably 
a r i s e s due to a difference in the s i a l i c acid content of the 
two charge va r i an t s (Smith and Kel leher , 1980j Aussel and 
Masseyoff, 1977; Versee and Bare l , 1976; V/atanabe ot a l , 
1975; Benassayag et a l . 1975) . 
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ANALYSIS OF CON-A AFFINITY MOLECUL/Jt VARIAM!S OF RAT /iPP 
AND THBIR IMMUNOLOGICAL IDENTITY 
P u r i f i e d r a t AFP was chromatographed on Con A-sepharose 
column t o e v a l u a t e Con A - r e a c t i v e a n d n o n - r e a c t i v e AFP 
con ten t a cco rd ing t o Smith ot a l (1977) . AFP was a p p l i e d on 
Con A-sepharose column ( 0 . 8 x 10 cm) an.d unadsorbed f r a c t i o n 
was e l u t e d wi th t h e s t a r t i n g bu f f e r (0 .05 M Tr i s -HCl , pH 7.6 
c o n t a i n i n g 1 M NaCl, 1 mM MgCl2» "'' ^^ ^nCl^ and 1 mM CaCl^) . 
Adsorbed f r a c t i o n (Con-A r e a c t i v e AFP) was then e l u t e d wi th 
the s t a r t i n g buf fe r c o n t a i n i n g 0 . 1 M mannose, E l u t i o n 
p r o f i l e was monitored by measur ing o p t i c a l d e n s i t y a t 280 
nM. AFP con ten t i n the unadsorbed and adsorbed f r a c t i o n s 
was ana lyzed by rocke t a s s a y . Con A-nonreac t ive and 
r e a c t i v e v a r i a n t s were 52 + 2% and 47 + 4^° of t he t o t a l AFP, 
Con A-nonreac t ive AFp v a r i a n t T^hen rechromatographed on 
the same Con A-sepharose column, i t did not r e v e a l any 
b i n d i n g i n d i c a t i n g t h a t i t was not contaminated w i th over 
loaded Con A - r e a c t i v o v a r i a n t , Our v a l u e s cor responds wel l 
wi th the r e p o r t e d va lue fo r Con A - r e a c t i v o and n o n - r e a c t i v e 
i'lFP v a r i a n t (Smith and K e l l e h e r , 1980 ) . 
Con A - r e a c t i v e and n o n - r e a c t i v e r a t AFP v a r i a n t s 
were a l s o ana lyzed for -their immunological r o l a t e d n e s s by 
double d i f f u s i o n . The two v a r i a n t s i n d i v i d u a l l y formed a 
s i n g l e p r e c i p i t i n l i n e wi th a complete fus ion among each 
o t h e r and wi th /J'P ( t o t a l ) and amnio t ic f l u i d ( F i g . 5 E ) . 
This o b s e r v a t i o n i n d i c a t e t h a t t h e two v a r i a n t s obta ined 
Gx 
from Con A-sepharose a f f i n i t y chromatography a r e immuno-
l o g i c a l l y i d e n t i c a l . H e t e r o g e n e i t y of r a t AFP on Con-A 
sepharose have now been shown t o he due to a d i f f e r e n c e i n 
t h e amount of N-ace ty lg lucosamine , g a l a c t o s e and s i a l i c 
ac id i n the two v a r i a n t s (Bayard and K e r c k a e r t , 1981 ) . I t 
ha s a l s o been demonst ra ted t h a t Con A - a f f i n i t y molecu la r 
v a r i a n t s of AFp have d i f f e r e n t o r i g i n s and a r e g l y c o s y l a t e d 
d i f f e r e n t l y (Smith and K e l l e h e r , 1980; R u o s l a h t i and Adamson, 
1978) , The y o l k sac s y n t h e s i z e s Con A-nonreac t ive wh i l e 
f e t a l l i v e r e x c l u s i v e l y produces Con A - r e a c t i v e APp v a r i a n t , 
ESTRADIOL BINDING ASSAY OF RAT AFP 
I n t e r a c t i o n of e s t r a d i o l wi th r a t AFP was s tud ied by 
dex t ran coated cha rcoa l p r o c e d u r e . Sca tchard a n a l y s i s of 
[ ^ H ] - e s t r a d i o l b i n d i n g assay of AFP ( F i g , 7 ) y i e l d e d an 
a s s o c i a t i o n c o n s t a n t Ka = 1.4 x 10 M wi th about one 
b ind ing s i t e per mol of AI'P, This s t o i c h e i o m e t r y of e s t r a -
d i o l i n t e r a c t i o n with r a t AFP i s i n agreement with o b s e r v a t -
ions of s e v e r a l au thors (Aussel e t a l , 1979, 1978j Versee 
and B a r e l , 1978a; Aussel and Massyeff, 1977; Soloff o t a l , 
1976) . Sca tchard p l o t of E was c u r v i - l i n e a r with uniform 
s l o p e . This obse rva t ion a l s o suppor t s t h e view t h a t t h e r e 
i s no h e t e r o g e n e i t y in AFP wi th r e g a r d t o E b ind ing 
p r o p e r t y . However, s e v e r a l o t h e r s ( V a l l e t t e t a l , 1977; 
Nunez e t a l , 1976; Benassayag e t a l , 1975) have c o n s i s t a n t l j r 
observed the ex i s t ence of two c l a s s e s of b i n d i n g s i t e s w i th 
d i f f e r e n t a f f i n i t i e s fo r e s t i r a d i o l and wi th a f r a c t i o n a l 
GZ 
number of 'E 'binding s i t e s pe r mol of APP. The source of 
t h e s e d i s c r e p a n c i e s i s not c l e a r . I t may be due to the 
t e c h n i c a l d i f f e r e n c e s and b i o l o g i c a l source of AFP. 
E s t r a d i o l b inding of r a t AFP v a r i a n t s was a l s o 
ana lyzed on PAGE, AFP was incuba ted wi th [-^H]-E- i n 
p resence or absence of excess e s t r o n e (E l ) and t r e a t e d 
wi th DCC; the s u p e r n a t a n t s , ob t a ined by c e n t r i f u g a t i o n were 
e l e c t r o p h o r e s e d on lO/o (pAGE), After e l e c t r o p h o r e s i s , g e l s 
were s l i c e d a t 1 mm i n t e r v a l s and each s l i c e was d i s s o l v e d 
i n 0 .3 ml H^O^ a t 55°C for 5 h r s and [ % ] - r a d i o a c t i v i t y 
de te rmined . The r e s u l t s a r e d e p i c t e d i n F i g . 8 . The two 
charge v a r i a n t s of AFP showed Bp b ind ing which could be 
d i s p l a c e d by i ncuba t i on w i th excess e s t rone p r i o r t o e l e c t o -
p h o r e s i s . These r e s u l t s , a l t h o u g h i n c o n c l u s i v e , i n d i c a t e 
t h a t t h e two charge v a r i a n t s bind e s t r a d i o l wi th s i m i l a r 
c a p a c i t y and high s p e c i f i c i t y . This o b s e r v a t i o n s u p p o r t s 
t h e r e s u l t s of s e v e r a l a u t h o r s who a l s o find t h a t the charge 
v a r i a n t s of ^^ Fp do not d i f f e r i n t h e i r e s t r a d i o l b ind ing 
p r o p e r t i e s (Aussel c t a l , 1979; Vorsee and B a r e l , 1 9 7 8 a ) . 
MQLJJlCfU-L;.^  W1?TGH^  D^^ TERMINATIOK OF PURIFIED RAT AFP 
Molecular weight a n a l y s i s of p u r i f i e d r a t AFP by PAGE 
i n the p re sence of SDS and p -morcap toe thano l (under d e n a t u r -
ing c o n d i t i o n s ) shows t h a t i t i s composed of a s i n g l e p o l y -
p e p t i d e cha in wi th a m o l e c u l a r weight of 70,000 d a l t o n s • 
( F i g , 5 F ) . This v a l u e i s i n good agreement wi th t h e molecu la r 
weight of r a t /iFP p u r i f i e d by v a r i o u s p rocedures ( R u o s l a h t i 
Bound EjlMXlO ) 
FIG 7. Scachard Ptot ForThc InteractionOf Estradiol 
With Purified Rat AFP 
t o 
X 
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a. 
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FIGO E£tra>Jio\ Binding Of Rat AFP Variar.tsOnPAGE 
EoBinding in presenceo—o ^and absence •—• 
of ex:ess estroneCE,) 
and Seppala , 1 9 7 9 ) . 
RBOOVRRT OF AF? FROM AMWTOTTn FLUID BY DIRECT MIGATIYE 
IMMMOABSORPTION PROCEDURE 
A flow s h e e t of -ftie p r e s e n t p rocedu re f o r i s o l a t i o n 
of AFP from amnio t i c f l u i d i s p r e sen t ed i n F i g . 9 . The l o s s 
of AFP a t each s t e p was checked by rocke t a s s a y . I t appears 
t h a t t h e r e i s no s i g n i f i c a n t l o s s of AFP i n t h e f i r s t s t e p 
(Table V I I ) , T o t a l r ecovery of ilFP from amnio t i c f l u i d i s 
about 97^ , 
PURIFICATION OF HUMN AFP 
iunniot ic f l u i d ( l 4 t h week of g e s t a t i o n ) served a s the 
source for i s o l a t i o n of human AFP. Nega t ive immunoabsorption 
of amniot ic f l u i d wi th r a b b i t a n t i - n o r m a l human serum IgG 
was used e s s e n t i a l l y as d e s c r i b e d for r a t AFp i s o l a t i o n , 
CH/Jlt\GTERIZ/vTION OF HUMN AFP 
P u r i f i e d human AFP y i e l d e d s i n g l e p r e c i p i t i n l i n e wi th 
ant i-human AFP on double d i f f u s i o n showing complete l i n e of 
i d e n t i t y wi th i lFP's p r e s e n t i n cord serum and amnio t i c f l u i d 
(F ig ,10 A) . I t a l s o did no t r e a c t e d wi th anti-HSA and a n t i -
NHS, Antiserum r a i s e d a g a i n s t human AFP d id no t c r o s s r e a c t 
wi th any a d u l t s human serum p r o t e i n s , i t n l s o formed a s i n g l e 
p r e c i p i t i n a r c a t the co r re spond ing p o s i t i o n of AFP p resen t 
i n i t s n a t i v e source (AF) (F ig .10 B ) . P u r i f i e d human AFP 
was homogeneous on lOfo (PAGE) (F ig .10 C ) . 
Amniot ic Fluic' 
1. A r P z^ 50 7o 
2 .ALB ^/;0-4S°/o 
^ .Trans ^ i, i n o/„ 
Normal Adult Rat Serun. 
i 
Rabbit Ar. f i -NRS 
I 
UEAt-CeMulose 
Chromatography 
S t e p l . Immiinoprocipitation 
of AF prote ins i^  
r , 1 g G 
at 37 C for 2 hrs. 
and -i4*C for ll^hrs., 
c e n t r i f uge 
I mmunoprccipi t ate 
( ALB,Trans.,Y^glob. e tc . ) 
I 
A d s o r b e d 
( A F P and t race i . offolob.) 
EiutG w i th p buffer 
containg C.02M NaCI 
E l u t e d t r a c e s IgG-II 
1 
Supernatan t 
( AFP and excess fgG) 
Step 2. 
DEAE-CeMulose 
Chromatography 
.02Mp buffer pH 8 
1 
Unadsor b ed 
( IcG-I ) 
Ad £.or b e o 
E lu t e w i th p b jf^er 
contg. 0.2 M NaCl 
L A F P 
•'^  b . h <- m k ;so!a t .on J * R i 1 A '- P 
TABLE V I I : RECOVERY OF AFP 
T o t a l APP fo 
u n i t s ^ recovery 
Amniotic f l u i d 4500 
AEP. Y-g lobu l in 4366 97 
m i x t u r e 
P u r i f i e d p r e p a r a t - 3917 87 
ion of APp 
Amniotic f l u i d was a r b i t r a r i l y a s s igned t o 
c o n t a i n 1000 u n i t s of AFP pe r ml a s 
quant i ta toc l by rocke t immunoassay. 
FIG.10 CHAfiACTERIZATION OF HUMAN AFF 
10,A: Double immunodiffusion a n a l y s i s 
of p u r i f i e d human AFP and f e t a l b r a i n 
AFP. 
P e r i p h e r a l -well 1 , p u r i f i e d human 
AFpj 2 , human cord serum; 3$ human 
amnio t i c f l u i d ; 4, human f o t a l 
b r a i n e x t r a c t (20th week)j 5 , f e t a l 
b r a i n e x t r a c t a f t e r immunoproci-
p i t a t i o n of AFP, 
10.B: IBP a n a l y s i s of p u r i f i e d human AFP, 
HAFP, p u r i f i e d human AFPj AF, human 
amnio t i c f l u i d j AbHAFP, ant i -human 
iiFP. 
10.Cs lEP a n a l y s i s of human f e t a l b r a i n AFP, 
BE, human f e t a l b r a i n e x t r a c t 
(20th week) ; HAFP, p u r i f i e d human 
AFP; Ab HAFP, an t i -human /iFP. 
10.D: PAGB (lO/O of p u r i f i e d human AFP. 

Estradiol binding activity of the cord serum and 
purified human AFp was analyzed by DOG procedure. Both cord 
serum and human AFP were devoid of E binding. Our observat-
ions also support the numerous reports indicating the non-
estrophilic nature of human (Smith and Kelleher, 1980j 
Ruoslahti and Seppala, 1979). 
CHARACTERIZATION OF fiSA AND HSA 
RSA purified by affinity chromatography on blue-
sepharose was homogeneous on PAGE (10^) (Fig.llA). Antiserum 
raised against purified RSA formed single precipitin arc on 
lEP with RSA and NRS (Pig.llC), Purified HSA was also 
homogeneous on PAGE (Fig.llB). Antiserum raised in rabbits 
against HSA also formed single precipitin arc with NHS and 
HSA (Fig.llD). 
DISTRIBUTION AND ONTOGENY OF AFP IN FETONEONATAL TISSUES 
OF RAT 
AFP was found to be present in the tissue extracts, 
arranged in order of decreasing concentration of AFP at 18E 
as liver skin brain kidney stomach lung heart 
intestine adrenal. Thymus, spleen and panereas were devoid 
of AFP when analyzed by double diffusion (Fig.l2A). High 
levels of iiFP were found in all tissue during fetal life 
(18 and 20 E) and its concentration registered a continuous 
decline with development. Ontogeny of AFP in various tissues 
of rat, as presented in Fig.l5 indicates that AFP disappears 
after: 7P in brain and adrenalsj 14P in lung, heart, stomach, 
FIG. 11 CHARACTERI7ATTQN OF EAT AND HUM/iN SERUM 
ALBUMIN 
11.As PAGE (7/0 of purified rat serum 
albumin 
11,B5 PAGE ilfo) of purified human serum 
albumin 
11.CJ IBP analysis of purified rat serum 
albumin. 
RSA, rat serum albumin; NRS, normal 
rat serum; AbRSA, anti-RSA 
11.D: lEP analysis of purified human serum 
albumin. 
H3A, human serum albumin; NHS, normal 
human serum; AbHSA, anti-human serum 
albumin, 

FIG.12 CHAEAOTERIZATION OF R/iT TISSUES AFP 
12.Aj Double immunodiffusion analysis of 
various newborn rat tissues AFP, 
1. fetal serum 7. lung 
2. amniotic fluid 8. brain 
3. spleen 9. heart 
4. pancreas 10. kidney 
5. thymus 11. intestine 
6. l i v e r 12 . stomach 
Wells in the central row contain anti-
AFP. 
Various t i s sue e x t r a c t s , f e t a l serum and 
amniotic fluid were adjusted t o contain 
50 |ig AFP/ml as deteiTnined by rocket 
assay. 
12.B: IBP analysis of var ious t i s s u e s AFP 
1 , kidney 2. f e t a l serum 
5, skin 4. bra in 
Trough contain anti-AFp. 
12.0; Diagrammatic representation of the 
analysis of various tissues AFP by 
PAGE coupled with immunodiffusion. 
Polyaerylamide gel 1, fetal serumj 
2, skin; 3, brain; 4, kidney. 
Trough contain anti-AFp. 
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Gu 
i n t e s t i n e and k idney : 21P in l i v e r and s k i n . The f e t a l blood 
con tamina t ion i n v a r i o u s t i s s u e e x t r a c t p r e p a r a t i o n s could 
not account for more than 5-IO/" of the observed l e v e l s i n 
v a r i o u s t i s s u e s . 
IiyMJNOLOGIGAL AND ELEGTRQPHORETICAL PROPERTIES Of TISSUES AFP 
4FP p r e s e n t i n v a r i o u s t i s s u e s was immunological ly 
i d e n t i c a l and d i sp layed si complete l i n e of i d e n t i t y (F ig ,12A) . 
IBP of ;iPP from serum, b r a i n , sk in and k idney a l s o showed 
s i m i l a r e l e c t r o p h o r e t i c m o b i l i t y ( F i g . l 2 B ) . A l i q u o t s of 
b r a i n , sk in and kidney c y t o s o l (100 \xg t o t a l p r o t e i n ) and 
f e t a l serum were e l e c t r o p h o r e s e d on 10/° (PAGE) and a f t e r 
e l e c t r o p h o r e s i s g e l s were cu t l o n g i t u d i n a l l y i n t o two h a l v e s 
and one h a l f of each ge l was p l aced on 1^ a g a r o s e . Anti-AFP 
was then f i l l e d i n t roughs made p a r a l l e l t o each ge l and 
al lowed t o d i f f u s e for 24 h r s . Each g e l y i e l d e d s i n g l e 
p r e c i p i t i n a r c f o r AFP a t t h e same p o s i t i o n ( F i g . 1 2 C ) . 
This o b s e r v a t i o n f u r t h e r i n d i c a t e s t h a t AFP de r ived from t h e s e 
t i s s u e s i s a l s o s i m i l a r wi th r e s p e c t t o c h a r g e . 
ESTROGEN BCTDm& OHARAOTERISTIGS OF BRAIN AND SKIN AFP 
E s t r a d i o l b ind ing of b r a i n and sk in c y t o s o l was 
s t u d i e d by DOC procedure a s d e s c r i b e d fo r r a t AFP. 
Scatchard p l o t s of E^ i n t e r a c t i o n wi th b r a i n and sk in APP 
y i e l d e d an a s s o c i a t i o n c o n s t a n t s of I . 3 x 10 M and 
1.0 X 10 M r e s p e c t i v e l y . These v a l u e s a r e s i m i l a r t o AFP 
p u r i f i e d from r a t amnio t ic f l u i d . Our r e s u l t s of b r a i n AFP 
a l s o cor responded wel l w i th t h e a s s o c i a t i o n c o n s t a n t 
G:, 
r e p o r t e d e a r l i e r ( A t t a r d i and R u o s l a h t i , 1976; P l a p i n g e r 
e t a l , 1973 ) . I t would t h u s appear t h a t AFP p r e s e n t i n b r a i n 
and sk in a l s o d i d not d i f f e r i n t h e i r es t rogen b ind ing 
c h a r a c t e r i s t i c s . 
ANALYSIS 0? GQN A APFMITY MQLEOUI.-.R VARMNT CT BR/.DT AND 
Brain and s k i n c y t o s o l p repa red from newborn r a t were 
chromatographed on Con A-sepharose column a s d e s c r i b e d e a r l i e r , 
Amount of Con A - r e a c t i v e and n o n - r e a c t i v e AFP v a r i a n t were 
determined by rocke t a s s a y . Amount of Con A-nonreac t ive AFP 
v a r i a n t were 37 ±. 3% and 46 + 4/0 i n sk in and b r a i n cy toso l 
r e s p e c t i v e l y . T h o anount ofCon A - r e a c t i v e v a r i a n t i n newborn 
r a t serum was 45 ±. 2.5/°. This i s in c l o s e agreement with t h e 
r e p o r t e d v a l u e a!b t h i s s t a g e of development (Smith and 
K e l l e h e r , 1 9 8 0 ) . The d i f f e r e n c e i n t h e r e l a t i v e con ten t of 
Con A-nonreac t ive AFP v a r i a n t i n serum, b r a i n and sk in may 
r e f l e c t a d i f f e r e n c e i n t h e amount of ca rbohydra te moiety 
( s i a l i c n,cid, mannose, g lucose e t c . ) a t t a c h e d t o AFP v a r i a n t 
i n t h e s e t i s s u e s . Other t i s s u e s l i k e yolk sac and l i v e r a r e 
known t o d i f f e r i n the r e l a t i v e p r o p o r t i o n of Con A - a f f i n i t y 
molecu la r v a r i a n t s (Smith and K e l l e h e r , 1980; R u o s l a h t i and 
Adamson, 1978) . 
ONTOGENY .'iND DISTRIBUTION OF AFP IN FETO-NEONATAL RAT BR/iIN 
Whole b r a i n s wore removed from f e t a l (18 and 20 S ) , 
n e o n a t a l r a t s ( 1 , 3 , 7, I 4 and 21 d old) and p regnan t r a t 
( a t 20 E ) , and washed s e v e r a l t i m e s wi th 0 .01 M T r i s , 1.5 mM 
G7 
BDTA, pH 7.4 (TB buffer). The brains from several rats of 
each age group, after stripping the meninges, were macro-
scopically dissected into olfactory, cerebrum, cerebellum 
and the remaining portions. The homogenates prepared from 
whole brain or pooled discrete regions of the brains in TE 
buffer were cleared by centrifugation at 22,000 for 30 min at 
4°G. The clear supematants were used for AFP determination 
by rocket assay to study the distribution of APP in develop-
ing rat brain. Extent of blood contamination in various 
samples of brain extract was determined by measuring heme 
concentration as described earlier. 
Distribution of APP in whole brain aad its discrete 
regions during development is shown in Fig,14. AEp seems to 
be distributed uniformly throughout the brain. Different 
regions of the brain contained APP in the following order: 
Olfactory cerebrum cerebellum remaining portions. 
Ontogeny of APP either in v:hole brain or in its discrete 
regions is similar. High levels of APP were observed in each 
region during fotal development which show almost similar 
decline with development. APP disappeared simultaneously from 
olfactory cerebrum cerebellar as xxell as rest portions of the 
brain after one week of postnatal development. It is possible 
that /vFP may still be present (after 7P) in brain but is not 
detectable by the present assay system. Attardi and Ruoslahti 
(1976) reported that feto-neonatal estradiol binding protein 
(iiPP) is present in mouse brain in very low level, detected by 
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radioimmunoassay, upto 3 weeks of p o s t n a t a l development . 
F e t a l b lood con tamina t ion i n c y t o s o l of d i f f e r e n t 
r eg ions of t h e b r a i n was not more t h a n 3-5^ a s determined 
by measuring heme c o n c e n t r a t i o n . Severa l a u t h o r s 
(Pa lp inge r e t a l , 1977, 1973) have a l s o r eached t o t h e same 
conclus ion and sugges t t h a t con tamina t ion of AFP from f e t a l 
blood could not account f o r t h e h igh l e v e l s of AFP in 
immature r a t or mouse b r a i n . This i s a l s o suppor t ed by t h e 
f ac t t h a t p regnan t r a t b r a i n was devoid of AFP, a l though 
serum c o n c e n t r a t i o n in pregnant r a t (20 B) i s s i g n i f i c a n t l y 
h igh ( S t i l l m a n and S e l l , 1 9 7 9 ) . 
ilFP i n p r e s e n t v a r i o u s d i s c r e t e r e g i o n s of r a t b r a i n 
could bind e s t r a d i o l wi th h igh a f f i n i t y . I t i s very l i k e l y 
t h a t b i n d i n g c h a r a c t e r i s t i c s of AFP i n v a r i o u s r e g i o n s a r e 
s i m i l a r t o t h a t observed i n whole b r a i n c y t o s o l ( F i g . 7 ) i 
ONTOGENY OF AFP M HUMM FETAL BMIM 
AFP was a l s o found t o be p r e s e n t i n human f e t a l b r a i n 
du r ing e a r l y embryonic l i f e . O u c h t e r l o n y ' s double d i f fu s ion 
a n a l y s i s of b r a i n e x t r a c t s y i e l d e d s i n g l e p r e c i p i t i n l i n e and 
complete l i n e of i d e n t i t y w i th AFP's p r e s e n t in cord serum, 
amnio t i c f l u i d and p u r i f i e d AFP, i n d i c a t i n g t h e a n t i g e n i c 
s i m i l a r i t y of b r a i n wi th o t h e r t i s s u e s AFP ( F i g . l O A ) . 
A l i q u o t s ( 0 . 2 ml) of f e t a l b r a i n e x t r a c t (20 th week) and 
cord serum samples were incuba ted wi th ant i -AFP human (0 .5 ml) 
a t room temp, f o r 1 hr and a t 4 0 o v e r n i g h t . The immunopreci-
p i t a t e s v/ere removed by c e n t r i f u g a t i o n and s u p e r n a t a n t s 
GJ 
analyzed by double diffusion to determine whether immuno-
recipitation of AFP from human fetal brain extracts (20th 
week) removed protein species reactive with anti-human AFP, 
The supernatant (after immunoprecipitation) failed to give 
any precipitin line with anti-human AFP in both fetal brain 
extract (Fig.lOA) and cord serum indicating that AFP is the 
reactive protein species. IBP of brain extract also 
yielded a single precipitin arc with electrophoretic mobility 
similar to that of purified human AFP (Fig.IOC). These 
observations indicate that human fetal brain AFP is immuno-
logically and eloctrophoretically identical to serum AFP, 
iiFP could be detected in fetal brain after 12 weeks of 
gestational age. It registered a peak level in fetal brain 
at 20th week and declined rapidly to low levels after 24th 
weeks of gestation and was absent, as measured by rocket 
assay, in the fetal brain of subsequent ages. 
Developmental profile of AFp in human fetal brain, as 
summarized in Fig,15, is different from that observed in 
amniotic fluid and fetal serum where peak level of AFP are 
found around 14th week of gestation and from maternal serum 
attaining peak level at about 28-52 weeks of gestation 
(Ruoslahti and Seppala, 1979; aitlin, 1975; Seppala, 1975). 
Interestingly, when AFP level in amniotic fluid and fetal 
serum register a decline, AFP in fetal brain starts shotting 
steady rise. However, the peak level of AFP in brain 
coincides with the period at which the AFP level are also 
F i G 15. DEVELOPMENTAL PRO =1LR OF AFP IN HUMAN FET^L BFAU 
8-
c 
% 
• ^ 
o 
5 6-
o 
</) 
o 
f J 
en 
< 
• Number o' samples 
i 
• 
2 
\7 
1 . 
4 
16 
3 
20 
3 
% 
not d>2taLtal)to. 
-^ . '1 r •• 
2B 32 36 
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higher in cerebrospinal fluid (CSF) (Adinolfi and Adinolfi, 
1976). 
The high concentration of AFP found in human fetal 
brain could not be accounted for by fetal blood contaminat-
ion which could contribute only 7-10/" of the observed levels 
of AFP as determined by heme concentration in various fetal 
brain extracts. Further, no AFP was detected in fetal 
brain after 24th week of gestational life when AFP level 
continues to remain high in both fetal serum and amniotic 
fluid. The origin of AFP in brain is not clear. Intra-
cellular localization of AFP in developing rat (Toran-
Alterand, 1980; Trojan and Uriel, 1979; Benno and Williams, 
1978) and human (Mollgard et al, 1979) brain is suggestive 
of its synthesis by brain cells. Uptake from CSF or fetal 
blood may in part, account for the observed AFP levels in 
human brain, 
Ep binding of AFP was measured in human fetal brain 
extract and cord serum samples by DCC procedure. Aliquots 
(0.3 ml) of brain extract (5 mg protein/ml) in triplicate 
or cord serum (diluted 10 times with saline) were incubated 
with 5 M-l of [-^ H]-Ep in various concentrations (0.25-100 mM) 
with or without 1000 fold concentration of cold E^ for 3 hrs 
at 0 G. After incubation 50 lil dextran coated charcoal 
(107" charcoal and l/° dextran T 70 in 0.1 M phosphate buffer, 
pH 7.3) was added to each tube and mixed thoroughly, 
followed by centrifugation at 800 x g for 10 min. Radio-
activity was measured in the clear supernatants. Further, 
7 
a l i q u o t s of b r a i n e x t r a c t s and cord serum were mixed with, a 
l i t t l e excess of anti-human APP, i ncuba ted fo r 24 h r s a t 
4°C and oen t r i fuged a t 20,000 x g fo r 30 min. The s u p e r -
n a t a n t s t h u s ob ta ined were as sayed f o r AFP by double 
d i f f u s i o n and B^ b ind ing by DCC p r o c e d u r e . 
Ep b i n d i n g assays in whole f e t a l b r a i n e x t r a c t , cord 
serum and t h e i r s u p e r n a t a n t s o b t a i n e d a f t e r immunoprec ip i t -
a t i o n of AFP did not diow any s p e c i f i c b i n d i n g of [ H]-Ep 
(Table V I I I ) . This o b s e r v a t i o n f u r t h e r suppo r t s t h a t human 
AFP, i r r e s p e c t i v e of i t s s o u r c e , i s devoid of Ep b ind ing 
a b i l i t y {Smith and E e l l e h e r , 1980; Mendelson e t a l , 1980j 
R u o s l a h t i and Seppala , 1979; Swartz e t a l , 1974; Nunez e t 
a l , 1974; Savu e t a l , 1 9 7 4 ) . 
SYNTHESIS AND SBHRT^ TION OF AFP AMD ALBUMIN BY NEWBOM 
RilT BR/. IN CELLS T]\r CULTURE 
Syn thes i s and s e c r e t i o n of AFP and albumin was s t u d i e d 
by i n c u b a t i n g 1-2 x 10 b r a i n c e l l s i n each c u l t u r e f l a s k 
c o n t a i n i n g 5.0 ml l e u c i n e f r e e medium supplemented wi th O.6/0 
g l u c o s e , 1 mM g lu tamine , 25 mM HEPES, and a n t i b i o t i c s 
( P e n i c i l l i n 100 U/ml, s t r ep tomyc in 100 | ig /ml )a t 37 C . in a 
m e t a b o l i c s h a k e r . R a d i o a c t i v e p u l s e exper iments were 
i n i t i a t e d by add ing 3 ^iCi DL [ 1 - ^ C ] - l e u c i n e . Cycloheximide 
was added i n t o some f l a s k s 15 min p r i o r t o a d d i t i o n of 
l a b e l l e d l e u c i n e a t a f i n a l c o n c e n t r a t i o n of 10 | ig /ml . 
Incuba t ion was t e rmina ted a t s p e c i f i c i n t e r v a l s by removing 
t h e f l a s k s and c h i l l i n g t h e s o l u t i o n i n i c e b a t h . The c e l l s 
TABLE V I I I ; ESTRi\DIOL BINDING ANALYSIS OF 
EUMM FETAL BRxlIN EXTRACTS AND CORD SERUM 
Samples Ep b i n d i n g 
Cord serum 127 cpm 
Cord serum ( a f t e r immuno- I46 cpm 
p r e c i p i t a t i o n of AFp) 
Bra in e x t r a c t (20th week) I66 cpm 
Bra in e x t r a c t ( a f t e r 152 cpm 
immunoprec ip i t a t ion of AFP) 
•^For d e t a i l s see t a x t . 
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were separated by centrifugation and incubation medium 
recovered. The cells were washed several times with phosphate 
buffered saline containing 0.r/» DL-Leucine (PBS-leucine), 
The cell lysate was prepared by sonication of brain cells 
for 3 min at O-4 C. 
Intracellular synthesis (in cell lysate) and secretion 
(in medium) of AFP and albumin by brain cells was determined 
by following the incorporation of [ C]-leucine into immune-
precipitable APP and albumin, and total proteins (TCA 
insoluble) as described earlier (Material and Methods), 
Incubation of dissociated newborn brain cells with 
medium containing [ C]-leucine resulted in linear incorporat-
ion of radioactivity into immunoprecipitable AFP, albumin 
and TCA insoluble total proteins synthesized in the brain 
cells (Fig,16A). The radioactivity into the secreted 
labelled AFP, albumin and total proteins also showed a 
linear increase during 6 hrs in culture (Fig.l6B), The 
addition of cycloheximide into the cultures inhibited the 
incorporation of [ C]-leucine into AFP and albumin (Fig.l6A) 
and their secretion into the medium (Fig.l6B), Labelled-APP 
accounted for II-13/0 and albumin 5^ of the total proteins 
synthesized in the brain cells and their secretion into the 
medium accounted for 27-30/° and II-15/" of the total proteins 
secreted by the brain cells. It appears that bulk of the 
proteins synthesized in the brain cell are not secreted, .\Fp 
and albumin, the two secretory proteins, together constitute 
'. / 
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about 4.0^ of the t o t a l p r o t e i n s p r e s e n t i n t h e c u l t u r e 
medium of newborn r a t b r a i n c e l l s . 
I n t r a c e l l u l a r con ten t of iiPP and albumin i n c e l l 
l y s a t e s and t h e i r s e c r e t i o n i n t o t h e medium (10 t imes 
c o n c e n t r a t e d ) by b r a i n c e l l s du r ing 6 h r s i n c u b a t i o n per iod 
were de te rmined by r o c k e t immunoassay. I n t r a c e l l u l a r 
content of bo th ilFP and albumin d id not change s i g n i f i c a n t l y 
dur ing 6 h r s i n c u b a t i o n pe r iod (F ig .17 A) , However, 
q u a n t i t a b l e amounts of AFP and albumin l i n e a r l y accumulated 
( s e c r e t e d ) i n t o the c u l t u r e medium, a s a f u n c t i o n of 
i n c u b a t i o n pe r iod (F ig .17 B) , i n d i c a t i n g a cont inuous 
p roduc t ion of t h e s e p r o t e i n s by b r a i n c e l l s . F u r t h e r , t o t a l 
amounts of ilFP and albumin s e c r e t e d by t h e s e c e l l s d u r i n g 
6 h r s c u l t u r e per iod i s f a r i n excess of i n t r a c e l l u l a r 
con ten t of t h e two p r o t e i n s i n b r a i n c e l l s a t t h e i n i t i a t i o n 
of c u l t u r e s . These o b s e r v a t i o n s c l e a r l y i n d i c a t e s t h a t AFP 
and albumin a r e syn thes i zed in. s i t u i n newborn r a t b r a i n 
c e l l s . 
GHAMCTERIZAIIQN OF AFP /IITL ALBUMIN SECRETED BY NEWBORN 
RAT BRAIN CELLS IN CTTLTITP-R 
The medium c o l l e c t e d a f t e r i n c u b a t i o n of b r a i n c e l l s 
fo r 6 h r s i n c u l t u r e medium was d i a l y z e d e x t e n s i v e l y a g a i n s t 
PBS-leucine and concen t r a t ed (about 10 t i m e s ) by l y o p h l i z a t -
ion and w i l l be r e f e r r e d t o a s c o n c e n t r a t e d medium (CM). 
CM was analyzed by v a r i o u s immunological and Ep b i n d i n g 
assay t o c h a r a c t e r i z e t h e AFP and albumin s e c r e t e d by 
newborn b r a i n c e l l s . 
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IMMJNQLOGIG/IL I-pRWTrFTnATIQU LWD OHARAOTBRIZATIQN OF AFP 
AND ALHJMIU SEGRT^ TET^  RY NEWBORN R/iT BRillN CELLS 
IBP of the CM r e v e a l e d t h e p resence of bo th AFP and 
albumin ( F i g . 1 8 A) wi th complete l i n e of i d e n t i t y and 
e l e c t r o p h o r e t i c m o b i l i t y s i m i l a r t o c o r r e s p o n d i n g serum 
AFP (F ig .18 B) and albumin ( F i g . 1 8 C ) . A l i q u o t s of CM 
were s e p a r a t e l y t r e a t e d w i th anti-RSA and anti-AFP t o 
remove albumin and AFP from CM. The immunoprec ip i t a t e s 
were removed by c e n t r i f u g a t i o n and s u p e m a t a n t s c o l l e c t e d . 
A l i q u o t s of t he s u p e m a t a n t s (albumin and AFP f r e e ) thus 
ob ta ined and CM (without removal of AFP and albumin) were 
e l e c t r o p h o r e s e d on 10/° PAGE t o observe t h e p r o f i l e of 
s e c r e t e d ( l a b e l l e d ) p r o t e i n s . A f t e r e l e c t r o p h o r e s i s t h e 
g e l s were s l i c e d a t 1 mm i n t e r v a l s , each s l i c e d i s s o l v e d 
i n 0 .3 ml H2O a t 55°G for 3 h r s , and [ G ] - r a d i o a c t i v i t y 
measured. A s e p a r a t e ge l [ a f t e r 10/° PAGE of t h e CM] was 
cut l o n g i t u d i n a l l y and one h a l f s t a i n e d wi th commassie b lue 
and ano the r h a l f p l aced on Vfo aga rose and d i f fu sed a g a i n s t 
ant i-AFP and anti-RSA t o l o c a t e t h e AFP and a lbumin . 
F u r t h e r , a n o t h e r ge l ( a f t e r lO/o PAGE of CM) was s l i c e d a t 
2-3 mm i n t e r v a l s ( t r a n s v e r s e l y ) and s l i c e s wore kept 
s e r i a l l y on a g l a s s p l a t e on which aga rose g e l {Vf^ aga rose ) 
was poured l a t e r on. A f t e r d i f f u s i n g t h e s l i c e s f o r about 
2 h r s a t room t empera tu r e , t hey were a l lowed t o d i f f u s e 
overn igh t a g a i n s t a s e r i e s of w e l l s c o n t a i n i n g ant i -AFp and 
anti-RSA t o f u r t h e r i d e n t i f y t h e p o s i t i o n of AFP and albumin 
on the po lyacry lamide g e l . 
FIG.18 CHABAOTERIZATION OF AFP ANP ALBUMIN SECEETED 
BY NEWBORN RAT BRAIN CELLS IN CULTURE 
18.A : IBP analysis of AFP and albumin secreted 
by brain cells in culture. 
CM, concentrated medium obtained after 
6 hrs culture of newborn rat brain cells; 
Ab^, anti-RSA; Ab , anti-AFP. 
18.B : Immunological identity of /LPP secreted 
by brain cells -with serum AFP, 
FS, fetal serum, 
18«C : Immunological identity of albumin 
secreted by brain cells with rat serum 
a2bumin. 
RSA, rat serum albumin. 
18,D : Identification of AFP and albumin 
present in CM on PAGE (lO/O coupled 
with immunodiffusion. 
G, polyacrylamide gol (10?^ ) after 
electrophoresis of CM. G was cut 
longitudinally and diffused against 
specific antisormn (Ab, and Ab_). 
18.B : Identification of AFp and albumin 
present in CM by PAGE (lO/O coupled 
with immunodiffusion. G, polyacryl-
amide gel sections (2-3 mm). The 
gel was cut transversely after 
electrophoresis of CM and each section 
diffused against specific antiserum (Ab^ 
and Abg). Arrow number 1 shows the 
formation of precipitin line for 
albumin. Arrow number 2 shows the 
linos for AFP. 
18.F : An electrophoretogram of CM (lO/^  PAGE) 
showing the proteins secreted by 
newborn rat brain cells in culture. 
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PAGE p a t t e r n of the t o t a l p r o t e i n s s e c r e t e d by newborn 
r a t b r a i n c e l l i s d e p i c t e d i n F i g , 1 9 A (upper c u r v e ) . 
S p e c i f i c immunoprec ip i t a t ion of AFp ( F i g . 19 B) and albumin 
( F i g , 1 9 C) from CM removed the r a d i o a c t i v i t y from t h e 
co r respond ing r e g i o n s . That /iFP and albumin a r e t h e two 
f a s t e r moving component ( a s i s evident from F i g . 1 9 A) was 
f u r t h e r confirmed by d i f f u s i n g the g e l ( a f t e r PAGE of CM) 
a g a i n s t r e s p e c t i v e a n t i s e r a and subsequent fo rmat ion of 
s i n g l e p r e c i p i t i n a r c ( F i g . 1 8 D ) . When t h e same ge l was cut 
t r a n s v e r s e l y and d i f fused a g a i n s t anti-AFp and ant i -RSA, t h e 
p r e c i p i t i n l i n e s were only formed in the s l i c e s co r r e spond-
i n g t o the p o s i t i o n AFP and albumin ( F i g . 1 8 B) a s observed 
i n F i g . 1 9 A (upper curve) and F i g . 1 8 D. Im e l e c t r o p h o r e t o -
gram of the s t a i n e d gel a f t e r PAGE of CM i s shown i n F i g . l B F . 
I t i s ev iden t from F i g . l 8 F and Fig, ISA t h a t b r a i n c e l l s of 
newborn r a t s e c r e t e s a number of p r o t e i n s a long with two 
major p r o t e i n s i d e n t i f i e d a s AFP and albumin. These 
r e s u l t s a r e i n accordance with the high amount of r a d i o -
a c t i v i t y found i n immunoprec ip i tab le AFP and albumin s e c r e t e d 
by b r a i n c e l l s ( F i g , 1 6 ) . 
IDENTIFICATION MD CHARZ-tCTERIZ/.TION OF E2 BINDING PROTEET 
SECRETED BY NEWBORN RAT BRAIN CELLS IN CULTURE 
B^ b i n d i n g a c t i v i t y of t h e p r o t e i n s s e c r e t e d by b r a i n 
c e l l s and i d e n t i f i c a t i o n of t h e a c t i v e p r o t e i n s p e c i e s was 
i n v e s t i g a t e d as f o l l o w s . A l i q u o t s of CM ( t o t a l p r o t e i n 100 
|ig) -were i ncuba ted with [ H]-E„ with or wi thout 100 fiM 
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Estradio l Binding Analysis Of CM 
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nonradiolalDelled B_ for 3 li3?s at 0 G. After incubation 
50 [xl DOC was added to each tube , nixed and centrifuged 
a t 800 X g for 5 nin a t 0 C, Result ing supernatants were 
electrophoresed on 10/° PAGE. After e l ec t ropho re s i s , the 
ge ls were s l i c e d , d isso lved, and [ H] - r ad ioac t iv i t y counted, 
3 
In another cet of experiment CM was incubated with [ H]-Ep, 
t r ea ted with DOC, and AFP immunoprecipited by an t i APP. 
The icimunoprecipitate and the supernatant were recovered and 
3 [ H] - rad ioac t iv i ty counted to determine whether spec i f ic 
inmun©precipitation of AFP removed the Ep binding 
component from the CM, 
3 [ H] - rad ioac t iv i ty p r o f i l e , as presented in Pig,19A 
(middle curve) demonstrates that APP and the prote in 
binding [-^Hj-E co-migrate on PAGE. Fur ther , [^E'l-'E^ 
binding could be almost completely displaced i f CM was 
incubated with excess of cold E before e lec t rophores is 
(Fig,19A, lower curve) . Immunoprecipitation of AFP also 
removed the E binding a b i l i t y of CM (4770 cpm/100 |ag t o t a l 
prote in) and almost a l l [ '^H]-radioactivity was recovered 
(4527 cpm) in the immunoprecipitate. These observations 
c lear ly i nd i ca t e tha t AFp i s the only ac t i ve pro te in 
species secreted by brain c e l l s of newborn r a t tha t binds 
Ep with high s p e c i f i c i t y . 
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MOLliinULAR WEIGHT ANALYSIS OF AFP AND ALBUMIN SECRETED 
BY NEVJBORN Ri\T BRAIN CELLS IN CULTURE 
Molecular we igh t s of [ ^ C ] - l a b e l l e d AFP and silbuniin 
syn the s i zed and s e c r e t e d de. novo, were de termined by 
s p e c i f i c immunoprec ip i t a t ion of AFP and albumin from CM 
and subsequent a n a l y s i s of t he immunoprec ip i t a te on SDS-PAGE 
(Schapi ro e t a l , 1 9 6 7 ) . [" ' '^C]-labelled AFP and albumin 
were i n m u n o p r e c i p i t a t e d u s i n g anti-ZiFP and a n t i - a l b u m i n a s 
d e s c r i b e d e a r l i e r . The immunoprec ip i t a t e s were washed with. 
PBS and d i s s o l v e d i n 0 .2 ml 3/" sodium dodecyl s u l p h a t e 
( S D S ) - t r i s g l y c i n e b u f f e r , pH 8»6 by i n c u b a t i o n f o r 18 h r s 
a t 37 C, A l i q u o t s of c l e a r s u p e r n a t a n t s c o n t a i n i n g 75-100 
[ig p r o t e i n were ana lyzed on lOf" PAGE c o n t a i n i n g 0.l/° SDS. 
Af te r e l e c t r o p h o r e s i s t h e g e l s were s l i c e d i n t o 1 mm 
s e c t i o n , each s l i c e d i s s o l v e d and counted fo r [ C ] - r a d i o -
a c t i v i t y . Mob i l i t y of the r a d i o a c t i v e p r o t e i n s was 
compared t o known molecu la r weight p r o t e i n markers e l e n t r o -
phoresed s i m u l t a n e o u s l y . Newly s y n t h e s i z e d and s e c r e t e d 
AFP and albumin gave a m o l e c u l a r we igh t s of 70,000 and 
65,000 d a l t o n s r e s p e c t i v e l y ( F i g . 2 0 ) . These v a l u e s a r e i n 
c lo se agreement with molecu la r weights r e p o r t e d for t h e s e 
p r o t e i n s ( R u o s l a h t i and Seppa la , 1979? A t t a r d i and 
R u o s l a h t i , 1 9 7 6 ) . 
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r>wBLOPiymTAL GHAI^QES m THB RATE OF SYNTHESIS OF AFP AND 
ALBUMIN IN BRAIN i GQRREMTTQN WITH THEIR BRADT CONTE^ TT 
The changes i n the s y n t h e s i s of AFP and albumin 
accompanying the m a t u r a t i o n of the r a t b r a i n were s t u d i e d 
by measuring the r a t e of s y n t h e s i s of t h e two p r o t e i n s by 
t h e b r a i n c e l l s , p repa red from r a t b r a i n a t v a r i o u s s t a g e s 
of f e t o - n e o n a t a l development . The r e s u l t s a r e expressed a s 
dpm [ C ] - l e u c i n e i n c o r p o r a t e d i n t o immunoprec ip i tab le AFP 
and albumin i n t h e b r a i n c e l l l y s a t e s ( s y n t h e s i s ) p e r h r 
p e r mg c e l l u l a r p r o t e i n s . 
The r e s u l t s p r e s e n t e d i n F i g . 2 1 summarizes the 
developmental changes i n the r a t e of s y n t h e s i s of AFP and 
albumin in b r a i n a l o n g wi th t h e i r t i s s u e l e v e l s . I t i s 
appa ren t t h a t AFP and albumin a r e syn the s i zed a t a h i ^ e r 
r a t e du r ing f e t a l l i f e and p o s t n a t a l development of t h e 
b r a i n i s accompanied by a r a p i d dec rease i n the s y n t h e s i s of 
t h e two p r o t e i n . C e l l s p repared from r a t b r a i n a f t e r 1 week 
of p o s t n a t a l l i f e r e v e a l e d no i n c o r p o r a t i o n of [^^C]-l eucine 
i n t o AFP or a lbumin. This i n d i c a t e s t h a t s y n t h e s i s of iXF'2 
and albumin i n the b r a i n i s t u rned off a f t e r 1 week of 
p o s t n a t a l development , AFP and albumin l e v e l s i n b r a i n 
d u r i n g development a l s o r e g i s t e r e d a r ap id d e c l i n e and t h e 
two p r o t e i n d i s a p p e a r s , a s determined by r o c k e t a s s a y , a f t e r 
1 week of p o s t n a t a l deve lopment . 
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A correlation between APP and albumin level in brain 
and their rate of ^nthesis by brain cells in culture, during 
development is presented in Fig,22 A and Fig.22 B, 
respectively. Results are expressed as percent decrease 
in AFP and albumin level in brain and rate of their 
synthesis by brain cells during development over the values 
observed in 18 E fetal brain (control). A linear 
relationship was displayed. It is clear from Fig.22 that 
high levels of AFP and albumin in brain could be accounted 
for due to their high rates of synthesis in the brain cells. 
The decline in the brain AFP and albumin level with age 
is due to a proportionate decrease in the rate of qy-nthesis 
of these proteins. It may be concluded that levels of 
AFP aiad albumin in brain directly reflects their rate of 
synthesis in the brain. 
EFFECT OF HORMONES ON THE RATE OF AFP SYNTHESIS AND 
SECRETION BY NEWBORN RAT BRAIN OELLS IN CULTURE 
Newborn rat brain cells were prepared and maintained 
in culture for 24 hrs. Various hormones (Insulin, 0.05 lU 
ml" ; dbcAMP, 100 \xg ml" ; dexamethasone, 2 \xg ml" j 
estradiol, 3 fig ml ) were added at the initiation of 
cultures. AFP synthesis and secretion were determined 
after 24 hrs culture of brain cells as described earlier. 
Amount of AFP and albumin secreted into the medium were 
determined by rocket assay. The alterations in the rate 
of synthesis and secretion of AFP by brain cells due to 
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i n c u b a t i o n with hormones i s expressed a s p e r c e n t change 
over the c o n t r o l v a l u e s ( t h e c e l l s incuba ted w i t h t h e 
d i l u e n t o n l y ) . 
R e s u l t s summarized i n F i g , 2 3 i n d i c a t e t h a t dexameth-
asone and dbcAMP were e f f e c t i v e i n r e d u c i n g t h e r a t e of AFP 
s y n t h e s i s and s e c r e t i o n . However, r e d u c t i o n i n AFP 
s y n t h e s i s by dexamethasone was most e f f e c t i v e (40?^ d e c r e a s e ) 
t han dbcAMP (28^ d e c r e a s e ) . S i m i l a r e f f e c t s were a l s o 
e x h i b i t e d i n t h e amount of AFP accumulated ( s e c r e t e d ) i n 
t h e c u l t u r e medium over a 24 h r s c u l t u r e p e r i o d . I t would 
t h u s appear t h a t s y n t h e s i s and s e c r e t i o n of AFP and albumin 
i s a coupled p r o c e s s . A change i n t h e r a t e of s y n t h e s i s of 
t h e p r o t e i n i s r e l a t e d t o a p r o p o r t i o n a t e change i n t h e 
amount of t h e p r o t e i n s e c r e t e d i n t o the medium. I n s u l i n 
and e s t r a d i o l d id not r e v e a l any s i g n i f i c a n t change i n 
e i t h e r the s y n t h e s i s or s e c r e t i o n of AFP by newborn r a t 
b r a i n c e l l s . None of t h e hormones a f f e c t e d the r a t e of 
albumin s y n t h e s i s and s e c r e t i o n , 
DEMONSTRATION OF AFP SYITTHESIS BY IMMTUHE RAT SKIN 
New born r a t sk in e x p l a n t s were ma in t a ined i n l e u c i n e 
f r e e medium c o n t a i n i n g 1.0 | iCi/ml [ C ] - l e u c i n e a s r a d i o -
a c t i v e t r a c e r . Con t ro l f l a s k s inc luded c y c l o h e x i -
mide (100 ij,g/ml medium) added 30 min p r i o r t o t h e a d d i t i o n 
of l a b e l l e d l e u c i n e . Cu l tu re f l a s k s were i ncuba t ed a t 37°C 
i n a m e t a b o l i c s h a k e r . I n c u b a t i o n was t e r m i n a t e d a f t e r 
2 ,4 and 6 h r s and cualture medium recovered by d e c a n t a t i o n . 
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Skin explants were washed severa l times with PBS-leucine 
and homogenized in PBS. The homogenates were centrifugod 
a t 22,000 X g for 50 min a t 4°C. The clear supernatants 
were co l lec ted and t r e a t e d as skin l y s a t e . Incorporat ion 
of [ ^C] - l euc ine in to immunoprecipitable APp and albumin 
was determined, as descr ibed e a r l i e r , i n a l i quo t s of skin 
l y s a t e s (synthes is ) and c u l t u r e medium ( s e c r e t i o n ) . Total 
p ro te in synthesis and sec re t ion was determined by following 
[ C]-leucine incorporat ion i n to TCA insoluble p r o t e i n s . 
Resul ts are expressed as dpm of [ '^C]-leucine incorporated 
i n t o AFP or t o t a l p ro t e in s per mg wet weight of skin 
explants cu l tu red . 
Time course of [ C]- leucine incorpora t ion i n t o 
immunoprecipitable APP in skin l y s a t e s ( syn thes i s ) and in 
medium (secre t ion) during 6 h r s cul ture period i s presented 
in P ig .24 . Incorporation of [ C]-leucine i n t o APP and 
TCA insoluble f ract ion ( t o t a l pro te ins) both in skin l y s a t e s 
(synthes is ) Pig,24A and in medium (secre t ion) Pig.24B was 
l i n e a r during 6 hrs cu l tu re per iod . Addition of cyc lo -
heximide inhib i ted the incorpora t ion of [ C]-leucine in to 
APP (synthesis)(Pig.24A) i nd i ca t i ng that AFP i s indeed 
synthesized by newborn r a t skin explants in c u l t u r e . Accum-
u la t ion of l abe l l ed APP i n t o the medium ( sec re t ion) was a lso 
i nh ib i t ed by cycloheximide. Newly synthesized AFP was 10-
12/" of the t o t a l prote in synthes is in these explan ts . 
[ G]- label led AFP secreted in to the medium accounted for 
about 22-30f» of the t o t a l l a b e l l e d pro te ins secreted by 
these cu l tu res . 
T 4 6 
TIME ^HOURS) 
14 
F1624- Time Course Of ( C Meucine Incorp 
-oration (nto Total Protelns^AFP 
By Newborn Rat Skin Explants. 
Total ProteinsA-A jAFP • - • land AFP 
in presence o^  cyclohexinnide,o~o 
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No s i g n i f i c a n t i n c o r p o r a t i o n of [ ^C] - l euc ine i n t o 
immunoprec ip i tab le albumin was found i n t h e s e c u l t u r e s . I t 
a p p e a r s t h a t albumin i s not s y n t h e s i z e d i n t h e s k i n , 
NATURE OF AFP SBOR£TED BY NBWBOM RAT SKIN EXPLAHTS 
IN CULTURE 
The medium obta ined a f t e r 6 h r s c u l t u r e of newborn 
r a t sk in exp lan t was d i a l y z e d e x t e n s i v e l y a g a i n s t f i r s t w i t h 
PBS~leucine and then w i t h PBS on ly . I t was concen t r a t ed 
(10 t imes) by l y o p h i l i g a t i o n and w i l l be r e f e r r e d a s CMS 
( c o n c e n t r a t e d medium from newborn r a t sk in e x p l a n t c u l t u r e s ) . 
CMS was sub j ec t ed t o v a r i o u s a n a l y s e s t o c h a r a c t e r i z e AFP 
s e c r e t e d by s k i n , 
IBP a n a l y s i s of CMS y i e l d e d s i n g l e p r e c i p i t i n a r c fo r 
AFP i n a- , - region wi th an e l e c t r o p h o r e t i c m o b i l i t y s i m i l a r t o 
serum AFP ( F i g , 2 5 ) . The immunological i d e n t i t y of sk in AFP 
t o t h a t of serum AFP i s a l s o a p p a r e n t by a complete l i n e of 
fus ion between the two AFP's ( P i g . 2 5 ) . 
Ac t ive Ep b ind ing p r o t e i n s p e c i e s among t h e p r o t e i n s 
s e c r e t e d by newborn r a t sk in e x p l a n t s was i d e n t i f i e d in CMS 
by t h e procedure s i m i l a r t o t h a t used for b r a i n AFP 
c h a r a c t e r i z a t i o n , [ H]-E b i n d i n g observed in the CMS 
[7730 cpm/100 |ig p r o t e i n ] could almost comple te ly be d i s -
p laced by excess of cold E- (587 cpm). F u r t h e r , immuno-
p r e c i p i t a t i o n of AFP by ant i -AFP from t h e CMS p r e c i p i t a t e d 
a lmost a l l t he [ •^H]- rad ioac t iv i ty (7190 cpm) and the 
s u p e r n a t a n t s did not show any s i g n i f i c a n t E_ b i n d i n g . 
FIG.25 CHARACTERIZATION OF APP SECRETED BY NEWBORN 
SKIN EXPLANTS IN CTTLTUPE 
2^*jL : Immunological i d e n t i f i c a t i o n of AFP 
s e c r e t e d by sk in explant s i n c u l t u r e wi th 
serum AFP. 
FS, f e t a l serum; CMS, c u l t u r e medium 
( c o n c e n t r a t e d ) ob ta ined a f t e r 6 h r s 
c u l t u r e of newborn r a t sk in explantjAbAFp, 
a n t i - A F P . 
F / ^ ^Q . d^*P '• Molecular w e i ^ t d e t e r m i n a t i o n of AFP 
s e c r e t e d by newborn r a t sk in e x p l a n t s 
i n c u l t u r e by SDS-PAGE. 
CMS ( c u l t u r e medium of newborn 
r a t s k i n e x p l a n t ) 
CMS ( c u l t u r e medium of 3 weeks 
o ld r a t sk in e x p l a n t ) . 
F^c-izs' 
f ' 4 i £ 
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Simi l a r r e s u l t s were a l s o o b t a i n e d in newborn r a t sk in 
c y t o s o l . These o b s e r v a t i o n s c l e a r l y i n d i c a t e s t h a t AFP i s 
t h e only a c t i v e p r o t e i n s e c r e t e d by newborn r a t sk in t h a t 
b i n d s B- with h igh s p e c i f i c i t y . 
Molecular weight of [ ^ C ] - l a b e l l e d AFP s e c r e t e d by 
newborn r a t sk in exp l an t s was determined fo l lowing immuno-
p r e c i p i t a t i o n of l abe l led-AFP from CMS by a n t i - A I ^ and 
subsequent a n a l y s i s of t he immunoprec ip i t a te on SDS-PAG-E 
( s e e b r a i n AFP mol. wt , d e t e r m i n a t i o n ) . The medium ob ta ined 
from s k i n e x p l a n t s c u l t u r e of 3 weeks old r a t (non producer 
of AFP; see below) was a l s o p rocessed i n a s i m i l a r manner 
and inc luded a s c o n t r o l , AFp y i e l d e d s ing le band on SDS-
PAG-E cor responding t o m o l e c u l a r weight of 68,000 dsi l tons 
(F i g ,26 ) which i s s i m i l a r t o t h a t observed f o r p u r i f i e d - ra t 
j^pp and b r a i n AFP. Cont ro l g e l did not r e v e a l e d any r a d i o -
a c t i v i t y cor responding t o AFP p o s i t i o n , a s observed i n CMS, 
i n d i c a t i n g t h a t ant i-AFp used fo r immunoprec ip i ta t ion of^APP 
from CMS i s monospecif ic and t h a t 3 weeks old r a t s k i n 
exp lan t do no t produce AFP, 
ONTOGENY OF AFP M SKm 
Developmental p r o f i l e of j,'j.FP in r a t sk in was s t u d i e d 
by measur ing AFP l e v e l i n sk in c y t o s o l s , a t v a r i o u s s t a g e s 
of development, by the rocke t a s s a y . The r e s u l t s a r e 
p r e s e n t e d i n Fig .27A. High l e v e l s of sk in AFp, observed 
du r ing f e t a l l i f e (18 and 20E) decreased p r o g r e s s i v e l y to 
very low l e v e l s a t 21P and the p r o t e i n d i sappea red t h e r e a f t e r , 
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Measurement of heme c o n c e n t r a t i o n s i n v a r i o u s sk in c y t o s o l 
samples r e v e a l e d t h a t f e t a l b lood con tamina t ion could 
c o n t r i b u t e about 5-10°/° of the t o t a l AFP l e v e l s observed i n 
s k i n . I t became apparen t t h a t an independant pool of ilPp 
c o n t r i b u t e d by iji, s i t u s y n t h e s i s may probably e x i s t i n sk in 
which could account for h i ^ 71FP l e v e l s i n deve lop ing r a t 
s k i n , 
AGE RELATED GHilNGBS IN THE RATE OF AFP SYNTHESIS IN RAT SKIW 
Rat sk in explant c u l t u r e s were e s t a b l i s h e d from 
f e t u s e s of 18 d g e s t a t i o n a l age and 1 , 7 , 1 4 , 21 and 28 d old 
p o s t n a t a l r a t s . Synthes i s of AFp was determined a s desc r ibed 
e a r l i e r . R e s u l t s a r e expressed a s r a t e of [ C ] - l e u c i n e 
i n c o r p o r a t e d i n t o immunoprecip i table AFP per h r p e r mg of 
s k i n e x p l a n t s c u l t u r e d . The d iange i n the r a t e of AFP 
s y n t h e s i s w i th age i s d e p i c t e d i n F ig .27B . I t appears t h a t 
ma tu ra t i on of sk in wi th age r e s u l t s i n con t inuous dec rease 
i n t h e r a t e of AFP s y n t h e s i s . The AFp s y n t h e t i c r a t e s i n 
14 d old r a t sk in were g r e a t l y reduced (12.05/" of t h e v a l u e s 
a t 18E) , No i n c o r p o r a t i o n of [ C ] - l e u c i n e i n t o immunopreci-
p i t a b l e AFP was observed in t h e sk in exp lan t c u l t u r e s 
e s t a b l i s h e d from 3 and 4 weeks old r a t . I t appears t h a t 
s y n t h e s i s of AFP i n skin i s t u r n e d off a f t e r two weeks of 
p o s t n a t a l l i f e . 
8.1 
n^ffRMATION OF AFP nQNTFJJT WITH ITS R/iTT^. OV SYNTHEBIS 
IN SKIM 
AFP level as well as its rate of synthesis in skin 
explant cultures showed a continuous decline during develop-
ment, A correlation between the rate of AFP synthesis and 
its content in skin during development is presented in Fig.28, 
Results are expressed as percent daange in these parameters 
over the values observed in 18 E fetal rat skin (control). 
A linear relationship between the AFP level and its rate of 
synthesis by skin explants in culture demonstrate that 
high level of AFP in skin is due to its high rate of synthesis 
in skin. Age related decline in AFP content in skin reflects 
a proportionate decrease in the rate of its synthesis. 
EFFBOT OF HORMONES ON THE RATE OF /J'P SYNTHESIS BY NEWBORN 
Effect of incubating the skin explant cultures with 
hormones (insulin, dbcAHP dexamethasone, estradiol) on the 
rate of AFP synthesis over a 24 hrs culture period of 
newborn rat skin explant is depicted in Fig,29. Results are 
expressed as percent change in the rate of AFP synthesis 
over the control (18 E fetal skin explant culture). 
Dexamethasone and insulin were effective in decreasing the 
rate of synthesis upto 26% and ll/° respectively. Estradiol 
increased the rate of AFP synthesis by 105^  over control. 
dbc/iMP did not show any significant change. 
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FiY^THESIS MT) SECRETION OF AFP M P ALBTTNTN BY ITEWBOM 
RAT HEPATQCYTES DT CULTURE 
Hepa tocy tes were p r e p a r e d from newborn r a t l i v e r 
and ma in ta ined in l e u c i n e f ree medium f o r 6 h r s . 
I n c o r p o r a t i o n of [ C]~leuc ine i n t o immunoprec ip i tab le AFP 
and albumin i n c e l l l y s a t e s ( s y n t h e s i s ) and i n the medium 
( s e c r e t i o n ) was determined t o s tudy "the s p e c i f i c p r o t e i n 
s y n t h e s i s , F i g , 3 0 summarizes the k i n e t i c s of t h e i n c o r p o r -
a t i o n of [ ^ C ] - l e u c i n e i n t o AFP, albumin and t o t a l p r o t e i n s . 
Newborn r a t h e p a t o c y t e s s y n t h e s i z e AFP a t a ve ry h igh r a t e , 
a c c o u n t i n g for about 80% of the t o t a l p r o t e i n s y n t h e s i s . 
Albumin s y n t h e s i s i n t h e s e c e l l s was about 3..% of t he t o t a l 
p r o t e i n s y n t h e s i s , AFP and albumin t o g e t h e r c o n s t i t u t e 
about 90/o of the t o t a l p r o t e i n s y n t h e s i s i n the l i v e r . 
S i m i l a r r e s u l t s have been r e p o r t e d by o the r a u t h o r s ( S e l l 
e t a l , 1 9 7 9 ) . Sec re t ion of AFP by t h e h e p a t o c y t e s i n t o the 
medium was about 76fo and fo r albumin about 10?^ of the t o t a l 
s e c r e t e d p r o t e i n s , Cycloheximide can i n h i b i t the s y n t h e s i s 
and s e c r e t i o n of AFP and albumin (Fig,30A and 30B). 
SERUM AFP AND ALBUMIN PROFILES DURING DEVELOPMENT 
REL^ITIQNSHIP BETWEEN AFP AND ALBUMIN CONTENT IN LIVER AND 
SERUM LEVELS OF TFIESE PROTEINS V/ITH THEIR R/.TE OF 
SYNTHESIS IN TlfE DEVELOPING HEPATOCYTES 
Blood was c o l l e c t e d from f e t a l (18 and 20 E) , p o s t -
n a t a l ( l , 3 , 7 , 14 , 21 , 28 and 35 d old) and a d u l t r a t s . 
Sera were s e p a r a t e d and AFP and albumin l e v e l s determined by 
Ti MElhrs.) 
14 
F(G. 30 Incorporation Of ( C )-leuc i ne Into 
Total Protains AFP and MbuminBy 
^Jewborn Rat Hepatocytes . 
TotuI P ro te insdP ) i^-A ^ AFP •--• f 
Albumin o—o.AFPandAlbunr)in In 
presence of cycloheximide •—• f 
C PyCell p r o t e i n . 
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rocket assay. Amount of AFP and albumin was also determined 
in the cytosol samples prepared (see Material and Methods) 
from rat liver at various stages of development, The 
hepatocytes were prepared from rat liver at the specified 
ages and maintained in leucine free medium. Rates of AFP 
and albumin synthesis by these hapatocyte cultures were 
determined as described earlier. 
Developmental changes in serum level of APP, its 
content in liver, and rate of ^nthesis are depicted in 
Fig,31. The same parameters were also studied for albumin 
and the results are summarized in Fig.32. Serum levels of 
AFP and albumin showed an inverse relationship during 
development (Fig,31A and Fig.32A). Serum AFP concentration 
-1 -1 
decline from 11.5 mg ml at 18 E fetuses to 130 fig DI1 i^i 
28 d old neonatal rats. During this period AFP concentration 
in serum declined to about l/lOOth to that observed in 18 B 
fetuses, while albumin level increased about 35 times during 
the same period. Liver contents of /;FP and albumin also 
displayed similar relationship (Fig,3lB and Fig.32B), AFP 
content in liver declined by about 92/» in 28 d old liver 
(results are compared to 18 B fetal liver). Albumin content 
of the liver showed a constant increase during development. 
These observations indicates that age related changes in the 
serum levels of AFP and albumin and their content are closely 
related and might be a reflection of their rate of synthesis 
in liver. 
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A comparative study of the synthesis of Ihe two 
prote in in the hepatocytes revealed tha t maturation of the 
hepatocyte i s marked by a spec i f ic pa t te rn of development 
of AFP and albumin s y n t h e s i s . Immature r a t hepatocytes 
(18 and 20 B fe tuses) showed a very high r a t e of AFP synth-
e s i s in comparison to albumin. Rate of /xPP synthesis in 
the hepatocyte cu l tu res es tab l i shed from ra t l i v e r a t 
various s tages of development showed a continuous decline 
with age (Pig ,31 C). Hepatocyte cu l tu res from 4 weeks 
old ra t l i v e r did not incorporated [ C]- leucine in to AFP. 
I t appears t h a t synthesis of AFP i s turned off a t t h i s 
stage of development. Rate of AFp synthesis during 
development (maturation) of hepatocytes were 80.7?^, 70.99^o, 
43.27", 32.4/» and 0.45/° in 20 E, I P , 7 P, 14 P and 21 P r a t 
respect ive ly (Resul ts are expressed as ^ decl ine over the 
r a t e of AFP synthesis observed in 18 E f e t a l l i v e r ) . 
On the other hand, age r e l a t ed development of 
hepatocyte i s associated with an increase in the r a t e of 
albumin synthesis (Fig,32 C), l i v e r content (Fig.32 B) and 
serum leve l (Fig.32 A). Rate of albumin synthesis in the 
hepatocytes during foto-neonatal development were 14.07^, 
22.05/", 27.94/°, 61.76/0, 70.58/" and 92.64/" in 18 E, 1 P, 7 P, 
14 P, 21 P and 28 P ra t r espec t ive ly (Results are compared 
with the r a t e of albumin synthes is obtained in the 
hepatocytes prepared from 35 d old r a t l i v e r ) , 
8 J 
I t i s apparent t h a t m a t u r a t i o n of h e p a t o c y t e i s 
accompanied by a d e c l i n e i n t h e r a t e of AFP s y n t h e s i s and 
an i n c r e a s e i n the r a t e of albumin s y n t h e s i s . R a t i o s of 
t h e r a t e of albumin t o AFP s y n t h e s i s i n t h e h e p a t o q y t e s 
were 0 . 0 5 , 0 . 1 0 , 0 . 2 8 , 0.35 and 48 i n 18 E and 1 , 7 , 14 and 
21 d old r a t s , 
CORRELATION OF AFP AND ALBUMIN CONTMI IN RAT LIVER WITH 
THEIR RATE OF SYNTHESIS IN THE HEPATOCYTES DURING DEVELOPMENT 
The l i v e r con ten t of APP and albumin and r a t e s of 
t h e i r s y n t h e s i s were d i r e c t l y c o r r e l a t e d ( F i g . 3 3 ) . R e s u l t s 
a r e p r e s e n t e d as p e r c e n t change i n the r a t e of AFP s y n t h e s i s 
i n the h e p a t o c y t e s and i t s l i v e r conten t over t h e v a l u e s 
observed in 18 B f e t a l l i v e r ( c o n t r o l ) ( F i g , 3 3 A ) . Rate of 
albumin s y n t h e s i s and i t s l i v e r con ten t a r e p r e s e n t e d as 
p e r c e n t change i n t h e s e p a r a m e t e r s over t h e c o n t r o l (35 d 
old r a t ) . I t would appear from Fig.33A and 33B t h a t l i v e r 
con ten t of AFP and albumin depends upon t h e i r r a t e s of 
s y n t h e s i s i n the deve lop ing h e p a t o c y t e . Age r e l a t e d dec rease 
i n AFP and i n c r e a s e i n albumin content i n l i v e r d i r e c t l y 
r e f l e c t s magnitude of t h e i r s y n t h e s i s i n l i v e r . 
CORRELATION OF SERUM AFP AND ALBUMIN LEVEL WITH RATES OF 
THEIR SYNTHESIS IN THE DEVELOPCTg HEPATOCYTES 
A c o r r e l a t i o n of serum albumin l e v e l and i t s r a t e s 
of s y n t h e s i s p r e s e n t e d in Fig.34^1. R e s u l t s a r e expressed as 
p e r c e n t change i n these two pa rame te r s over t h e c o n t r o l 
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F'G 33.Correlation Of LiverContentsOf AFP 
And Alb uminWith Their Rates Ov Syn 
nthesis in The Hepatocytes During 
Development. 
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r iG 34. Correlat ion Of Serum Albu min And AFP 
With Their Rates Of Synthesis In The He> 
patocytes During Development 
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values (35 d old r a t ) . An increase in serum albumin l eve l 
may be accounted due to propor t ionate increase in the r a t e 
of APP synthesis and secre t ion by the developing hepatocyte . 
Rela t ionship between AFP l eve l in serum and i t s r a t e of 
synthesis by the developing hepatocyte i s presented in F ig . 
34 B. Serum AFP l eve l dur ing f i r s t two weeks of pos tna ta l 
development decrease more rapid ly than i t s r a t e of syn thes i s 
i n the hepatocyte . During t h i s period r a t e of AFP synthesis 
decreased by 3 2 . # while serum AFP l eve l declined by 7.7/° over 
the values observed in 18 B f e t a l r a t . In other words serum 
AFP l e v e l were lower than i t s r a t e of qjrnthesis and secre t ion 
by the hepatocytes . I t may be due to a l a rge increase i n 
the body w o i ^ t ( t o t a l blood volume) r e s u l t i n g in greater 
d i l u t i o n of AFP secreted by l i v e r during f i r s t two weeks of 
pos tna t a l l i f e , and due to a decreased r a t e of AFP synthesis 
and secre t ion by the developing hepatocyte . The l o s s of 
yolk sac a t term i s a lso responsible for a more r ap id f a l l in 
serum AFP l e v e l . In r a t , yolk sac i s ac t ive i n the synthes is 
and secre t ion of AFP throughout the ges ta t ion period and at 
term i t may account about half of the t o t a l serum AFP l eve l 
( G i t l i n , 1975). The curve represented by dotted l i n e s in 
Fig .33 B would have been t rue i f AFP synthesis and i t s serum 
l e v e l were decl ining at the same r a t e . 
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HORMONAL CONTROL OF AFP AWD ALBUMIN SYNTHESIS IN 
flEPATOCYTE OF NEWBORN RAT 
Hepa tocy tes from newborn r a t were c u l t u r e d i n 
l e u c i n e f ree medium as d e s c r i b e d e a r l i e r . E f fec t of v a r i o u s 
hormones ( i n s u l i n , dbcAMP, e s t r a d i o l and dexamethasone) on 
t h e r a t e of AFP and albumin s y n t h e s i s i n t h e s e c e l l s was 
determined over a 24 h r s c u l t u r e p e r i o d . E f f ec t of t h e s e 
hormones on t h e r a t e of amount of AFP and albumin s e c r e t e d 
i n t o the medium d u r i n g t h e same c u l t u r e pe r iod i n p resence 
of v a r i o u s hormones was a l s o s t u d i e d , 
Dexamethasone and dbcAMP reduced t h e r a t e of AFP 
s y n t h e s i s by 45fo and 7f° over t h e co r r e spond ing c o n t r o l 
v a l u e s (P ig .35 B ) . I n s u l i n i n c r e a s e d t h e r a t e of AFP 
s y n t h e s i s by 2lf°. S imi l a r e f f e c t s of t h e s e hormones were 
a l s o e x h i b i t e d i n the r a t e of s e c r e t i o n of AFP when expressed 
a s | ig/hr/mg c e l l u l a r p r o t e i n (F ig .35 A ) . E s t r a d i o l d id not 
a f f e c t e i t h e r t h e r a t e of s y n t h e s i s or s e c r e t i o n of AFp, 
E f f e c t s of i n s u l i n , dexamethasone, dbcAMP seems t o 
be s p e c i f i c fo r AFP s ince albumin s y n t h e s i s o r s e c r e t i o n by 
newborn h e p a t o c y t e was not s i g n i f i c a n t l y a l t e r e d under t h e s e 
c o n d i t i o n s . 
EFFECTS OF HORMONES ON SERUM AFP LEVEL IN NEWBORN RATS J2L VIVO 
Var ious hormones were a d m i n i s t e r e d t o newborn r a t s 
t o s tudy t h e i r e f f e c t s on serum AFP l e v e l . Dexamethasone 
(2 tag g d ) , e s t r a d i o l (3 |j,g g twice a week) , i n s u l i n 
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I nsu l i nd ) , dbcAMP(A ) , dexamcthaso 
-ne(o ) , estradio l (E), 
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(0.05 lU g"""" d""^ ) and dbc/xMP (10 ^ ig g" d" ) were injected 
intraperitoneally into newborn rats, while control group 
received equal volume of saline. Blood samples were 
collected from hormone treated and control rats after 
specified intervals of time. Serum AFP and albumin levels 
were determined by rocket assay. Results are depicted in 
Fig.36. 
Control group showed the normal disappearance of AFP 
from serum after 4 weeks of postnatal life. Dexamethasone 
induced a premature fall in serum AFP and it disappeared 
8 days earlier than control group. Dibutyryl cAMP also 
suppressed /iFp level and resulted in its disappearance from 
serum about 4 days earlier. Estradiol and insulin did not 
affect AFP level significantly. 
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D I S C U S S I O N ' 
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APP i s one of t h e b e s t c h a r a c t e r i z e d o n c o f e t a l 
a n t i g e n s known t o be exp res sed p r i m a r i l y i n yo lk sac 
v i s c e r a l endometrium and f e t a l l i v e r parenchyma ( G i t l i n , 
1978, 1975 ) . Both c e l l t y p e s have common o r i g i n du r ing 
o n t o g e n e s i s . AFP i s r e - e x p r e s s e d in tumors of t h e s e c o l l 
t y p e s and t he r eby i t ha s a t t a i n e d a g rea t s i g n i f i c a n c e a s 
a d i a g n o s t i c a i d f o r h e p a t o c e l l u l a r carcinoma and germ 
c e l l t e r a t o c a r c i n e m a s ( R u o s l a h t i and Seppala , 1 9 7 9 ) . 
Slowly i t i s be ing a p p r e c i a t e d t h a t o t h e r d e v e l o p i n g 
t i s s u e s a l s o express AFP gene. 
Albumin and AFP a r e u se fu l d i f f e r e n t i a t i o n markers , 
They a r e i n v a l u a b l e i n i n v e s t i g a t i n g d i f f e r e n t i a t i o n 
r e l a t e d a c t i v a t i o n or qu i scence of s p e c i f i c gene e x p r e s s i o n , 
This d i s s e r t a t i o n i s aimed a t deve loping r e l e v a n t methodo-
logy and g a i n i n g an i n s i g h t i n t o r e g u l a t i o n of APp and 
albumin genes by l o o k i n g a t on togenes i s of s y n t h e s i s aad 
l e v e l s of t h e s e p r o t e i n s i n d i f f e r e n t deve lop ing t i s s u e s . 
AN IMPROVED PROCEDURE FOR ISOLATION OF AFP 
I s o l a t i o n of homogeneous AFP by a d i r e c t n e g a t i v e 
immunoabsorption fo l lowed by DEAE-cellulose column 
chromatography i s a d e f i n i t e and s i g n i f i c a n t improvement 
over the p rocedures r e p o r t e d f o r p u r i f i c a t i o n of AFP 
(Ruos l ah t i and Soppala , 1 9 7 9 ) . AFP and albumin a r e major 
p r o t e i n s ( 80°/°) of t h e amn io t i c f l u id (Tomasi e t a l , 1 9 7 7 ) 
and they share many phys icochemlca l p r o p e r t i e s ( R u o s l a h t i 
9x 
and Seppala, 1979; Ruoslahti and Engvall , 1978; Smith and 
Kel leher , 1973). This has rendered t h e i r separa t ion , by-
conventional means, d i f f i c u l t , 
P a r t i a l success in pu r i f i ca t i on of AF'B has been 
achieved by an array of physicochemical procedures inc lud -
ing gel f i l t r a t i o n , i s o e l e c t r i c focussing, ion exchange 
chromatography, so l id phase l e c t i n / e s t r a d i o l a f f i n i t y 
chromatography (Ruoslahti and Seppala, 1979) . Such 
procedures have not only been mul t i s tep and time consuming 
but have a l so resu l t ed in poor recoveries of the p ro t e in . 
This leaves immunochemical procedure as the method of 
choice for i s o l a t i o n of the p r o t e i n . Aff ini ty procedure 
involving adsorption of the p ro te in t o anti-APP sepharose 
column has proved useful (Ruoslahti and Seppala, 1979; 
Sel l et a l , 1972). However, t h i s procedure has obl igatory 
requirement for a h i ^ l y spec i f i c antiserum agains t APP, for 
the preparat ion of immunoadsorbent, which may not be 
ava i l ab le i n i t i a l l y . Moreover, e lu t ion of adsorbed APP 
from anti-APP sepharose column needs d r a s t i c condi t ions 
(low pH, 8 M urea e t c ) which may affect the b io log ica l 
potency of AFP ( e s t r ad io l binding, immunosuppression, 
binding of various l igands e t c . ) . However, no comparison 
has yet been reported regarding the b io log ica l a c t i v i t y of 
APP pur i f ied by d i f fe ren t procedures. This may ind ica t e 
the reported discrepancies regarding the s to ichcionotry of 
Bp-APP i n t e r a c t i o n , and magnitude of immunosuppression by 
d i f fe ren t preparat ions of APP (Ruoslahti and Seppala,1979). 
9o 
Class ica l antibody a f f i n i t y chromatography frequently leads 
t o the constant leakage of covalent ly coupled l igand (IgG) 
from the agarose column matr ices during e lu t ion of AFP 
(Ruoslahti , 1976j Pihko et a l , 1973), thereby, n e c e s s i t a t i n g 
another immunoadsorbent column or gel f i l t r a t i o n s tep t o 
get r id of the contaminating IgG, 
Absorption of antibody with an t igen(s ) i s commonly 
used t o make the heterogenous antiserum spec i f i c for a 
•phase Specif ic an t igen ' (see preparat ion of anti-APP ) , 
Similarly undesired an t igen(s ) can a lso bo removed by 
absorption with monospecific or polyvalent a n t i s e r a to 
p r e c i p i t a t e out the undesired a n t i g e n ( s ) . Present procedure 
based on t h i s p r inc ip le could y ie ld homogeneous AFP with 
p roper t i es i d e n t i c a l t o l i t e r a t u r e repor t s for AFP pur i f ied 
by other procedures. Moreover, spec i f ic antiserum ra i sed in 
r a b b i t s agains t AFP pur i f i ed by the procedure was a l s o used 
for the preparat ion of anti-AFP sepharose. Rat AFP i s o l a t e d 
from amniotic f lu id by these two procedures did not reveal 
any difference with respec t to molecular weight, e s t r a d i o l 
binding, and Con A~affinity molecular v a r i a n t s . 
Negative immunoabsorption procedure r e s u l t e d in 
high y ie ld ( 8770 o^ ^ P » Fur ther , the procedure employed 
very gent le i s o l a t i n g cond i t ions . The inherent disadvantage 
associa ted with the present procedure l i e s in the use of 
r e l a t i v e l y l a r g e r amount of pur i f ied anti-NRS IgG, While 
immunoadsorbent having anti-AFP (IgG) coupled to sepharose 
G 
can be reused for many times. The present procedure for 
isolation of APP may also be useful for isolation of other 
phase Specific antigens like carcinoembryonic protein and 
uteroglobin. 
QNTO&BNY MT) DISTRIBUTION OE AFP IN FETO-NEONATAL 
TISSUES OF RAT AND HUMlN FETAL BRAIN 
The expression of a common protein in a tissue 
during feto-neonatal life and in carcinogenesis have 
favoured the concept of common gene expression during 
development and oncogenesis. AFP is known to be mainly 
synthesized by the yolk sac, fetal liver and to a small 
extent by the gastrointestinal tract, kidney and placenta 
of all mammals so far studied (Mackiewicz and Breborowicz, 
1980; Breborowicz and Nishi, 1979; Mackiewicz et al, 1978; 
Gitlin, 1975). Recently, immature rat uterus has also 
been demonstrated to synthesize AFP (Smalley and Sarciono, 
1980). However, ontogeny of AFP in these tissues has not 
been studied. Most of the studios of AFP wore concentrated 
on neoplastic tissues and the possibility that the protein 
may also bo of significance in the development of tissues 
other than liver and yolk sac has not attracted much 
attention. Studies on AFP conducted during the last decade 
have made it clear that tumors arising in the adult tissues 
which are known to synthesize AFP during early development 
(Liver, yolk, sac, gastrointestinal tract) often lead to 
elevated levels of AFP in serun (Ruoslahti and Seppala, 
<j 
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1979). In addition, tumors arising in other tissues (non-
procedures of APP) such as testis, ovary lung, skin and brain 
may also produce elevated levels of serum AFP (fiuoslahti 
and Seppala, 1979; Arita et al, 1980; Soltani et al, 1978). 
In view of these observations various feto-neonatal tissues 
were investigated for the presence of APP and its ontogeny. 
AFP was found to be present in most of the fetal 
tissues except pancreas, spleen, and thymus. AFP present 
in serum, brain, skin, and kidney was immunologically, 
electrophoretically, and with regard to estradiol binding 
identical. Immunological identity of AFP produced by 
human fetal organs such as yolk sac, liver,intestine and 
kidney has been already demonstrated (Mackiewicz and 
Breborowicz, 1980). This may indicate the expression of 
AFP gene in these physiologically and functionally different 
tissues. However, the origin of AFP in various tissues is 
not clear at present. It may bo speculated that fetal 
blood contamination, having h i ^ concentration of AFP, may 
give rise to detectable levels of AFP in various tissues. 
The level of AFP in various tissues at a specific stage of 
development was found to be different. In addition, AFP 
disappeared from various tissues at a different yet 
specific period after postnatal development. These 
observations strongly suggest that AFP in various tissues does 
not arises due to the contamination from fetal blood. 
Otherwise, ontogeny of AFP in various tissues should have 
q ' 
been a l i k e . Determination of heme concentrat ions in 
various t i s s u e ex t rac t s showed t h a t f e t a l blood contaminat-
ion could, a t the most, con t r ibu te upto 10/° of the observed 
AFP l e v e l s in various fe to-noonata l t i s s u e s of r a t . 
However, t h i s t e s t would not account for APp in ext ra vascular 
f l u i d s ( i . e . AFP may d i s t r i b u t e in both i n t r avascu la r and 
ext ra vascular compartments whereas heme in blood c e l l s i s 
present only in the i n t r avascu la r compartment). I t may 
a lso be argued a t t h i s s tage t h a t var ious t i s s u e s d i f f e r 
i n t h e i r capacity t o absorb or concentrate AFP from f e t a l 
c i r c u l a t i o n , thereby, d i f f e r i n g i n t i s s u e content of AFP. 
No d i r ec t evidence i s ava i l ab l e to prove or disprove any 
of the above a l t e r n a t i v e s . 
Another p o s s i b i l i t y which can account for the 
observed t i s s u e l eve l s of AFP i s : in s i t u synthesis of AFP 
by d i f ferent t i s s u e s . Synthesis of AFP has a l ready been 
demonstrated in the yolk sac , f e t a l l i v e r , stomach, 
i n t e s t i n e , kidney and p lacenta (Mackiewicz and Breborowicz, 
1980; Breborowicz and Nish i , 1979| G i t l i n , 1975)• While 
evidence for synthesis of AFP by developing r a t brain and 
skin i s presented in th i s d i s s e r t a t i o n . Fur ther , support 
for t h i s hypothesis i s derived from the r epor t s t h a t AFP 
produced by human yolk sac , f o t a l , l i v e r , i n t e s t i n e and 
kidney may d i f f e r from serum APP with respec t t o i t s 
r e l a t i v e proportion binding t o Con-A and l e n t i l a g ^ u t i n i n 
(Mackiewicz and Breborowicz, 1980). Our r e s u l t s a l so 
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indicate that brain and skin cytosol differ from serum in 
their relative amounts of Con A-nonreactive AFP variant. 
These observation also support that contamination of AFP in 
these tissues from fetal blood may partly account for the 
observed AFP levels in these tissues. 
HYNTtlBSIS OF AFP BY DEVELOPING RAT BRAIN. SKIN. AND LIVER 
Feto-neonatal estradiol binding protein in rodent 
brain has earlier been reported as AFP (Attardi and 
Ruoslahti, 1976; Plapinger and McEwen, 1975; Plapinger et 
al, 1973). Intracellular localization of both AFP and 
albumin has also been confirmed in the central and 
peripheral nervous systems of developing rodents (Toran-
Allerand, 1980; Trojan and Uriel, 1979; Benno and Williams, 
1978) and human fetuses (Mollgard et al, 1979) by immune-
histochemical procedures. Studies by Eppenburger and Hsia 
(1972) have indicated the presence of an Ep binding protein 
in the skin cytosol of immature rats. However, no 
information is available regarding its origin in these tissues. 
The presence of high levels of AFp and its distinct 
ontogeny in brain and skin led us to propose that AFP 
might be synthesized in these tissues and may account for 
all the above observations. 
An extensive biochemical and morphological character-
ization of dissociated mammalian brain cells in primary 
culture (Raizada et al, 1981, 1980; Hansson et al, 1980; 
Labourdette et al, 1979; Benda ot al, 1975) and skin 
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explant cultures (Vorma and Boutwell, 1980} Hawley-Nelson 
et al, 1980; Halprin et al, 1979; Epstein, 1979) has 
provided a good jn vitro model systems to study the bio-
chemical events accompanying the growth and differentiation 
of these tissues. Dissociated newborn rat brain cells and 
skin explant cultures were used to answer the following 
questions: Is Ep binding protein in newborn rat brain and 
skin AFP ? If so, where does this protein originate from 
and what is its ontogenie profile in different tissues ? 
Synthesis of AFP and albumin by immature rat hepatocytes 
is well established (Erazier ot al, 1977; Tsukada and 
Hirai, 1975; Sell and Skelly, 1975; Leffert and Sell, 1974). 
This system was used in the present study to compare with 
AFP synthesis in brain cell culture and skin explant. 
Our observations, derived from [ ^ C]-leucine 
incorporation into immunoprecipitable AFP and albumin by 
dissociated brain cells and skin explant maintained in 
short term cultures provide evidence for the synthesis of 
AFP and albumin in brain, and AFP in skin of newborn rat, 
Cycloheximide mediated inhibition of incorporation of 
[ C]-leucine into: AFP and- albumin in brain cells and 
into AFI' in skin explant cultures strongly suggests that 
neonatal rat brain and skin are sites for synthesis of these 
proteins. This observation also eliminated the possibility 
of the labelled AFP having arise from an artifact of culture 
such as AFP being released from dead cells or carried over 
from fetal scrum and released subsequently later in 
cultures or due to nonspecific adsorption of free [ C]-
leucine. 
Further, intracellular content of AFP and albumin 
in brain cell did not change significantly during 6 hrs 
culture period. To the contrary, these cells demonstrated 
a linear secretion of AFP and albumin, as a function of 
incubation time. Total amount of AFP as well as albumin 
secreted into the culture medium was also far in excess 
of the intracellular content of these proteins at the 
initiation of brain cell cultures. In view of these 
observations, it may bo concluded that AFP and albumin 
observed in brain cell cultures arise entirely as a result 
of iSL situ synthesis of the two proteins in the brain. 
AFP and albumin secreted by the brain cells and newborn 
rat of skin explants were immunologically, electrophore-
tically and with regards to molecular weight and B^ 
binding properties similar to sorum AFP. Demonstration of 
the synthesis of estrophilic AFP by developing brain and 
skin also provide an explanation for the presence of E2 
binding protein in the cytosol of rat brain (Attardi and 
Ruoslahti, 1976; Plapinger ot al, 1973) and skin 
(Bppcnburger and Hsia, 1972). Intracellular pool of AFP 
and albumin found in the diverse region of the developing 
rodent (Toran-Allorand, 1980| Trojan and Uriel, 1979; 
Bonno and Williams, 1978) and human brain (Mollgard ot al, 
1979) and the presence of AFP in human fetal brain 
cultures (Mackiowicz ct al, 1978) may also arise from their 
10, 
4fl situ synthesis in the brain. 
One of the important question which remain unexplained 
is the fate of AFP and albumin secreted by developing rat 
brain and skin, Vftiethcr AFP and albumin synthesized in 
the brain are restricted to brain only or find thoir'way 
to the common pool i.e. fetal blood. The blood-brain 
barrier is not fully developed till 8 d of postnatal life 
(Davson, 1976), It may be speculated that there may be an 
exchange of proteins between the two compartment. 
Equilibration of AFP and albumin from the brain to the 
blood may not be possible because levels of these proteins 
are extremely lower in brain in comparison to serum. 
Inspite of this large concentration gradient, equilibration 
of these protein between the two pools (including fetal 
blood to brain) does not occur as is evident from the level 
of these proteins in serum and brain. Developmental 
profile of AFP in human fetal brain as observed in the 
present study was similar to that reported in cerebrospinal 
fluid (Adinolfi and Adinolfi, 1976). It is possible that 
fetal brain might be contributing to CSF levels of AFP and 
albumin. It appears that AFP and albumin synthesized and 
secreted by the developing rat brain are probably restricted 
to this compartment only. Clarification of these speculat-
ion may have a direct bearing on the physiological role of 
these proteins in mammalian brain 
10 CJ 
OTTTOGENY AlfD DISTRIBUTION OF AFP MT) ALBUMIN CT BAT 
BR4TN: CORRELATION WITH THBIR RATE OF SYNTHESIS 
Reg iona l d i s t r i b u t i o n of AFP i n o l f a c t o r y , 
cerebrum, cGrebclianSind t h e r e s t p o r t i o n of the b r a i n did not 
r e v e a l any d i f f e r e n c e i n d i c a t i n g a uniform d i s t r i b u t i o n of 
t h i s Bp b i n d i n g p r o t e i n . F e t o - ^ o o n a t a l development of t h e 
r a t b r a i n was accompanied by a s t r i k i n g change i n AFl' 
l e v e l s i n e i t h e r whole b r a i n or i t s d i s c r e t e r e g i o n s . 
During f i r s t week of p o s t n a t a l l i f e , AFP and albumin l e v e l s 
i n the b r a i n were reduced d r a s t i c a l l y and t h e p r o t e i n could 
not be d e t e c t e d a f t e r 7 d of p o s t n a t a l development. The 
r a t e s of AFP and albumin s y n t h e s i s i n b r a i n a l s o dec l ined 
r a p i d l y and, no s y n t h e s i s of t h e s e two p r o t e i n s could be 
demonstra ted a f t e r one week of p o s t n a t a l development , 
I n t e r e s t i ng3 ,y , i n t r a n e u r a l l o c a l i z a t i o n of bo th AFP and 
albumin has been observed only be fore 8 d of p o s t n a t a l 
l i f e (Toran~Allerand, 1 9 8 0 ) . The p r o p o s i t i o n t h a t i n t r a -
c e l l u l a r AFP and albumin i n b r a i n may a r i s e from the uptake 
of ttiese p r o t e i n s by b r a i n c o l l s from f e t a l blood 
(Mollgard e t a l , 1979) may not t h u s e x p l a i n i n t r a c e l l u l a r 
pool of AFP and a lbumin in b r a i n . I f t h i s were s o , l o c a l i z a t i o n 
of those p r o t e i n s in b r a i n should have been demonstra ted 
even a f t e r 8 d of p o s t n a t a l l i f e because t h e serum AFp and 
albumin l e v e l s remain h igh upto 5 weeks of p o s t n a t a l l i f e , 
p o s t n a t a l development of the r a t b r a i n i s known t o 
be accompanied by a rap id d e c r e a s e i n p r o t e i n s y n t h e s i s i n 
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either whole brain (Johnson, 1976; Gilbert and Johnson, 
1972; Andrews and Tata, 1971) or various regions of the 
CNS (Dunlop et al, 1978| Dunlop et al, 1977). Rate of 
protein synthesis is quite hi^i in fetal rat brain and its 
maturation is accompanied by a rapid decline in the same 
during first week of postnatal life and by 12 d protein 
synthesis in rat brain is only 10% of that observed in 
newborn rat (Johnson, 1976; Gilbert and Johnson, 1972). 
The docn.lr.ratiQnof protein synthesis during early 
development is presumably due to a change in intracellular 
mechanism (Johnson, 1976). It is difficult to conclude 
at this stage whether inhibition of the synthesis of AFP 
and albumin during brain development is a reflection of 
overall inhibition of protein synthesis observed during 
this process. AFp and albumin synthesis takes place on 
membrane bound polysomes (Peters and Heed, 1980; Belanger 
et al, 1979). It has been observed that decline in the 
rate of protein synthesis with age is more intense for the 
proteins synthesized on membrane bound polysomes than for 
those synthesized on free polysomes (Andrews and Tata, 
1971). In view of this observation the rates of synthesis 
of AFP and albumin are expected "bo show faster decline with age, 
This has indeed been observed during the present investi-
gation. However, the significance of a decrease in 
specific protein synthesis (AFP and albumin) in brain 
remains to be elucidated. 
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C o - e x i s t en CO of AFP and albumin has been demonst ra ted 
w i t h i n t h e same b i ^ i n c e l l (To ran -Al l e r and , 1 9 8 0 ) . I t i s 
p o s s i b l e t h a t t h e s y n t h e s i s and s e c r e t i o n of AFP and albumin 
t a k e s p l a c e i n t h e same c e l l . In t h e p r e s e n t study we have 
demonstra ted t h e syn thes i s of AFP and albumin by b r a i n 
c e l l s ( d e r i v e d from whole b r a i n ) of d e v e l o p i n g r a t which 
r e p r e s e n t a he te rogeneous p o p u l a t i o n of v a r i o u s c e l l t y p e s . 
I t i s not c l e a r , a t t h e moment, whether a l l c e l l t ypes of 
t h e b r a i n s y n t h e s i z e AFP and albumin or whether i t i s 
r e s t r i c t e d t o any s p e c i a l c e l l type amongst a s t r o c y t e s , 
neu rones , and o l i godend rocy t e s e t c . Ma tu ra t ion of t h e 
b r a i n i s known t o accompany a change i n the r e l a t i v e 
p r o p o r t i o n of neurona l and g l i a l c e l l s (Johnson and 
B e l l i n g e r , 1971) which may f u r t h e r d i f f e r i n t h e r a t e of 
p r o t e i n and RNA s y n t h e s i s (Yanag ihara , 1 9 7 9 ) . In view of 
t h e s e o b s e r v a t i o n s , i t appea r s t h a t t h e s y n t h e s i s of APP 
and albumin by i s o l a t e d n e u r o n a l and g l i a l c e l l s i n c u l t u r e 
or b r a i n c e l l s enr iched i n p a r t i c u l a r c e l l t y p e ( s ) would 
prove h e l p f u l i n de te rmin ing t h e p r e c i s e r o l e of AFP and 
albumin i n t h e d i f f e r e n t i a t i o n and growth of mammalian 
b r a i n , 
QNTOGENIC PROFILES OF SERUM AFP M P ALBUMIN; CORRELATION 
WITH RATE OF THEIR SYNTHESIS CT THE HEPATOGYTES 
S y n t h e s i s and s e c r e t i o n of AFP and albumin t a k e s 
p l a c e e x c l u s i v e l y i n t h e h e p a t o c y t e s and o t h e r c e l l t ypes 
of the l i v e r a r e not known t o s y n t h e s i z e t h e s e p r o t e i n s 
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(Abelev, 1979; Gitlin, 1975). Human fetal liver starts 
synthesizing AFP and albumin and secreting them into the 
serum as early as 29 days after conception (Rothschild ct 
al, 1977? Gitlin, 1975). Considerable information is 
available regarding -the change in serum profiles of AFP 
and albumin accompanying the development of rat and human 
(Ruoslahti and Seppala, 1979j Stillman and Sell, 1979; 
Gitlin, 1978, 1975| Nayak and Mittal, 1977} Abelev, 1971) 
but a direct correlation with their rate of synthesis 
throughout the development of hepatocyte is not documented. 
Feto~neonatal development of rat liver is accompanied 
by a striking change in the serum levels of AFP and albumin. 
AFP is the major serum protein during early fetal life and 
its level shows a continuous decline with postnatal 
development.[L'o the contrary, serum albumin levels registered 
a continuous increase. The changing seixun profile of these 
protein and their contents in liver correlated well with 
their rate of synthesis in the developing hopatocytes, 
AFP is the major protein species synthesized and secreted 
by tbe fetal hepatocytes and its synthesis may account 
upto 85/0 of the total protein synthesis. However, as the 
hepatocytes undergo maturation, the rate of AFP synthesis 
shows a continuous decline vdiich is also reflected in the 
proportionate decrease in serum AFP content. AFP synthesis 
in the hepatocytes seems to be turned off after 3 weeks of 
postnatal development. At 3 weeks postpartum i^tc of AFP 
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synthesis in the hepatocyte was only 3/0 of that observed in 
18 d gestation hepatocytes. During the same period,serum 
AFP level also declined by more than 95^. Concomitantly 
serum albumin concentration and its rate of synthesis in 
the hepatocyte shows an increase with age. It is now 
apparent that differentiation and maturation of hepatocytes 
is accompanied by a sequential switch over from APP to 
albumin as the major protein species synthesized and 
secreted by the hepatocytes. Similar conclusion has been 
drawn from the immunocytochemical localization of APP 
and albumin in the developing hepatocyte (Kuhlman, 1979j 
Nayak and Mittal, 1977). In fetal liver as much as 80/° 
hepatocytes may contain APP (Abolev, 1979). During 
postnatal development, the number of albumin producing 
cells are known to increase while APP positive cells 
exhibits a continuous decline and after 4 weeks, APP 
containing hepatocytes could no longer be detected (Kuhlman, 
1979; Nayak and Mittal, 1977). APP and albumin have been 
localized in the same hepatocyte (Kuhlman, 1979; Nayak and 
Mittal, 1977) indicating that these two proteins may be 
synthesized and secreted by the same cell. It is not clear 
whether ago related decrcaso in the rate of synthesis of 
APP reflects a simultaneous and slow decline in APP gene 
expression in all the APP synthesizing hepatocytes or API 
gene expression is sequentially turned off in different 
hepatocytes. A decrease in the number of APP positive 
hepatocytes with increas ing age seems to favour the l a t e r 
proposal . However, such a process would involve a highly 
specif ic regula tory nechanism capable of s e l ec t i ng a spec i f i c 
population of hepatocytes . 
Recently, some of the aspec ts of the regula t ion of 
AFP and albumin synthesis during development have been 
c l a r i f i e d . I t was demonstrated t h a t AFP and albumin 
synthesis i s d i r e c t l y r egu la t ed , a t the l eve l of t r ans~ 
c r i p t i o n , by con t ro l l ing the amount of mRNA of these 
prote in in the l i v e r (Liao et a l , 1980; Sa la t repa t e t a l , 
1979J Sel l e t a l , 1979; Belangor e t a l , 1979; Hofer e t a l , 
1979; Nishi e t a l , 1979;Miura e t a l , 1978; l i o et a l , 
1976; Tamaoki et a l , 1976; Koga and Tamaoki, 1974). Tho 
albumin mENA l e v e l s increase while AFP mENA l e v e l s in the 
l i v e r decl ine during pos tna ta l development and lack of AFP 
synthesis in the adult hopatocytes i s due to the absence 
of i t s mfilTA. Several condi t ions (CCl. i n t o x i c a t i o n , 
p a r t i a l hopatectomy, carcinogonesis) which induce AFP 
synthesis in the adult l i v e r have a lso boon a t t r i b u t e d t o 
a d i rec t increase in the amount of mRNA AFP (Atryzek et a l , 
1980; Liao et a l , 1980; Gommor et a l , 1979; Sala t repat 
et a l , 1979; Chiu et a l , 1979; Miura et a l , 1979; Sel l 
e t a l , 1979; Belanger et a l , 1979; Innis and Mil ler , 1979) 
r a the r than any change in t r a n s l a t i o n a c t i v i t y . However, 
the molecular mechanism responsible for r egu la t ing the AFP 
gene a c t i v i t y during normal development and 
carcinogenesis remains to be e luc ida ted . 
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AFP -m SKIN; AGE RELATED CHMGES DJ THE SKIN AFP PROFILE 
AWT> ITS RATE OF SYNTHESIS 
ThG p r e s e n t s tudy p r o v i d e s evidence t h a t e s t r a d i o l 
b ind ing p r o t e i n i n sk in c y t o s o l from d e v e l o p i n g r a t i s AFP. 
Bppenberger and Hsia (1972) have a l s o found an Ep b ind ing 
p r o t e i n i n sk in c y t o s o l w i t h a molecu la r w e i ^ t of 58,000 
d a l t o n s determined by ge l f i l t r a t i o n . We have demonstrated 
t h a t such E_ b i n d i n g p r o t e i n (AFP) a r i s e s i n sk in a s a 
r e s u l t of i t s independent s y n t h e s i s i n t h e t i s s u e . A n a l y s i s 
of t h e t o t a l p r o t e i n s s e c r e t e d i n t o the medium by newbcTrn 
skin e x p l a n t s main ta ined i n c u l t u r e r e v e a l e d t h a t AFP i s 
t h e only Ep b ind ing p r o t e i n . This conc lu s ion i s a r r i v e d 
a t from the o b s e r v a t i o n t h a t i n m u n o p r e c i p i t a t i o n of AFP by 
anti-AFP p r e c i p i t a t e d t h e Bp b ind ing p r o t e i n from both t h e 
sk in cy toso l (newborn r a t ) a s we l l a s the medium obta ined 
from newborn r a t sk in exp lan t c u l t u r e s . I t would appear 
t h a t Bp b i n d i n g p r o t e i n observed by Bppenberger and Hsia 
(1972) i s indeed AFP. They had not c h a r a c t e r i z e d Ep b i n d i n g 
p r o t e i n beyond molecu la r weight d e t e r m i n a t i o n . The 
d i s c r e p a n c i e s between our r e s u l t s and Bppenberger and Hsia 
(1972) r e g a r d i n g tbe molecu la r weight may be due to a 
d i f f e r e n c e i n t e c h n i q u e s used fo r the e v a l u a t i o n of the 
molecu la r weight of Bp b i n d i n g p r o t e i n (AFp). No o the r 
r e p o r t s a r e a v a i l a b l e r e g a r d i n g the c h a r a c t e r i z a t i o n of 
sk in B b ind ing p r o t e i n (AFp). 
Like other tissues of rat,iv!FP levels in skin also 
showed an age dependent decline with a proportionate fall 
in the rate of AFP synthesis in the tissue. During first 
two weeks of postnatal development, rate of AFP synthesis 
and its level in skin declined by 90^. It is likely that 
AFP synthesis in skin during development is also regulated 
by controlling the amount of its mMA as in other tissues. 
EXPRESSION OF AFP Aim ALBUMIN GENES IN THE DEVELOPING 
RAT BRAIN. LIVER, AND SKIN: A COMPARATIVE STUDY 
Although we have demonstrated that genes for AFP and 
albumin are expressed in developing rat brain and skin as 
well but a marked difference exists in the rate of their 
synthesis in brain, skin, and liver. 
A comparative study of the pattern of AFP synthesis 
during development revealed that it is turned off in brain, 
skin and liver after 7, 14, and 21 day of postnatal 
development, respectively. Magnitude of AFP synthesis in 
newborn rat skin, brain and liver showed a ratio of 19?2:1. 
Similarly, albumin synthesis in brain is turned off after 
1 week of postnatal life while liver shows a continuous 
increase throughout postnatal development and attaining an 
adult basal rate of albumin synthesis by about 8-9 weeks 
after birth. On the other hand, albumin is not synthesized 
in the skin. Magnitude of albumin synthesis in developing 
brain and liver showed a striking change during development, 
Ratios of the rate of albumin synthesis in liver; brain at 
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18E, 1 P and 7 P wore 1,2 and 16. It appears that the 
genos for AFP and albumin are expressed in developing liver, 
brain and skin of rat and probably regulated independently. 
An effective way of doing this would bo through the control 
of the amount of functional (translatable) mRNA^ p^p and 
mENA -,•, . available in different tissues. This concept 
albumin 
is supported by the findings of Liao et al (l980) who 
demonstrated that amount of mBITA^ p^p are different in rat 
yolk sac and liver at a specified period of postnatal 
development. Such a situation may also be valid for 
synthesis of AFP and albumin in developing brain, skin and 
liver of rat depending upon the functional requirement of 
these proteins in a given tissue. 
HORMONAL CONTROL OF AFP AND ALBUNTN HYTJTRESIS IE NEWBORN 
RAT LIVER, BRAIN, AND SKIN 
Ontogeny related decline in the rate of AFP synthesis 
in various tissues suggests that an effective mechanism 
for regulating AFP synthesis exists. Amongst different 
hormones studied, dexamethasono was the most potent 
inhibitor of AFP synthesis in hcpatocytes, brain cells and 
skin cxplants. Administration of the hormone also lead to 
a significant fall in serum AFP level in the newborn rat. 
However, response in different tissues varied significantly. 
Rate of AFP synthesis in skin explant cultures decreased by 
25f° in comparison to 45/0 and 4O'/ decline observed in 
hcpatocybe and brain cell cultures respectively. 
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Dibutyryl cAMP mediated decrease in rate of AFr 
synthesis also showed variable response in various tissues. 
It was more intense in brain cells (-155^ ) followed by 
hepatocyte (-1%) vrhile skin explants were almost refractory. 
Acceleration of the rate of decline of AFP after db&i\MP 
administration supports that the above in. vitro observation 
also holds true under in, vivo conditions for intact newborn 
rat. 
Insulin exhibited a dual effect on the rate of AFP 
synthesis in various tissues. It increased AFP synthesis 
in the hepatocyte (+21/0 and showed an opposite effect in 
brain cells (-15/0 and skin (-4^), However, insulin did 
not reveal any significant effect on serum AFP levels 
in yj.vo. Discrepancies in ^ a vivo and in. vj,tro effects of 
insulin and a differential response to various tissues is 
not clear at present. 
Because AFP in rats binds estradiol with high 
affinity and specificity, its administration is expected to 
increase AFP synthesis in various tissues in, vitro and to 
delay the normal disappearance of serum AFP in vivo. 
However, estradiol did not significantly affect the rate of 
AFP synthesis in hepatocyte and brain cells in culture. 
Similar conclusion may be drawn from the observation that 
induction of AFP synthesis in rats does not affect the 
serum estradiol (Aussel et al, 1980). However, estradiol 
caused a decrease of about lO/^  in the rate of AFp synthesis 
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in skin explants in culture which seems to be unusual on 
the basis of expected estradiol and AFP relationship. 
Dexamethasone, dbcAMP, insulin and estradiol did not 
show any significant and consistent effect on the rate of 
albumin synthesis in the hepatocyte or brain cells in 
culture. Serum levels of albumin in newborn rats were also 
not affected by these hormones. It appears that effects 
of dexamethasone, dbcAMP and insulin are specific for AFP 
synthesis. 
A few reports are available to compare the effects 
of various hormones on AFP synthesis in. vitro and in, vivo 
and that too in liver only (Bdanger et al, 1979, 1975). 
These authors also reported that exogeneously administered 
glucocorticoids, ACTH, thyroxin, adrenalin and dbcAMP load 
to premature fall in serum AFP without affecting albumin 
and total protein levels. Recently a few workers have 
tried to investigate the mechanism of hormone mediated 
control of AFP gene expression. Commer et al (1979) have 
demonstrated that suppression of AFP synthesis by 
glucocorticoids is mediated by a direct decrease in the 
amount of mRNA,^p. However, dexamethasone also showed an 
opposite effect during induction of AFP (CCl. intoxiction, 
3'-DAB carcinogenesis) and may increase serum AFP levels 
(Belanger et al, 1978). Neonatal adrenalectomy (at day 6), 
radiothyroidectomy (day 0), ovariectomy (day 5) do not 
sij^ nific-jitly .Iter the neonatal curve of serum AFP level 
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(Belanger et al, 1978), Additionally, neonatal 
adrenalectomy does not modify the effect of prednisolone 
but suppresses the response to ACTH and reduces the effect 
of thyroxine. It appears that glucocorticoids may have a 
permissive effect on thyroxine mediated regulation of AFP 
synthesis. 
However, not all aji vitro effects reproduce in 
neonatal animals in vivo. Insulin shows a stimulating effect 
on AFP production by hepatocytes but has no apparent effect 
in vivQ, Similar results have also been observed by 
Belanger et al (1979) for insulin and glucagon. Further, 
some hormones may also exhibit variable in. vitro effect on 
AFp synthesis, depending on dosage and/or culture 
conditions (Belanger et al, 1979). 
It may be stressed that the postnatal repression of 
AFP in rats normally takes place during a distinct develop-
mental stage of biochemical differentiation of the liver, 
the third postnatal week, which coincides with a complete 
expression of several hormone function (Greengard, 1973). 
It is also notable that the AFP suppressive agents 
(glucocorticoids, thyroxin, dbcAMP) are known to exert a 
number of differentiation events in various fetal and 
neonatal tissues. Glucocorticoids in particular induce 
multiple biochemical maturation processes in the liver 
(Belanger et al, 1979). How this relates to the quiescence 
of the AFP gene function remains to be clarified. The dual 
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effects of some hormone on different tissues also needs 
much, more attention, 
Althou^ a bulk of information is available on the 
course of AFP appearance in normal and abnormal development, 
exact role of AFP is far from clear (Euoslahti and Seppala, 
1979? Smith and Kelleher, 1980| Stillman and Sell, 1979). 
It is now well established that rodent AFP binds estrogens 
with high affinity and specificity (Ruoslahti and Seppala, 
1979; Nunez et al, 1979j Uriel, 1979). AFP has also been 
identified as estrogen binding protein in immature rat 
uterus (Attardi and Ruoslahti, 1977j Radanyi et al, 1977j 
Uriel et al, 1976), brain (Attardi and Ruoslahti, 1976; 
Uriel et al, 1976; McBwen et al, 1975) and bone (Chen and 
Feldman, 1978) cytosol. Our studies have also recognized 
AFP as Ep binding protein in skin. It has been proposed 
that AFP modulates the transport of estrogens in estrogen 
target tissues and may prevent the uterotrophic action of 
natural estrogen by decreasing their uterine uptake 
(Uriel, 1979; Nunez et al, 1979; Raynaud et al, 1971). 
Alternatively, AFP may also compoto with the estrogen 
metabolizing tissue enzymes (Aussel et al, 1976). Hovrcvcr, 
the physiological implications of these observations aro 
yet to be recognized. 
Estrophilic AFP is found to be distributed throughout 
fetoneonatal rat brain (Toran-Allerand, 1980; Trojan and 
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Uriel, 1979; Benno and Williams, 1978; Plapinger and 
McBven, 1975? Plapinger et al, 1973). It is known that 
sexual differentiation of rodent, which occurs during the 
early neonatal period, is influenced by steroid hormones 
(Fox et al, 1978; McBven et al, 1974). Steroid administ-
ration to females before the 10th day postnatal life has 
resulted in failure to stimulate ovulation, decreased 
behavorial responsiveness to exogenous ovarian hormones, 
and masculinization of external morphological features 
(Clemens et al, 1978; Hart, 1977). Since rodent APP avidly 
binds estrogens, it is suggested that AFP acts as estrogen 
scavanger and protects the developing female rodent brain 
against the effects of high concentration of circulating 
maternal estrogens (Trojan and Uriel, 1979; Attardi and 
Ruoslahti, 1976; Plapinger and McBven, 1975; Plapinger ct 
al, 1973). This concept is further supported by the 
observation that 'masculinization or neonatal androgeni-
zation' can also be brought about by the neutralization of 
neonatal brain AFP by its homologous antibody 
(Mizojewski ot al, 1980). However, such a function may 
not operate in human fetal brain where AFp is nonestrophilic 
in nature as observed in the present study. Induction of 
AFP in adult rats does not affect serum E concentration 
indicating that AFP is not directly related with 
circulatory B^ level (Aussel et al, 1980), These observat-
ions are compelling to consider some more general role for 
AFP. Recently, it was demonstrated that ilFP inhibits the 
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growth of B sensitive cells (Soto and Sonnenschein, 1980). 
It is possible that AFP plays a role in detorraining the 
relative growth rate of birain cell types - a phenomenon 
crucial to brain differentiation. 
The present observations reveal that skin AFP level 
are high during first two weeks of postnatal life (anagen 
phase of hair growth). Skin is not only sensitive to 
steroid hormones but also capable of transforming them to 
an active form which in turn influences cellular 
activities (Rampini et al, 1971). Administration of 
exogenous estradiol inhibits hair growth during this 
period by modulating growth rate and increasing duration 
of telophase (resting phase) (Davis, 1963). It is possible 
that AFP acts as E trap for excess of circulating 
estrogens and probably protects developing rat skin from 
the premature growth inhibitory action of estrogens. 
Overhelming evidence supports that most of the 
mammalian species (human, guinea pig, hamster, bovine, 
rabbit and chicken), unlike rodents (rat and mouse), are 
devoid of demonstrable estrogen binding (Ruoslahti and 
Scppala, 1979i Nunez et al, 1979j Uriel, 1979; Kiang ct al, 
197S; Swartz and Soloff, 1975J Savu et al, 1974). It 
would thus appear that estradiol mediated role proposed for 
AFP may not be applicable to species having nonest'rophilic 
AFP. 
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Developmental profile of Lfl' in rat and human brain 
is different. Human fetal brain AF? disappears during 
fetal life while it persists in rat, at least, upt-> 7 d 
of postnatal life. The critical hypothalamic differentiation 
is reported to occur both in rat (Toran-Allerand, 1976) 
and human (Dorner, 1978) when fetal brain AFP level is 
hi^. It is, therefore, tempting to speculate that species 
specific appearance of AFP has some, as yet unidentified, 
role in the development of mammalian brain. 
Human and rat AFP can bind a variety of small 
molecular weight ligands (fatty acids, bilirubin, 
deoxycholate, cu"*"^  and Ni"*"*" etc.) (Ruoslahti and Seppala, 
1979). It may, therefore, mediate or modulate the 
intracellular transport of these biologically active 
substances in various developing tissues. This properly 
of AFP may play an important role in differentiation 
and detoxification during development. 
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Ontogeny of tissue specific protein markers provides 
useful experimental model for investigating regulation of 
gene expression during differentiation. Alpha fetoprotein 
and albumin are important specific differentiation markers 
and they bear a reciporcal relationship during ontogeny. 
The following lines summarize the results obtained 
regarding ontogeny of AFP and albumin in different tissues 
of rat as well as developmental profile of AFP in human 
brain. 
AN IMPROVED PRQOEDURE FOR ISOLATION OF AFP 
A direct negative immunoabsorption procedure was 
developed to isolate homogeneous preparation of rat and 
human AFP from amniotic fluid. It requires no more than 
two steps: (a) removal of adult serum proteins present in 
amniotic fluid by a direct negative immunoabsorption 
(immunoprecipitation) with rabbit anti-normal adult rat 
or human serum IgG, and (b) removal of excess of immuno-
globulins using DEAE-cellulose chromatography. Purified 
AFP was characterized by double immunodiffusion, Immuno-
electrophoresis, crossed immunoelectrophoresis, PAGE, 
SDS-PAG-E, Con-A affinity chromatography, and estradiol 
binding. Rat AFP has Ka = I.4 x 10® M"-*" for estradiol-17p 
with one binding site for estradiol per mole of AFP. 
Isolation of homogeneous AFP by a direct negative 
immunoabsorption is a significant improvement over the time 
consuming, multistep procedures reported for AFP. In 
1 O v^ > 
a d d i t i o n , t h e p r e s e n t p rocedu re d id no t r e q u i r e s p e c i f i c 
an t i s e rum a g a i n s t AFP and employed ve ry g e n t l e i s o l a t i n g 
c o n d i t i o n s . The p rocedure y i e l d e d 87^ recovery of AFP. 
ONTOGENY MJ) DISTRIBUTION OF AFP M FETO-NEONATAL TISSUES 
OF EIiT AND HUMkN FETAL BRATN 
Most of the f e t o - n e o n a t a l t i s s u e s , e x c e p t thymus, 
sp l een and p a n c e r a s , of r a t were found to c o n t a i n e l e v a t e d 
l e v e l s of AFP, H i ^ l e v e l s of AFP observed d u r i n g f e t a l 
l i f e i n v a r i o u s t i s s u e s r e g i s t e r e d a d e c l i n e wi th 
development . Ontogeny of AFP i n t h e s e t i s s u e s was 
d i f f e r e n t from t h a t observed in serum. AFP d i s a p p e a r s 
a f t e r 7 d of p o s t n a t a l l i f e (P) i n b r a i n and a d r e n a l s ; 
14 P i n l u n g , h e a r t , s tomach, i n t e s t i n a l and k idneyj 21 P 
i n l i v e r and s k i n . De t e rmina t i on of heme c o n c e n t r a t i o n i n 
t h e s e t i s s u e e x t r a c t r e v e a l e d t h a t con tamina t ion of AFP 
from f e t a l blood could no t account f o r more than 5-10;^ of 
t h e observed l e v e l s of AFP i n v a r i o u s f e t o - n e o n a t a l 
t i s s u e s of r a t . 
AFP p r e s e n t i n v a r i o u s f e t o - n e o n a t a l t i s s u e s of r a t 
was immunological ly i d e n t i c a l t o serum AFP, AFP from 
serum, b r a i n , sk in and k idney a l s o d i s p l a y e d a s i m i l a r 
e l e c t r o p h o r e t i c m o b i l i t y on lO/o PAGE and lEP. E s t r a d i o l 
b i n d i n g assay of AFP i n b r a i n and sk in gave an a s s o c i a t i o n 
c o n s t a n t , Ka = 1.3 x 10® M"""" and 1.0 x 10® M*"-"-. However, 
b r a i n and s k i n c y t o s o l s from newborn r a t were found t o 
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d i f f e r in the r e l a t i v e amounts of Con A-non r eac t ive AFP 
va r i an t and contained yjlo and 42^ of t h i s va r i an t 
r e s p e c t i v e l y . In view of these observations i t appears 
t h a t AFP in var ious fe to-neonata l t i s s u e s of r a t does not 
e n t i r e l y represent f e t a l blood contamination and probably 
a r i s e s as a r e s u l t of i t s independent synthes is in each 
t i s s u e . 
Studies on the d i s t r i b u t i o n of AFP in fe to-neonatal 
r a t brain have revealed t h a t i t i s d i s t r i b u t e d uniformally 
throughout the b r a in . Ontogeny of AFP in olfactory region, 
cerebrurm, cerebellum and r e s t port ions of the ra t brain 
was s imi lar to t ha t in whole brain and i t disappeared in 
these d i s c r e t e regions a f t e r 7 d of pos tna ta l development. 
Presence of AFP was also demonstrated in human f e t a l 
b r a i n . I t was immunologically and e l ec t rophore t i ca l l y 
i d e n t i c a l t o human f e t a l serum AFP. Developmental p ro f i l e 
of AFP in human brain was d i s t i n c t from tha t observed in 
serum compartment. I t r e g i s t e r e d a peak l e v e l in brain a t 
20th week and declined rap id ly to low l e v e l s a f t e r 24th week 
of ges t a t ion . I t was absent (as measured by rocket assay) 
i n the human f e t a l bra in of subsequent ages . Unlike rodent 
AFP and l i k e human ilFP, i t did not i n t e r a c t with 
e s t r a d i o l . Brain AFP does not a r i se from f e t a l blood 
contamination since the blood contamination could account 
for t r a c e s of the AFP present in b ra in . Fur ther ontogeny 
or AFP in brain i s d i s t i n c t from tha t obseipved in serum. 
1 '^  
DBVTiLQPMENTAL CH/iN&ES IN / J P /JTD /iLBUMIN CONTENT IN 
s m J M OF M T 
D e v e l o p m e n t a l p r o f i l e o f serum AFP e x h i b i t e d a n 
i n v e r s e r e l a t i o n s h i p w i t h a g e d u r i n g p o s t n a t a l l i f e of r a t . 
Serum AFP l e v e l d e c l i n e d a f t e r b i r t h t o 2»^1°ot t h e l e v e l 
o b s e r v e d i n newborn r a t , a t 2 l s t day of p o s t n a t a l l i f e . 
AFP cou ld n o t be d e t e c t e d i n s e r a of 28 d o ld r a t s by t h e 
p r e s e n t p r o c e d u r e . I n c o n t r a s t se rum a l b u m i n e l i c i t e d an 
i n c r e a s e by 57/° d u r i n g t h e same p e r i o d . The a l b u m i n l e v e l 
r o s e i n serum c o n t i n u o u s l y t o a d u l t v a l u e of 5 7 . 5 mg ml 
i n 9 weeks o l d r a t , 
SYNTHESIS AND SEORETION OF AFP M P ALBUMIN BY ISOLATED 
HEPATOCYTES IN OULTURE: GORBELATION OF SERUM AFP M P 
ALBUMIN PROFILES WITH THE LIVER CONTENT AND THEIR R^ i^TE 
OF SYNTHESIS IN THE HEPATOCYTES DURING DEVELOPMENT 
AFP and a l b u m i n a r e s y n t h e s i z e d i n t h e h e p a t o c y t e 
and s e c r e t e d i n t o t h e s e r u m . Serum l e v e l of t h e s e p r o t e i n s 
u n d e r g o e s s t r i l d . n g change d u r i n g f e t o n e o n a t a l d e v e l o p m e n t . 
H e p a t o c y t e s p r e p a r e d from r a t l i v e r a t v a r i o u s s t a g e s 
of deve lopmen t ( 1 8 , 20 E and 1 , 7 , 1 4 , 2 1 , 2 8 , 35 P and 
a d u l t ) by c o l l e a g e n a s e d i g e s t i o n p r o c e d u r e were m a i n t a i n e d 
i n s h o r t t e r m ( 2 4 h r s ) c u l t u r e . R a t e of s y n t h e s i s and 
s e c r e t i o n of AFP and a l b u m i n were d e t e r m i n e d by f o l l o w i n g 
t h e i n c o r p o r a t i o n of [ C ] - l e u c i n e i n t o i m m u n o p r e c i p i t a b l e 
ilFP and a l b u m i n by t h e h e p a t o c y t e s c u l t u r e d i n l e u c i n e - f r e e 
medium. H e p a t o c y t e s from newborn r a t s y n t h e s i z e d AFP a t a 
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very high r a t e accounting for about 85?° of the t o t a l 
protein synthes is while albumin synthesis was only 99&, 
Rate of AFP synthesis and secre t ion declined with the 
maturation of the hepatocytes , Hepatocytes from 21 d old 
r a t demonstrated only 3?^  of the r a t e observed in f e t a l 
hepatocyte from 18 E r a t . No synthesis of APP could be 
demonstrated in the hepatocytes prepared from 4 week old 
r a t s . Serum AFP l e v e l and i t s content in l i v e r a lso 
reduced to I.3/0 and ^1o r espec t ive ly in 3 week old r a t when 
compared to the values observed in 18 E f e t a l r a t s . I t 
appears t h a t age r e l a t e d change in serum AFP leve l and i t s 
content in l i v e r i s governed by the r a t e of AFP synthesis 
and secret ion by the developing hepatocytes . 
Maturation of the hepatocyte was accompanied by a 
marked increase in the r a t e of albumin syn thes i s , secre t ion 
and i t s i n t r a c e l l u l a r content . Ratios of the r a t e s of 
albumin t o AFP synthesis in the hepatocytes from 18 E fetus 
and 1, 7, 14, 21, 28 d old neonatal r a t s were 0.05, 0.10, 
0 .28, 3,5 and 48 r e s p e c t i v e l y . I t would thus appear t h a t 
an increase in serum albumin leve l and i t s i n t r ahepa t i c 
content i s due to a propor t ionate increase in the r a t e of 
albumin synthesis and sec re t ion in the developing r a t 
l i v e r . 
I t nay be concluded t h a t d i f f e r e n t i a t i o n and maturation 
of the hepatocyte i s accompanied by a sequent ia l i nac t i va t i on 
of AFP and ac t iva t ion of albumin ^QTXQ express ion. 
l^'J 
pT;;]VT9TSrc^ TRi.TI0N OF AFP MT) ALRTTMIW SYNTHESIS CT DEVELOPMa 
RAT BRAIN ixl^ D SKINr CORRELATION OF TISSUE CONTENT OF AFP 
ANB ALfflTMIN WITH THEIR R/.TE OF SYNTHESIS 
D i s s o c i a t e d mammalian "brain c e l l s and sk in e x p l a n t s 
i n primary c u l t u r e s o f f e r s a u s e f u l system t o i n v e s t i g a t e 
t h e b iochemical e v e n t s accompanying d i f f e r e n t i a l ! and growth 
of t h e s e t i s s u e s . D i s s o c i a t e d b r a i n c e l l s and sk in explan t 
c u l t u r e s from newborn r a t were used t o answer the fo l lowing 
q u e s t i o n s : I s e s t r a d i o l b i n d i n g p r o t e i n i n deve lop ing r a t 
b r a i n and sk in AFP ? I f s o , where does t h i s p r o t e i n 
o r i g i n a t e from ? 
Our o b s e r v a t i o n s , d e r i v e d from f C ] - l e u c i n e 
i n c o r p o r a t i o n i n t o immunoprec ip i tab le AFP and albumin by 
d i s s o c i a t e d b r a i n c e l l s and sk in exp lan t main ta ined i n sho r t 
term c u l t u r e s , have p rov ided ev idence fo r the s y n t h e s i s of 
AFP and albumin i n b r a i n and s k i n of newborn r a t , 
Cyclohexinide i n h i b i t e d the l i n e a r i n c o r p o r a t i o n of [ C ] -
l e u c i n e i n t o immunoprec ip i tab le AFP and albumin a s a 
func t ion of t ime by t h e s e c u l t u r e s . I t s t r o n g l y sugges t s 
t h a t [ ^ C ] - l a b e l l e d /iFP and albumin observed i n b r a i n c e l l s 
and sk in l y s a t e s ( s y n t h e s i s ) and i n medium ( s e c r e t i o n ) a r e 
c o n s t a n t l y syn thes i zed and s e c r e t e d by t h e s e c u l t u r e s . In 
a d d i t i o n , the i n t r a c e l l u l a r con ten t of both AFP and albumin 
i n b r a i n c e l l s did n o t change s i g n i f i c a n t l y d u r i n g t h e vrhole 
c u l t u r e p e r i o d . Moreover, t h e s e c e l l s e l i c i t e d a l i n e a r 
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accumulation (secretion) of the quantitable amounts of 
AFP and albumin into the medium. Total amounts of AFP and 
albumin secreted by brain cells were far in excess of their 
intracellular content at the initiation of the cultures. In 
view of these observations it was concluded that developing 
brain and skin represent sua independent pool of AFP and 
albumin, 
AFP and albumin secreted by newborn rat brain cells 
and skin explants cultures was immunologically, electro-
phoretically and with regards to molecular weights and 
estradiol binding properties similar to serum AFP and 
albumin. It may be concluded that genes for /iFP and albumin 
in developing brain and for AFP in skin are also oxproased 
these tissues. 
Rates of synthesis of AFP and albumin during feto-
neonatal development of rat brain showed a continuous 
decline and their synthesis seems to bo turned off after 7 d 
of postnatal life. H i ^ levels of these protein in fetal 
brain were due to their high rates of qynthesis, Age 
related decrease in brain AFP and albumin reflected a 
proportionate decrease in the rates at which they are 
synthesized in this tissue. 
Rate of synthesis of AFP in skin also decreased with 
increasing age and its synthesis is turned off after 14 d of 
postnatal life. A decrease in the skin AFP level can be 
accounted for by corresponding decline in the rate of its 
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synthesis in the developing skin. It may be concluded that 
intracellular levels of AFP aJid albumin in rat brain and 
AFP in rat skin reflect their rate of q7nthesis in these 
tissues. It is tempting to speculate, at this stage, that 
human brain also synthesize AFP, 
EXPRESSION OF AFP AND ALBUMIN GENES TO THE DEVELOPING 
RAT LIVER. BRAIN. AND SKIN; A COMPARATIVE STUDY 
A comparative study of the patterns of AFp synthesis 
during development revealed that it is turned off in rat 
brain, skin and liver after 7, 14, 21 d of postnatal 
development. The rate of AFP synthesis in newborn rat 
liver, brain and dc in exhibited a ratio of 19:2:1. Albumin 
synthesis in the brain is tuined off after 1 week of post-
natal life while liver shows a continuous increase in the 
rate of albumin synthesis throughout postnatal development 
and attains adult basal level by about 8-9 weeks after 
birth. On the other hand, albumin is not ^nthesized in 
the skin. Rate of the albumin synthesis in liverj brain in 
18 B, 1 P and 7 p were 1,2 and 16. It appears that genes 
for AFP and albumin are expressed in developing rat liver, 
brain and skin and probably regulated independently 
depending upon the functional requirement of these proteins 
in the developing tissues. 
J4: 
HOBMQWAL CONTROL OF AFP MT) /iLRUMIN RYlTTHEFilS IN NEWBORN 
RAT LIVER. BRAIN AND SKIN 
JBffect of various hormones on the r a t e of AFP and 
albumin synthesis in the hepatocytes , brain c e l l s and skin 
explant from newborn r a t s , was studied to gain some ins ight 
i n t o ontogeny r e l a t ed r egu la t ion of synthes is of these 
p ro te ins in r a t t i s s u e s , 
Dexamethasone was the most e f fec t ive in i n h i b i t i n g the 
r a t e of /iFP synthes is and secre t ion in v i t r o cu l tu res of 
hepatocytes (-45^0» brain c e l l s (-40/°) and skin explant 
(-25/0» I"t a lso caused an accelera ted decrease in serum AFP 
l e v e l j j i vivo in newborn r a t s . dbcAMP also decreased the 
r a t e of synthesis and sec re t ion of AFP in bra in c e l l s ( -15/0, 
hepatocytes (-7/0 and skin explants (-4/O. I t a l so 
suppressed the serum AFP l eve l in vivp in newborn r a t s 
supporting i t s in. v i t r o e f f e c t . 
Insu l in exhibi ted a dual effect on the r a t e of /iFP 
synthesis in var ious t i s s u e s . I t increased AFP synthes is in 
hepatocytes (+21^) and demonstrated an opposi te effect in 
bra in c e l l (-15?0 and skin explant (-4/0* However, i t did 
not affect serum AFP l e v e l s of newborn r a t s ir^. v i v o . 
Neither did e s t r a d i o l s i gn i f i can t ly affect the r a t e of 
ilFp synthesis in var ious t i s s u e s in v i t r o nor did i t change 
serum AFP l eve l in v i v o . The ef fec ts of dexamethasone, 
dbcAMP, in su l in and e s t r a d i o l on the r a t e of albumin 
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synthesis in vitro or its level in vivo were not significant. 
It appears that effects of these hormones are specific for 
AFP synthesis. 
It appears that expression of AFP gene is a function 
of undifferentiated or less differentiated stem cells or 
embryonal cells. Different embryonal cell types with diverse 
ontogenic history do indeed synthesize AFP although the 
extent of synthesis is different. Thus expression of AFp 
and albumin genes during development offer a useful model 
for investigating molecular mechanism underlying tissue 
dif f erent i at ion, 
